
<html lang="en"     class="pb-page"  data-request-id="491495a8-c675-40ae-aa65-3eb90023bc4f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b00397;issue:issue:10.1021/jmcmar.2017.60.issue-13;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor" /></meta><meta name="dc.Creator" content="Christopher J.  Helal" /></meta><meta name="dc.Creator" content="Eric P.  Arnold" /></meta><meta name="dc.Creator" content="Tracey L.  Boyden" /></meta><meta name="dc.Creator" content="Cheng  Chang" /></meta><meta name="dc.Creator" content="Thomas A.  Chappie" /></meta><meta name="dc.Creator" content="Kimberly F.  Fennell" /></meta><meta name="dc.Creator" content="Michael D.  Forman" /></meta><meta name="dc.Creator" content="Mihaly  Hajos" /></meta><meta name="dc.Creator" content="John F.  Harms" /></meta><meta name="dc.Creator" content="William E.  Hoffman" /></meta><meta name="dc.Creator" content="John M.  Humphrey" /></meta><meta name="dc.Creator" content="Zhijun  Kang" /></meta><meta name="dc.Creator" content="Robin J.  Kleiman" /></meta><meta name="dc.Creator" content="Bethany L.  Kormos" /></meta><meta name="dc.Creator" content="Che-Wah  Lee" /></meta><meta name="dc.Creator" content="Jiemin  Lu" /></meta><meta name="dc.Creator" content="Noha  Maklad" /></meta><meta name="dc.Creator" content="Laura  McDowell" /></meta><meta name="dc.Creator" content="Scot  Mente" /></meta><meta name="dc.Creator" content="Rebecca E.  O’Connor" /></meta><meta name="dc.Creator" content="Jayvardhan  Pandit" /></meta><meta name="dc.Creator" content="Mary  Piotrowski" /></meta><meta name="dc.Creator" content="Anne W.  Schmidt" /></meta><meta name="dc.Creator" content="Christopher J.  Schmidt" /></meta><meta name="dc.Creator" content="Hirokazu  Ueno" /></meta><meta name="dc.Creator" content="Patrick R.  Verhoest" /></meta><meta name="dc.Creator" content="Edward X.  Yang" /></meta><meta name="dc.Description" content="Phosphodiesterase 2A (PDE2A) inhibitors have been reported to demonstrate in vivo activity in preclinical models of cognition. To more fully explore the biology of PDE2A inhibition, we sought to id..." /></meta><meta name="Description" content="Phosphodiesterase 2A (PDE2A) inhibitors have been reported to demonstrate in vivo activity in preclinical models of cognition. To more fully explore the biology of PDE2A inhibition, we sought to id..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 16, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00397" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00397" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00397" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00397" /></link>
        
    
    

<title>Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00397" /></meta><meta property="og:title" content="Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0049.jpeg" /></meta><meta property="og:description" content="Phosphodiesterase 2A (PDE2A) inhibitors have been reported to demonstrate in vivo activity in preclinical models of cognition. To more fully explore the biology of PDE2A inhibition, we sought to identify potent PDE2A inhibitors with improved brain penetration as compared to current literature compounds. Applying estimated human dose calculations while simultaneously leveraging synthetically enabled chemistry and structure-based drug design has resulted in a highly potent, selective, brain penetrant compound 71 (PF-05085727) that effects in vivo biochemical changes commensurate with PDE2A inhibition along with behavioral and electrophysiological reversal of the effects of NMDA antagonists in rodents. This data supports the ability of PDE2A inhibitors to potentiate NMDA signaling and their further development for clinical cognition indications." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00397"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00397">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00397&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00397&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00397&amp;href=/doi/10.1021/acs.jmedchem.7b00397" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 5673-5698</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00352" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00426" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.8b00475"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Helal">Christopher J. Helal</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-9091-2091" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+P.++Arnold">Eric P. Arnold</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tracey+L.++Boyden">Tracey L. Boyden</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheng++Chang">Cheng Chang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+A.++Chappie">Thomas A. Chappie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kimberly+F.++Fennell">Kimberly F. Fennell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+D.++Forman">Michael D. Forman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mihaly++Hajos">Mihaly Hajos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+F.++Harms">John F. Harms</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+E.++Hoffman">William E. Hoffman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+M.++Humphrey">John M. Humphrey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhijun++Kang">Zhijun Kang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robin+J.++Kleiman">Robin J. Kleiman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bethany+L.++Kormos">Bethany L. Kormos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Che-Wah++Lee">Che-Wah Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiemin++Lu">Jiemin Lu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Noha++Maklad">Noha Maklad</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura++McDowell">Laura McDowell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>+</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scot++Mente">Scot Mente</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rebecca+E.++O%E2%80%99Connor">Rebecca E. O’Connor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jayvardhan++Pandit">Jayvardhan Pandit</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary++Piotrowski">Mary Piotrowski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne+W.++Schmidt">Anne W. Schmidt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Schmidt">Christopher J. Schmidt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hirokazu++Ueno">Hirokazu Ueno</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>□</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick+R.++Verhoest">Patrick R. Verhoest</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edward+X.++Yang">Edward X. Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 860-715-5064. E-mail: <a href="/cdn-cgi/l/email-protection#95f6fde7fce6bbffbbfdf0f9f4f9d5e5f3fceff0e7bbf6faf8"><span class="__cf_email__" data-cfemail="cfaca7bda6bce1a5e1a7aaa3aea38fbfa9a6b5aabde1aca0a2">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00397&amp;href=/doi/10.1021%2Facs.jmedchem.7b00397" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 5673–5698</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 2, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 March 2017</li><li><span class="item_label"><b>Published</b> online</span>16 June 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 July 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00397" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00397</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5673%26pageCount%3D26%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChristopher%2BJ.%2BHelal%252C%2BEric%2BP.%2BArnold%252C%2BTracey%2BL.%2BBoyden%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D13%26contentID%3Dacs.jmedchem.7b00397%26title%3DApplication%2Bof%2BStructure-Based%2BDesign%2Band%2BParallel%2BChemistry%2Bto%2BIdentify%2Ba%2BPotent%252C%2BSelective%252C%2Band%2BBrain%2BPenetrant%2BPhosphodiesterase%2B2A%2BInhibitor%26numPages%3D26%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5698%26publicationDate%3DJuly%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00397"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2326</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">20</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00397" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Helal&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;P. Arnold&quot;},{&quot;first_name&quot;:&quot;Tracey&quot;,&quot;last_name&quot;:&quot;L. Boyden&quot;},{&quot;first_name&quot;:&quot;Cheng&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;A. Chappie&quot;},{&quot;first_name&quot;:&quot;Kimberly&quot;,&quot;last_name&quot;:&quot;F. Fennell&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;D. Forman&quot;},{&quot;first_name&quot;:&quot;Mihaly&quot;,&quot;last_name&quot;:&quot;Hajos&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;F. Harms&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;E. Hoffman&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;M. Humphrey&quot;},{&quot;first_name&quot;:&quot;Zhijun&quot;,&quot;last_name&quot;:&quot;Kang&quot;},{&quot;first_name&quot;:&quot;Robin&quot;,&quot;last_name&quot;:&quot;J. Kleiman&quot;},{&quot;first_name&quot;:&quot;Bethany&quot;,&quot;last_name&quot;:&quot;L. Kormos&quot;},{&quot;first_name&quot;:&quot;Che-Wah&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Jiemin&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Noha&quot;,&quot;last_name&quot;:&quot;Maklad&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;McDowell&quot;},{&quot;first_name&quot;:&quot;Scot&quot;,&quot;last_name&quot;:&quot;Mente&quot;},{&quot;first_name&quot;:&quot;Rebecca&quot;,&quot;last_name&quot;:&quot;E. O’Connor&quot;},{&quot;first_name&quot;:&quot;Jayvardhan&quot;,&quot;last_name&quot;:&quot;Pandit&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Piotrowski&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;W. Schmidt&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Schmidt&quot;},{&quot;first_name&quot;:&quot;Hirokazu&quot;,&quot;last_name&quot;:&quot;Ueno&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;R. Verhoest&quot;},{&quot;first_name&quot;:&quot;Edward&quot;,&quot;last_name&quot;:&quot;X. Yang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;5673-5698&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00397&quot;},&quot;abstract&quot;:&quot;Phosphodiesterase 2A (PDE2A) inhibitors have been reported to demonstrate in vivo activity in preclinical models of cognition. To more fully explore the biology of PDE2A inhibition, we sought to identify potent PDE2A inhibitors with improved brain penetration as compared to current literature compounds. Applying estimated human dose calculations while simultaneously leveraging synthetically enabled chemistry and structure-based drug design has resulted in a highly potent, selective, brain penetrant compound 71 (PF-05085727) that effects in vivo biochemical changes commensurate with PDE2A inhibition along with behavioral and electrophysiological reversal of the effects of NMDA antagonists in rodents. This data supports the ability of PDE2A inhibitors to potentiate NMDA signaling and their further development for clinical cognition indications.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00397&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00397" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00397&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00397" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00397&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00397" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00397&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00397&amp;href=/doi/10.1021/acs.jmedchem.7b00397" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00397" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00397" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00397%26sid%3Dliteratum%253Aachs%26pmid%3D28574706%26genre%3Darticle%26aulast%3DHelal%26date%3D2017%26atitle%3DApplication%2Bof%2BStructure-Based%2BDesign%2Band%2BParallel%2BChemistry%2Bto%2BIdentify%2Ba%2BPotent%252C%2BSelective%252C%2Band%2BBrain%2BPenetrant%2BPhosphodiesterase%2B2A%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D13%26spage%3D5673%26epage%3D5698%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291236" title="Silica gel chromatography">Silica gel chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/jmcmar.2017.60.issue-13/20170713/jmcmar.2017.60.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0049.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0049.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Phosphodiesterase 2A (PDE2A) inhibitors have been reported to demonstrate in vivo activity in preclinical models of cognition. To more fully explore the biology of PDE2A inhibition, we sought to identify potent PDE2A inhibitors with improved brain penetration as compared to current literature compounds. Applying estimated human dose calculations while simultaneously leveraging synthetically enabled chemistry and structure-based drug design has resulted in a highly potent, selective, brain penetrant compound <b>71</b> (PF-05085727) that effects in vivo biochemical changes commensurate with PDE2A inhibition along with behavioral and electrophysiological reversal of the effects of NMDA antagonists in rodents. This data supports the ability of PDE2A inhibitors to potentiate NMDA signaling and their further development for clinical cognition indications.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31723" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31723" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Phosphodiesterases (PDEs) are enzymes that catalyze the hydrolysis of the key second messenger cyclic nucleotides cAMP and cGMP to their respective acyclic variants (AMP, GMP). PDE inhibitors have demonstrated therapeutic potential for a range of conditions such as pulmonary hypertension (sildenafil, PDE5 inhibitor), erectile dysfunction (sildenafil, vardenafil, tadalafil, PDE5 inhibitors), chronic obstructive pulmonary disease (roflumilast, PDE4 inhibitor), psoriasis and psoriatic arthritis (apremilast, PDE4 inhibitor), and heart failure (milrinone, PDE3 inhibitor), reflecting the wide range of biological functions regulated by cyclic nucleotide signaling. The abundant expression of PDEs in the human brain, coupled with a requisite role for cyclic nucleotides in neurotransmission and synaptic plasticity, has prompted efforts to discover PDE selective inhibitors with brain penetration suitable for treating neurological and psychiatric disorders. Brain penetrant clinical candidates have been disclosed as inhibitors for PDE10A for the treatment of schizophrenia and Huntington’s Disease<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> as well as PDE9A inhibitors for treatment of cognitive disorders.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a></div><div class="NLM_p last">Inhibitors of PDE2A have been reported to demonstrate activity in a variety of preclinical models that are suggestive of cognitive improvement. This includes enhanced performance in rodent novel object recognition and social recognition tasks and a reversal of performance deficits produced by treatment with the <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate (NMDA) antagonist MK-801 in the alternating T-maze.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> These behavioral effects are consistent with reports of enhanced hippocampal long-term potentiation, a measure of synaptic plasticity thought to underpin some forms of learning and memory. Additional data suggests that PDE2A inhibitors can reverse anxiolytic behavior in mice via cGMP-mediated processes.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> This aggregate information encouraged our investment in the discovery of potent, selective, and brain penetrant PDE2A inhibitors to more effectively probe the potential of this class of molecules to treat a range of neurological disorders. For medicinal chemistry lead optimization, tracking binding efficiency and minimizing estimated human dose were supported by structure-based drug design and parallel synthesis strategies.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10876" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10876" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The potent imidazotriazinone PDE2A inhibitor <b>1</b> ((BAY 60-7550), PDE2A IC<sub>50</sub> = 0.5 nM (our assay), 4.7 nM (literature assay)<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a>) has most often been used to explore the pharmacology of PDE2A inhibition<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). A ligand efficiency (LE)<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> of 0.37 (based upon our assay) indicated a high binding efficiency, and a lipophilic ligand efficiency (LLE)<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> of 6.7 placed <b>1</b> in a range comparable to clinical candidates with a desirable balance between potency and lipophilicity. Selectivity of <b>1</b> for PDE2A as compared to PDE1B (PDE1B IC<sub>50</sub>/PDE2A IC<sub>50</sub>) was ca. 500-fold and significantly higher for all other PDEs (PDE3A/4D/5-11). ADME measurements revealed <b>1</b> to have high human liver microsome (HLM) clearance as represented by the apparent intrinsic clearance (HLM CL<sub>int</sub>), short half-life (<i>t</i><sub>1/2</sub>) in rat liver microsomes (3 min), and significant efflux in a P-glycoprotein (P-gP) multidrug resistance protein (MDR1) overexpressing cell line, which is indicative of high probability of impaired brain penetration.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Potency, Selectivity, and in Vitro ADME Properties of PDE2A Inhibitor <b>1</b> (<b>1</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0024.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0025.gif" alt="" id="GRAPHIC-d50e493-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Values represent the HLM C<sub>lint</sub>, apparent scaled (mL/min/kg).</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">AB = apical to basolateral; BA = basolateral to apical.</p></div></div><div></div></div><div class="NLM_p">While <b>1</b> is a sufficient PDE2A inhibitor tool compound for in vitro studies, in vivo exposure both peripherally and in brain would be predicted to be poor. Indeed, low in vivo brain exposure has been reported recently<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and was corroborated in similar experiments by us (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00397/suppl_file/jm7b00397_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p">An X-ray crystal structure of <b>1</b> bound to PDE2A was determined which showed the binding mode in the active site and allowed development of a plausible hypothesis to explain the selectivity profile of <b>1</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). This crystal structure, determined independently, is isomorphous to the one described by Zhu  et al.,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> with an rms deviation of 0.39 Å for all backbone Cα atoms. We highlight here the critical features of the structure that we exploited in our subsequent medicinal chemistry design strategy. An induced pocket is seen, formed by the movement of Leu770, which accommodates binding of the propylphenyl group. The induced pocket, lined by mainly hydrophobic residues (Leu770, Leu809, Ile870, His773, and Leu774) had not previously been observed in any PDE structure and is absent in all the previous PDE2 crystal structures we had determined. We hypothesized that compounds capable of inducing this conformational change in PDE2 would retain the relatively high PDE selectivity of <b>1</b>. The conserved glutamine at the back of the binding pocket (Gln859) makes a pair of hydrogen bonds with the imidazotriazinone core C═O(NH). Gln859 assumes the same rotamer as it would if bound to cGMP. A water molecule that is bound by the side chain of Tyr655 and backbone carbonyl of Asp808 donates a hydrogen bond to N-6 of <b>1</b>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0001.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray structure of <b>1</b> bound to PDE2A cyclic nucleotide binding site (hydrogen bond distances in Å). Polar hydrogen atoms used in in silico docking calculations have been indicated in their modeled positions in this and all other figures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of the challenges with modifying <b>1</b> to attain the desired alignment of potency, selectivity, and ADME parameters, alternative PDE2A inhibitor lead matter was sought. High-throughput screening identified two novel series of PDE2A inhibitors: a pyrazolo[3,4-<i>d</i>]pyrimidine series (<b>2</b>) and a [1,2,4]triazolo[4,3-<i>a</i>]pyrazine series (<b>3</b>) (<a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Both <b>2</b> and <b>3</b> lacked the HBDs in <b>1</b> that potentially contributed to the observed efflux in the MDR1 BA/AB assay, resulting in poor in vivo brain penetration. Our goal was to achieve equivalent potency to <b>1</b> and equally high (or higher PDE selectivity) with these new series during lead development while maintaining the CNS-penetration favoring physical properties.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Potency, Selectivity, in Vitro ADME, and Physical Properties of Series <b>2</b> and <b>3</b> Identified via a PDE2A High Throughput Screen</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0026.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Estimated human dose (mg/day) = (10 × PDE2A IC<sub>50</sub> × HLM CL<sub>int</sub> × 24 h × 70 kg) × (MDR1 BA/AB); see <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a></p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. PDE Selectivity Profiles of <b>2</b> and <b>3</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0028.gif" alt="" id="GRAPHIC-d50e625-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">PDE selectivity is measured as the ratio of PDEX IC<sub>50</sub>/PDE2A IC<sub>50</sub>.</p></div></div><div></div></div><div class="NLM_p">Another goal of the lead optimization process was to minimize the estimated human dose because higher human drug dosages are strongly correlated with idiosyncratic adverse drug reactions.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The equation used for estimating the human dose for a brain targeted compound is shown in <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a> (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00397/suppl_file/jm7b00397_si_001.pdf" class="ext-link">Supporting Information</a> for derivation).<span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/jm-2017-00397j_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span></div><div class="NLM_p">In <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>, Tau is defined as the dosing duration (24 h or 1440 min) and BW is typical human bodyweight (70 kg).</div><div class="NLM_p">In the case of <b>2</b>, the estimated human dose projected by using this method afforded a value of 8787 mg/day. For <b>3</b>, the estimated human dose was >44142 mg/day. In both cases, it was clear that significant reductions in PDE2A IC<sub>50</sub> and HLM Cl<sub>int</sub> would be necessary while minimizing MDR1 BA/AB values to get to the desired target of estimated human dose <100 mg/day.</div><div class="NLM_p">To understand the critical binding elements for each series, PDE2A protein X-ray crystal structures were sought with compounds <b>2</b> and <b>3</b> bound. Compound <b>3</b> yielded a high-resolution crystal structure with PDE2A (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>a), but attempts at obtaining an X-ray crystal structure of <b>2</b> with PDE2A were not successful. Efforts with a related compound <b>4</b> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), with a similar PDE inhibition profile as <b>2</b> that was identified via initial lead optimization efforts, were successful (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0002.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) X-ray crystal structure of <b>3</b> bound to PDE2A cyclic nucleotide binding site (hydrogen bond distances in Å). (b) X-ray crystal structure of <b>4</b> bound to PDE2A cyclic nucleotide binding site (hydrogen bond distances in Å). (c) Overlap of PDE2A X-ray crystal structures of <b>3</b> (cyan) and <b>1</b> (blue). (d) Overlap of PDE2A X-ray crystal structures of <b>4</b> (yellow) and <b>1</b> (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. PDE2A Potency and PDE Selectivity Profile of <b>4</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0029.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0030.gif" alt="" id="GRAPHIC-d50e809-autogenerated" /></img><div></div></div><div class="NLM_p">The core heteroaromatic ring systems of <b>3</b> and <b>4</b> occupy roughly the same space as the corresponding imidazotriazinone ring system in <b>1</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>c,d). For a dual-specificity phosphodiesterase such as PDE2A, Gln859 is proposed to act as a switch, capable of freely rotating so as to form hydrogen bonds either with the exocyclic amino group of cAMP or the exocyclic carbonyl oxygen of cGMP.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In the structures of <b>3</b> and <b>4</b>, Gln859 must be in a flipped orientation relative to that seen in the structure of <b>1</b> to allow for optimal protein–ligand interactions with N-7 of <b>3</b> and N-5 of <b>4</b>.</div><div class="NLM_p">A second major difference is that <b>3</b> and <b>4</b> do not induce the conformational change in Leu770, which leads to the formation of the selectivity pocket, occupied by the phenpropyl moiety in <b>1</b>.</div><div class="NLM_p">In all three crystal structures, substituents on the core extend toward the protein surface. The methoxy phenyl groups in <b>3</b> and <b>4</b> extend out of the substrate-binding site and are oriented approximately perpendicular to the core ring, making an edge-to-face interaction with Phe862. These hydrophobic groups occupy a shallow channel on the surface of the protein, sandwiched between the side chains of Phe862 and Ile866 on one side and Phe830 and Met847 on the other side (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>a,b). An important observation is that the methoxy phenyl substituents on <b>3</b> and <b>4</b> would clash with Leu770 if it were to assume the “out” rotamer needed to create the selectivity pocket (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>c,d).</div><div class="NLM_p">Another common interaction is that of a core ring nitrogen (<b>1</b>, N6; <b>3</b>, N2; <b>4</b>, N2) with the structural water molecule which interacts with the side chain of Tyr655 and the backbone carbonyl of Asp808. All three compounds also have substituents (<b>1</b>, 2-hydroxyethyl; <b>3</b> and <b>4</b>, <i>i</i>Bu) which occupy a pocket that is filled by the ribose of cyclic nucleotides.</div><div class="NLM_p">Binding features unique to <b>1</b> and <b>4</b> relative to <b>3</b> are the interaction of C(4)═O and N-7, respectively, with Gln812. Comparatively, N-1 of <b>3</b> binds to a water molecule in the back of the pocket, whereas both <b>1</b> and <b>4</b> displace the water with a methyl group (<b>1</b>, C5; <b>4</b>, N1).</div><div class="NLM_p">The synthetic route to the pyrazolopyrimidine series (<a class="ref internalNav" href="#sch2" aria-label="Scheme 1">Scheme 1</a>) entailed acylation of malonitrile (<b>5</b>) with isobutyryl chloride (<b>6</b>) as the first step to afford <b>7</b>. O-Alkylation yielded <b>8</b>, followed by condensation with <i>N</i>-methyl hydrazine to afford aminopyrazole <b>9</b>. Acidic hydrolysis of the nitrile to primary amide (<b>10</b>), followed by condensation with formic acid yielded pyrazolopyrimidinone <b>11</b> that was chlorinated with POCl<sub>3</sub> to yield penultimate chloro pyrazolopyrimidine <b>12</b>. S<sub>N</sub>Ar reaction of <b>12</b> with amines afforded analogues of general structure <b>13</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0015.jpeg" id="GRAPHIC-d50e988-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to Pyrazolo[3,4-<i>d</i>]pyrimidine Targets of General Structure <b>13</b> with Key Diversity Points Highlighted in Green<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) NaH, THF, acid chloride, 76%; (b) Me<sub>2</sub>SO<sub>4</sub>, NaHCO<sub>3</sub>, dioxane, water, 56%; (c) MeNHNH<sub>2</sub>, EtOH, 35%; (d) H<sub>2</sub>SO<sub>4</sub>, 68%; (e) HCO<sub>2</sub>H, 71%; (f) POCl<sub>3</sub>, crude; (g) R′R″NH, K<sub>2</sub>CO<sub>3</sub>, THF, H<sub>2</sub>O (75% for <b>2</b>).</p></p></figure><div class="NLM_p">The synthetic route to the triazolopyrazines started with a selective S<sub>N</sub>Ar reaction between an alkoxide <b>14</b> and 2,6-dichloropyrazine (<b>15</b>) in step 1 to afford the ether <b>16</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 2">Scheme 2</a>). A second S<sub>N</sub>Ar with hydrazine yielded <b>17</b> (step 2). A one-pot hydrazone formation with isobutyraldehyde (<b>18</b>) followed by oxidative triazole formation with phenyl-iodoacetate in step 3 yielded <b>19</b>. Of particular note in contrasting the synthetic routes to <b>13</b> and <b>19</b> is that the isobutyl group in <b>19</b>, which overlays with that of <b>13</b> in the ribose region and with the potential to access the selectivity pocket, is introduced in the last step of the synthetic sequence and is amenable to variation via parallel synthesis, which is not the case for the isobutyl vector in <b>13</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0016.jpeg" id="GRAPHIC-d50e1094-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route to [1,2,4]Triazolo[4,3-<i>a</i>]pyrazine Targets of General Structure <b>3</b> with Key Diversity Points Highlighted in Green<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) KOtBu, CH<sub>2</sub>Cl<sub>2</sub>; (b) NH<sub>2</sub>NH<sub>2</sub>, EtOH; (c) (i) <b>17</b> + <b>18</b>, ClCH<sub>2</sub>CH<sub>2</sub>Cl, (ii) (diacetoxy)iodobenzene.</p></p></figure><div class="NLM_p">The starting hypothesis was that growing the isobutyl group of either <b>2</b> or <b>3</b> could lead to formation and filling of the PDE2A induced pocket with significant increases in both PDE2A potency and overall selectivity over other PDEs while maintaining low MDR1 BA/AB. The highly enabled nature of the isobutyl in <b>3</b> led to a parallel synthesis effort in this series. A key concern from a structural perspective during the design of the initial parallel synthesis compound sets was the observed movement of Leu770 toward the 2-methoxyphenyl group of <b>3</b> when the induced pocket is formed and the potential for negative protein–ligand interactions which could reduce potency as previously mentioned (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>d).</div><div class="NLM_p">To address this concern, removal of the ether substituent in the initial parallel synthesis to afford compounds of general formula <b>21</b> was undertaken, realizing that potency losses could be addressed in follow-up compounds by reincorporating ether substituents (<a class="ref internalNav" href="#sch4" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0017.jpeg" id="GRAPHIC-d50e1160-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. One-Step Synthetic Scheme to Vary Vector Headed towards Induced Pocket<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (i) <b>20</b> + <b>18</b>, ClCH<sub>2</sub>CH<sub>2</sub>Cl; (ii) (diacetoxy)iodobenzene.</p></p></figure><div class="NLM_p">More than 2000 virtual compounds were enumerated by using the available aldehydes in the Pfizer monomer file which were docked into the PDE2A X-ray crystal structure. Compounds were chosen for synthesis by using the following criteria:<table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">1.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Potential for accessing deep into the induced pocket in a manner analogous to the pendant phenyl of <b>1</b>.</p></td></tr><tr class="li1"><td valign="top">2.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Possible hydrogen bond interactions were observed in the ribose region, similar to the hydroxyl of <b>1</b>.</p></td></tr></table></div><div class="NLM_p">If there were highly similar aldehyde monomers available, a representative was chosen to minimize duplication and maximize diversity of the parallel synthesis library. Compounds were removed from consideration if clear negative interactions with the protein existed.</div><div class="NLM_p">This lead to 484 compounds being chosen for actual synthesis in a parallel format. From this set, 283 were successfully purified by HPLC (283/484 = 58% success rate) and were screened in the PDE2A inhibition assay. From this effort, one compound (<b>22</b>) was identified with μM potency and favorable physicochemical properties (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. PDE2A Potency, Lipophilicity, and Binding Efficiency of <b>22</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0031.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0032.gif" alt="" id="GRAPHIC-d50e1218-autogenerated" /></img><div></div></div><div class="NLM_p">Computational docking of <b>22</b> in the PDE2A protein and overlay with <b>1</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) suggested that the trifluoromethyl group was positioned in the same space as the pendant phenyl of <b>1</b> and that the pyrazole could engage in hydrogen-bonding interactions with tightly bound waters around the catalytic metals in a similar manner to the hydroxyl of <b>1</b>. The preferred pyrazole tautomer was not clearly defined, with the pyrazole having the potential to be either a hydrogen bond donor or acceptor. To further optimize this promising hit, three different approaches were explored: (1) reintroduction of the ether at the 5-position of the [1,2,4]triazolo[4,3-<i>a</i>]pyrazine core, (2) variation of the pyrazole nitrogen substituents to lock out a specific tautomer, and (3) evaluation of alternative aryl groups to the <i>para</i>-trifluoromethyl phenyl.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0003.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Modeled pose of <b>22</b> (cyan) overlaid with <b>1</b> (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the next rounds of parallel synthesis, two different parallel-enabled synthetic routes were used. The three-step synthetic route in <a class="ref internalNav" href="#sch3" aria-label="Scheme 2">Scheme 2</a> was employed to introduce different alcohols (<b>14a</b>–<b>b</b>) at the 5-position to see if potency could be increased while concurrently using pyrazolo-aldehydes (<b>23</b>) from the Pfizer monomer store, affording compounds of structure <b>24</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0018.jpeg" id="GRAPHIC-d50e1291-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Parallel Synthesis Route to Introduce Different Ether Substituents and Substituted Pyrazoles Using Methods of <a class="ref internalNav" href="#sch3" aria-label="Scheme 2">Scheme 2</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) KOtBu, CH<sub>2</sub>Cl<sub>2</sub>; (b) NH<sub>2</sub>NH<sub>2</sub>, EtOH; (c) (i) <b>17</b> + <b>18</b>, ClCH<sub>2</sub>CH<sub>2</sub>Cl; (ii) (diacetoxy)iodobenzene.</p></p></figure><div class="NLM_p">In the second library, the aryl group attached to the pyrazole was varied via a four-step sequence wherein the ether substituent was fixed as <i>n</i>-propyl (<a class="ref internalNav" href="#sch6" aria-label="Scheme 5">Scheme 5</a>). Starting with iodopyrazole <b>25</b>, Suzuki coupling with aryl boronates afforded <b>26</b>. Selective C-4 iodination gave <b>27</b> that could be carbonylated in the presence of triethylsilane to yield <b>23</b>. Condensation of <b>23</b> with <b>17a</b> followed by oxidative cyclization gave analogues <b>24a</b>. Compounds derived from both routes were resynthesized on larger scale for more thorough characterization via the route shown in <a class="ref internalNav" href="#sch7" aria-label="Scheme 6">Scheme 6</a>.</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0019.jpeg" id="GRAPHIC-d50e1364-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) ArB(OH)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DMF; (b) NIS, MeCN; (c) Pd(OAc)<sub>2</sub>, dppf, CO, TEA, SiHEt<sub>3</sub>; (d) 2-hydrazinyl-6-propoxypyrazine <b>17a</b>, EtOH, (diacetoxyiodo)benzene, EtOH.</p></p></figure><figure id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0020.jpeg" id="GRAPHIC-d50e1400-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Resynthesis Route for Key Library Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (i) <b>28</b> + <b>18</b>, ClCH<sub>2</sub>CH<sub>2</sub>Cl; (ii) (diacetoxy)iodobenzene; (b) ROH, NaH, THF.</p></p></figure><div class="NLM_p">Two different alcohol starting materials were employed in <a class="ref internalNav" href="#sch5" aria-label="Scheme 4">Scheme 4</a>: 2-(2-methoxyphenyl)ethanol which is in <b>3</b>, along with the lower molecular weight alcohol <i>n</i>-propanol which was expected to have reduced steric interactions with Leu770 due to its smaller size. As a direct comparator to <b>3</b>, 3-isobutyl-5-propoxy analogue <b>30</b> was prepared and a 5-fold decrease in PDE2A potency was observed, but LipE remained essentially equivalent due to reduced lipophilicity (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). LE increased, indicating more optimal interactions of <b>30</b> with protein relative to <b>3</b> on a per atom basis.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. PDE2A Potency, Physical Properties, and Binding Efficiencies of <b>3</b> and <b>30</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0033.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0034.gif" alt="" id="fx6" /></img><div></div></div><div class="NLM_p">Reincorporating the 5-ether substituent made a significant impact on potency (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). For example, the <i>n</i>-propoxy group (<b>31</b>) afforded a >10-fold increase in potency over the parent <b>22</b>. Lipophilicity was significantly higher for <b>31</b> vs <b>22</b> (clogP = 3.8 vs 2.2), yet LipE values were equivalent and LE was improved for <b>31</b>. As the ether substituent size and lipophilicity increased in <b>32</b>, potency values increased slightly relative to <b>31</b> with concomitant decreases in LE and LipE, indicating more efficient binding of <b>31</b>.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Impact of 5-Position Substitution on PDE2A Potency and Binding Efficiency Measures</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0035.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0036.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>Table a</sup><p class="last">PDE2A IC<sub>50</sub> data is from resynthesized samples, not from initial library compounds.</p></div></div><div></div></div><div class="NLM_p">The next key finding was that methylation of the pyrazole nitrogen adjacent to the aromatic ring afforded >10-fold increase in PDE2A inhibitory potency when compared to <b>33</b> and <b>34</b> (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>). To provide a second example of this trend, <b>35</b>, the <i>N</i>-methylated version of library compound <b>31</b>, was prepared and the matched pair (<b>31</b> and <b>35)</b> showed the same relative potency increase. This result was critical in that not only was potency improved but a HBD was removed that resulted in reduced MDR1 BA/AB efflux. The increased lipophilicity due to the methylation, however, increased HLM Cl<sub>int</sub>.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Impact of Pyrazole N-Substitution on PDE2A Potency, MDR1 BA/AB, and HLM Cl<sub>int</sub></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0037.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0038.gif" alt="" id="GRAPHIC-d50e1552-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>Table a</sup><p class="last">PDE2A IC<sub>50</sub> data is from resynthesized samples, not from initial library compounds.</p></div></div><div></div></div><div class="NLM_p">A number of analogues wherein the 5-aryl pyrazole group had differing substitution at the para-position were prepared in the library which showed larger substituents provided increased potency (<a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a>). These compounds were resynthesized, and two additional compounds (<b>35</b> and <b>36</b>) were prepared. The unsubstituted phenyl (<b>36</b>) had PDE2A IC<sub>50</sub> = 566.1 nM. Progressively larger substituent size led to significant increases in potency. For example, addition of a fluoro (<b>37</b>) gave a 2-fold potency increase, methyl (<b>38</b>) yielded a 20-fold potency increase, while the larger trifluoromethyl (<b>35</b>) and ethyl (<b>40</b>) resulted in 57-fold and 80-fold potency increases, respectively. Both LE and LipE increased with increasing substituent size, suggesting that the potency was being driven by more than nonspecific lipophilic interactions which would result in lower LE and LipE values.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Impact of 5-Aryl para-Position Substitution and Impact on PDE2A Potency and Binding Efficiency Measures</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0039.gif" alt="" id="fx10" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0040.gif" alt="" id="GRAPHIC-d50e1601-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>Table a</sup><p class="last">PDE2A IC<sub>50</sub> data is from resynthesized samples, not from initial library compounds.</p></div></div><div></div></div><div class="NLM_p">A protein X-ray crystal structure of <b>39</b> bound to PDE2A was obtained to help clarify the roles that the ether, methylated pyrazole, and phenyl para-substitution all play in potency enhancement (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a). First, the triazolopyrazine core of <b>39</b> maintains the same interactions with the enzyme as <b>3</b>. The <i>n</i>-propyl ether occupies the same space as the dimethoxyphenyl group in <b>1</b> while avoiding deleterious interactions with Leu770. The 1-methyl-5-arylpyrazole in <b>39</b> overlaps with the 2-hydroxy-6-phenylhexan-3-yl side chain in <b>1</b>. The sp<sup>2</sup> nitrogen (N-2) of the pyrazole is well-aligned with the hydroxyl in <b>1</b>, accepting a hydrogen bond from a water molecule. The vector to access the induced pocket off the pyrazole 5-position with a rigid phenyl linker allows para substituents to reach the deep recesses of the pocket, with a lower entropic penalty than in the conformationally flexible side chain of <b>1</b>.</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0004.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) X-ray crystal structure of <b>39</b> bound to PDE2A. (b) Overlap of <b>1</b> and <b>39</b> in PDE2A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In terms of understanding the increase in potency observed when methylating the pyrazole, the methyl does not appear to make any specific interactions in the pocket nor does it appear to displace any water molecules. Dihedral angle scans were performed on three truncated phenyl pyrazole systems (<b>40</b>, <b>41</b>, and <b>42</b>, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>), which suggest that the methyl on the pyrazole nitrogen has an effect on the orientation of the phenyl ring. The X-ray co-crystal structure of <b>39</b> with PDE2A reveals a preferred average dihedral angle of 67° in the bound conformation over the four structures in the asymmetric unit. The local minimum energy structures of <b>40</b> and the pyrazole tautomer <b>42</b> have dihedral angles of 35.3° and 28.6°, respectively, while that of <b>41</b> has a dihedral angle of 45.7° (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00397/suppl_file/jm7b00397_si_001.pdf" class="ext-link">Supporting Information</a>). This suggests that the methyl on the pyrazole ring causes the phenyl ring to adopt a conformation which is closer to that observed in the X-ray co-crystal structure, leading to a smaller conformational energy penalty upon binding. Optimization of the full systems and the dihedral scans of the truncated systems indicate that the conformational strain energy required to achieve the bound conformation for compounds without a methyl on the pyrazole, ∼1.4–2.4 kcal/mol (depending on the tautomeric mixture), is at least twice that of those with a methyl on the pyrazole, ∼0.6 kcal/mol.</div><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0005.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Truncated systems used to calculate dihedral angles in ground state.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>39</b> was profiled more extensively for ADME properties and PDE selectivity (<a class="ref internalNav" href="#tbl10" aria-label="Table 10">Table 10</a>). The selectivity of this compound against other PDEs was exceptionally high, driven most likely by efficient filling of the PDE2A induced pocket. HLM Cl<sub>int</sub> was high, but low MDR1 BA/AB efflux was observed. While the PDE2A potency was improved relative to <b>3</b>, the high HLM Cl<sub>int</sub> negatively impacted estimated human dose predictions, affording a value of >1438 mg/day.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Comparison of PDE2A Potency, Selectivity, and ADME Profiles of <b>39</b> and <b>3</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0041.gif" alt="" id="GRAPHIC-d50e1731-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup>Table a</sup><p class="last">Estimated human dose (mg/day) = 10 × PDE2A IC<sub>50</sub> × HLM CL<sub>int</sub> × 24 h × 70 kg × MDR1 BA/AB.</p></div></div><div></div></div><div class="NLM_p">To address the high estimated human dose, improving PDE2A potency and reducing HLM Cl<sub>int</sub> were targeted. Overlaying protein X-ray crystal structures of <b>4</b> and <b>39</b> showed that the heterocyclic cores aligned with one another regarding the substituents that projected into the ribose region, which were the isobutyl of <b>4</b> and aryl pyrazole of <b>39</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>a). A hybrid series was proposed which merged the pyrazolo[3,4-<i>d</i>]pyrimidine core with the aryl pyrazole side chain in <b>39</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>b).</div><figure id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0006.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Overlap of <b>4</b> (yellow) and <b>39</b> (gray) in PDE2A. (b) Merging <b>4</b> and <b>39</b> to yield a proposed hybrid series <b>43</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To access compounds of general structure <b>43</b>, pyrazole boronate <b>44</b> was coupled with an aryl bromide (<b>45</b>) to afford <b>46</b> (<a class="ref internalNav" href="#sch8" aria-label="Scheme 7">Scheme 7</a>). Formylation of <b>46</b> with dimethylformamide and phosphorus oxychloride yielded the 4-formyl pyrazole <b>47</b>. Low temperature lithiation of 4,6-dichloropyrimidine (<b>48</b>) at the 5-position followed by addition of <b>47</b> gave the carbinol <b>49</b>. Oxidation of <b>49</b> yielded the corresponding ketone <b>50</b>, which could be reacted with an amine (HNRR′) at room temperature to selectively provide the monoamino product <b>51</b>. Subsequent reaction with methyl hydrazine afforded the target compounds of general structure <b>44</b>.</div><figure id="sch8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0021.jpeg" id="GRAPHIC-d50e1852-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, NaHCO<sub>3</sub>, DME, H<sub>2</sub>O; (b) DMF, POCl<sub>3</sub>; (c) (i) <b>48</b>, LDA, THF, (ii) <b>47</b>; (d) Dess–Martin periodinane; (e) HNRR′, MeCN; (f) MeNHNH<sub>2</sub>, pyridine.</p></p></figure><div class="NLM_p">Initial analogues with varied amines were prepared via a two-step parallel chemistry protocol (<b>50</b> → <b>51</b> → <b>44</b>, <a class="ref internalNav" href="#sch8" aria-label="Scheme 7">Scheme 7</a>). Trends for potency were demonstrated in this initial library with azetidine and 3-substituted azetidines, providing the most potent PDE2A inhibitory activity (<a class="ref internalNav" href="#tbl11" aria-label="Table 11">Table 11</a>, <b>52</b>–<b>54</b>) comparable to or better than <b>39</b>. With lower clogP relative to <b>39</b> (ca. 1 unit), HLM Cl<sub>int</sub> was reduced for these compound while maintaining low MDR1 BA/AB efflux, which reduced the estimated human dose for <b>52</b> and <b>53</b> (160 and 337 mg/day, respectively). The polar methyl carbamate of <b>54</b> also showed reduced HLM Cl<sub>int</sub>. However, with significant MDR1 BA/AB efflux, the estimated human dose increased (954 mg/day). Overall, LE and LipE values were also in a desirable range, especially for <b>52</b> (LE = 0.43, LipE = 6). The reduced conformational flexibility of <b>52</b> (RB = 4) most likely resulted in a low-energy ground state that is similar to the PDE2A enzyme bound conformation, obviating an entropic penalty for binding, which is associated with the more flexible <b>1</b>. Pyrrolidines (<b>55</b>–<b>56</b>) provided slightly less activity than azetidines but had higher human dose due to greater MDR1 BA/AB efflux. Six-membered ring amines (<b>57</b>–<b>58</b>) showed significantly less PDE2A activity.</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Representative Parallel Synthesis Compounds Varying 5-Amino Substituent</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0042.gif" alt="" id="fx11" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0043.gif" alt="" id="fx12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t11fn1"><div class="footnote" id="t11fn1"><sup>Table a</sup><p class="last">PDE2A IC<sub>50</sub> data is from library compounds.</p></div><div class="footnote" id="t11fn2"><sup>Table b</sup><p class="last">Estimated human dose (mg/day) = 10 × PDE2A IC<sub>50</sub> × HLM, Cl<sub>int</sub> × 1440 min × 70 kg × (MDR1 BA/AB).</p></div><div class="footnote" id="t11fn3"><sup>Table c</sup><p class="last">PDE2A IC<sub>50</sub> is the geometric mean of two independent IC<sub>50</sub> measurements.</p></div></div><div></div></div><div class="NLM_p">An X-ray crystal structure of <b>56</b> bound to PDE2A was successfully solved (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). Consistent with the PDE2A X-ray crystal structure of <b>4</b>, the pyrazolopyrimidine core made the same polar and nonpolar interactions with the protein and the 1-methyl-5-arylpyrazole moiety resided in a similar position as in <b>39</b>. While azetidine and pyrrolidine were accommodated at the 4-position of the pyrazolopyrimidine, it is possible that the bulkier six-membered ring systems such as morpholine and piperazine cannot fit as well and make unfavorable contacts with side-chains lining the bottom and sides of the binding pocket (Ile-826, Phe-830, Met-847).</div><figure id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0007.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. X-ray crystal structure of <b>56</b> bound to PDE2A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><b>52</b> made via parallel synthesis was resynthesized on larger scale and more fully profiled. The PDE2A IC<sub>50</sub> for this resynthesized material was equivalent to the compound made via parallel synthesis. In an analogous manner to <b>39</b>, selectivity against other PDE families was >3000×, providing further support that efficient binding to the induced pocket in PDE2A could be a general approach to minimizing off-target PDE activity.</div><div class="NLM_p">The focus was nexted placed on exploring changes to the pyrazole 5-aryl group to reduce HLM Cl<sub>int</sub> while maintaining low MDR1 BA/AB. The route in <a class="ref internalNav" href="#sch8" aria-label="Scheme 7">Scheme 7</a> was used to synthesize other substituted phenyl derivatives. An alternative route was developed (<a class="ref internalNav" href="#sch9" aria-label="Scheme 8">Scheme 8</a>) to allow the incorporation of heterocycles which were low-yielding in the original method. Selective S<sub>N</sub>Ar of azetidine on <b>59</b> proceeded in high yield to afford <b>60</b>. The heteroaryl pyrazole moiety was constructed via Suzuki coupling between pyrazole boronic acid <b>61</b> and the halo-heterocycle <b>62</b> to give <b>63</b>. Direct iodination of <b>63</b> proceeded cleanly and in high yield to give <b>64</b>, which could be metalated with either <i>n</i>-BuLi or <i>i</i>-PrMgCl and then treated with <b>60</b> to yield the carbinol <b>65</b>. Oxidation then gave the 4,6-dichloro-5-keto-pyrimidine <b>66</b> (similar to <b>51</b>) which readily reacted with methyl hydrazine to provide the target compounds <b>67</b>.</div><figure id="sch9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0022.jpeg" id="GRAPHIC-d50e2101-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthetic Route to Heteroaryl Substituted Pyrazole Analogues <b>67</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Azetidine, DIPEA, CHCl<sub>3</sub>, 64%; (b) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,2-DME, H<sub>2</sub>O; (c) NIS, AcOH; (d) <i>n</i>-butyl lithium or <i>I</i>-PrMgCl, THF; (e) Dess–Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>; (f) NH<sub>2</sub>NHMe, pyridine.</p></p></figure><div class="NLM_p">Potency trends with regard to aryl para-substitution tracked with the triazolopyrazine results (compare <a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a> to <a class="ref internalNav" href="#tbl12" aria-label="Table 12">Table 12</a>). For example, adding a 4-methyl to the parent phenyl compound (<b>68</b> → <b>69</b>) gave an order of magnitude enhancement in potency and higher LE, both of which were further increased in the case of ethyl (<b>52</b>). Similarly, cyclopropyl (<b>70</b>) and trifluoromethyl (<b>71</b>, PF-05085727) also provided high potency. These more potent compounds maintained low MDR1 BA/AB with HLM Cl<sub>int</sub> still in the moderate to high range, with <b>71</b> having an estimated human dose <100 mg/day. The replacement of phenyl with pyridine did reduce HLM Cl<sub>int</sub> 2–3-fold when looking at matched pairs (<b>71</b> vs <b>72</b>; <b>70</b> vs <b>73</b>), but potency was reduced significantly (3–5-fold), which ultimately led to increased estimated human dose. Shifting from pyridine to the more polar pyrimidine (<b>73</b> → <b>74</b>) reduced HLM Cl<sub>int</sub> 2-fold but afforded a 100-fold loss in potency along with increased MDR1 BA/AB efflux.</div><div class="NLM_table-wrap" id="tbl12"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 12. SAR of Pyrazole 5-Aryl Group</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0044.gif" alt="" id="fx13" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0045.gif" alt="" id="fx14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t12fn1"><div class="footnote" id="t12fn1"><sup>Table a</sup><p class="last">Estimated human dose (mg/day) = 10 × PDE2A IC<sub>50</sub> × HLM, CL<sub>int</sub> × 1440 min × 70 kg × (MDR1 BA/AB).</p></div><div class="footnote" id="t12fn2"><sup>Table b</sup><p class="last">PDE2A IC<sub>50</sub> is the geometric mean of two independent IC<sub>50</sub> measurements.</p></div></div><div></div></div><div class="NLM_p">To explore in vivo PDE2A inhibition, <b>71</b> was chosen to be profiled extensively to assess its potential for use as an in vivo tool. Key to choosing this compound was its lower rat liver microsomal Cl<sub>int</sub> (145 mL/min/kg) as compared to other low estimated human dose compounds such as <b>52</b> (707 mL/min/kg) and <b>70</b> (>1000 mL/min/kg), which would be important in helping maximize exposure in the rodent-based in vivo models. Similar to <b>52</b>, the overall PDE selectivity remained high (>4000×) against all other isoforms (<a class="ref internalNav" href="#tbl13" aria-label="Table 13">Table 13</a>) and thus selective inhibition of PDE2A in vivo versus other PDEs would be readily attainable with <b>71</b>. Selectivity against a broad range of kinases (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>) and in a CEREP selectivity panel (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>) showed <b>71</b> to have no significant off-target activity, obviating concerns of pharmacology which would cloud interpretation of in vivo activity with <b>71</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00397/suppl_file/jm7b00397_si_001.pdf" class="ext-link">Supporting Information</a> for full data tables). Minimal inhibition of representative cytochrome P450 enzymes (CYPs) was observed, suggesting a low risk for <b>71</b> to elicit drug–drug interactions. Plasma protein binding was moderate across species. Assessment of human ether-à-go-go-related gene (hERG) ion channel affinity was conducted by displacement of the known radiolabeled ligand dofetilide and showed minimal binding. Profiling <b>71</b> in a cellular toxicity assay using transformed human liver endothelial (THLE) cells showed weak activity with IC<sub>50</sub> = 162 μM to induce cell death.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_table-wrap" id="tbl13"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 13. In Vitro Selectivity, ADME, and Toxicology Profile of <b>71</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0046.gif" alt="" id="GRAPHIC-d50e2296-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t13fn1"><div class="footnote" id="t13fn1"><sup>Table a</sup><p class="last">Values represent the Clint, apparent scaled (mL/min/kg).</p></div><div class="footnote" id="t13fn2"><sup>Table b</sup><p class="last">CYP = cytochrome P450.</p></div></div><div></div></div><figure id="fig8" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0008.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Activity of <b>71</b> in a kinase selectivity panel at a concentration of 10 μM (Invitrogen).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0009.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Activity of <b>71</b> in a selectivity panel at a concentration of 10 μM (CEREP).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In vivo subcutaneous (SC) administration of <b>71</b> to both mouse and rat gave a ratio of unbound brain (<i>C</i><sub>bu</sub>) to unbound plasma (<i>C</i><sub>pu</sub>) of ca. 0.27 and 0.37, respectively. <i>C</i><sub>bu</sub> was achieved which was >25-fold the PDE2A IC<sub>50,</sub> indicating significant target inhibition achieved in vivo in rodent brain (<a class="ref internalNav" href="#tbl14" aria-label="Table 14">Table 14</a>). In rat, CSF levels of <b>71</b> were also determined and were close to the <i>C</i><sub>bu</sub> (CSF/<i>C</i><sub>bu</sub> = 0.89).</div><div class="NLM_table-wrap" id="tbl14"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 14. In Vivo Brain, Plasma, and CSF Exposure of <b>71</b> in Mouse and Rat Following SC Administration<a class="ref internalNav" href="#t14fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">SC dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">total brain (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>bu</sub><a class="ref internalNav" href="#t14fn2" aria-label="b">b</a> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">total plasma (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>pu</sub><a class="ref internalNav" href="#t14fn3" aria-label="c">c</a> (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>bu</sub>/<i>C</i><sub>pu</sub></th><th class="colsep0 rowsep0" align="center" char=".">CSF (nM)</th><th class="colsep0 rowsep0" align="center" char=".">CSF/<i>C</i><sub>bu</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>bu</sub>/PDE2A IC<sub>50</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">452</td><td class="colsep0 rowsep0" align="char" char=".">43.0</td><td class="colsep0 rowsep0" align="char" char=".">798</td><td class="colsep0 rowsep0" align="char" char=".">160</td><td class="colsep0 rowsep0" align="char" char=".">0.27</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">26.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">950</td><td class="colsep0 rowsep0" align="char" char=".">90.2</td><td class="colsep0 rowsep0" align="char" char=".">776</td><td class="colsep0 rowsep0" align="char" char=".">248</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td><td class="colsep0 rowsep0" align="char" char=".">79.9</td><td class="colsep0 rowsep0" align="char" char=".">0.87</td><td class="colsep0 rowsep0" align="char" char=".">56.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t14fn1"><div class="footnote" id="t14fn1"><sup>a</sup><p class="last">Mouse <i>n</i> = 4, time point = 30 min postdose; rat <i>n</i> = 3, time point = 30 min postdose.</p></div><div class="footnote" id="t14fn2"><sup>b</sup><p class="last">Rat brain <i>f</i><sub>ub</sub> = 0.095: mouse <i>C</i><sub>bu</sub> estimated using rat <i>f</i><sub>ub</sub> value.</p></div><div class="footnote" id="t14fn3"><sup>c</sup><p class="last">Rat plasma <i>f</i><sub>up</sub> = 0.32 and mouse <i>f</i><sub>up</sub> = 0.20.</p></div></div></div><div class="NLM_p">An improved correlation between in vitro inhibition of PDE2A cGMP hydrolysis and target engagement of native PDE2A was sought via utilization of a radioligand. The high potency and selectivity of <b>71</b> along with its moderate protein binding would serve to minimize nonspecific tissue binding and made it an ideal candidate for radiolabeling. Treatment of <b>76</b>, a key intermediate in the synthesis of <b>71</b>, with hydrazine afforded <i>N</i>-1 <i>des</i>-methyl compound <b>77</b>. Treatment of <b>77</b> with base and CT<sub>3</sub>-I afforded N-1 CT<sub>3</sub> compound <b>78</b>, which following purification afforded a specific activity of 82 Ci/mmol as determined by mass spectrometry (<a class="ref internalNav" href="#sch10" aria-label="Scheme 9">Scheme 9</a>).</div><figure id="sch10" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0023.jpeg" id="GRAPHIC-d50e2616-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of <i>N</i>-1 CT<sub>3</sub> Radioligand <b>78</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) NH<sub>2</sub>NH<sub>2</sub>, THF, 56%; (b) NaH, THF, CT<sub>3</sub>I, HPLC purification.</p></p></figure><div class="NLM_p">A saturation radioligand binding assay was developed with <b>78</b> using striatal tissue from rat, dog, and monkey, a brain region with high PDE2A expression. The binding constant (<i>K</i><sub>d</sub>) for <b>78</b> in striatal tissue was consistent across species (<i>K</i><sub>d</sub> = 2.8–3.2 nM) and was very similar to the in vitro IC<sub>50</sub> for PDE2A cGMP hydrolysis demonstrated by <b>71</b> (IC<sub>50</sub> = 2 nM), suggesting that the PDE2A enzyme assay was predictive of target engagement in brain tissue (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>). Furthermore, the <i>B</i><sub>max</sub>, a measure of PDE2A enzyme concentration determined in this study, showed consistent protein levels across species (0.89 to 1.8 pmol/mg). The <i>B</i><sub>max</sub> value was sufficiently high to suggest that a positron emission tomography (PET) tracer could establish in vivo target occupancy.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Indeed, this data was also used to support development of a PDE2A PET ligand which successfully demonstrated specific uptake in the striatum of monkeys.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="fig10" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0010.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Saturation binding assay data in rat, dog, and monkey striatal tissue using <b>78</b> as radioligand.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Administration of <b>71</b> in mice led to an acute and exposure-dependent elevation in the accumulation of bulk levels of cGMP in cortex, striatum, and hippocampus as measured by enzyme-linked immunosorbent assay (ELISA, <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>).<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> Measurement of drug exposure in satellite animals was used to model the cGMP response across brain regions and resulted in a <i>C</i><sub>bu</sub> half effective concentration (EC<sub>50</sub>) relative to the maximum effect (<i>E</i><sub>max</sub>) for cGMP accumulation of 70–136 nM and a 50% increase relative to baseline (<i>E</i><sub>50</sub>) of 15–53 nM (<a class="ref internalNav" href="#tbl15" aria-label="Table 15">Table 15</a>). No cGMP changes were observed in cerebellum, which lacks significant expression of PDE2A and serves as a reference region (not shown). No changes in cAMP or its downstream signaling effector phospho-cAMP response element-binding protein (p-CREB) were apparent in any brain region.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> This suggests that the pool of cAMP regulated by PDE2A in these brain regions is relatively small and potentially regionally specialized relative to the large endogenous pool of cAMP measured in our bulk biochemical studies.</div><figure id="fig11" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0011.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Mouse <i>C</i><sub>bu</sub> of <b>71</b> plotted against brain cGMP levels in different brain regions. cGMP = cyclic guanosine monophosphate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl15"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 15. Potency Estimation of <b>71</b> for Mouse Brain cGMP %Increase by Brain Region</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0047.gif" alt="" id="GRAPHIC-d50e2752-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t15fn1"><div class="footnote" id="t15fn1"><sup>Table a</sup><p class="last">EC<sub>50</sub> = half effective concentration.</p></div><div class="footnote" id="t15fn2"><sup>Table b</sup><p class="last"><i>E</i><sub>max</sub> = maximum effect.</p></div><div class="footnote" id="t15fn3"><sup>Table c</sup><p class="last"><i>E</i><sub>50</sub> = 50% increase relative to baseline.</p></div></div><div></div></div><div class="NLM_p">Evaluating the behavioral consequences of PDE2A inhibition by <b>71</b> showed no effects on spontaneous locomotor activity or habituated locomotor activity in mice or rats (data not shown). <b>71</b> also showed no effect in selected positive symptom models of psychosis using rats, which included no significant attenuation of <span class="smallcaps smallerCapital">d</span>-amphetamine or MK-801 induced hyperactivity and no effect in the conditioned avoidance response model (data not shown). PDE2A protein is highly expressed in presynaptic synaptic compartment of glutamatergic principal neurons within the hippocampus and cortex,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> where it has been implicated in regulating presynaptic forms of short-term synaptic plasticity<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and in the induction of long-term potentiation.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Furthermore, PDE2A inhibitors have been shown to potentiate NMDAR-stimulated cGMP accumulation in cultured neurons,<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> suggesting that inhibition of PDE2A may have the ability to reverse deficits in NMDA signaling cascades by enhancing cyclic nucleotide signaling cascades downstream of receptor activation. To evaluate the consequence of PDE2A inhibition on a cognitive task dependent upon NMDA receptors, a ketamine-disrupted working memory model in rats was used. Systemic administration of <b>71</b> (0.032 to 1 mg/kg, SC) significantly attenuated the working memory errors produced by ketamine (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>).</div><figure id="fig12" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0012.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Effects of <b>71</b> on ketamine-disrupted working memory in LE rats in radial arm maze. doses of <b>71</b> are in mg/kg. Ket = ketamine; SEM = standard error of the mean; Veh = vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of measurement of exposure of <b>71</b> in satellite animals, the corresponding <i>C</i><sub>bu</sub> at the time of the 0.1 mg/kg dose was projected to be 2.3 nM and at the 0.32 mg/kg dose, 7.4 nM (<a class="ref internalNav" href="#tbl16" aria-label="Table 16">Table 16</a>).</div><div class="NLM_table-wrap" id="tbl16"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 16. Rat C<sub>bu</sub> of <b>71</b> at Doses Used in Radial Arm Maze</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dose (mg/kg)</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>bu</sub> (nM)</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">7.4</td></tr></tbody></table></div></div><div class="NLM_p">These effects were comparable to those produced by a positive control compound <b>79</b> (LY451646), which is a positive allosteric modulator of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic (AMPA) receptor.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> As compared to the ketamine-treated group, the 0.32 mg/kg doses of <b>71</b> also significantly improved several other performance indices including average time to maze completion, while the 0.10 and 0.32 mg/kg doses increased the percent correct choices on the maze (not shown). These data show that <b>71</b> afforded significant protection from the ketamine-induced working memory deficits on the rat RAM.</div><div class="NLM_p">Dysfunction of the prefrontal cortex (PFC) is considered to be an important factor contributing to working memory-related decrease in cognitive performance of schizophrenia patients.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Administration of the NMDA receptor antagonist MK-801 has been shown to disrupt spontaneous neuronal activity and synaptic plasticity in the mPFC of anaesthetized rats, and reversal of these changes have been observed with the positive allosteric modulator of the AMPA receptor (<i>R</i>)-<i>N</i>-(2-(4′-(2-(methylsulfonamido)ethyl)-[1,1′-biphenyl]-4-yl)propyl)propane-2-sulfonamide (LY451395).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Reversal of MK-801-induced disruptions in NMDA receptor signaling, detected with cortical electroencephalogram (EEG) recordings as changes in low frequency cortical delta oscillation and paired-pulse facilitation (PPF), were used as pharmacodynamic measures of PDE2A inhibition by <b>71</b> on glutamatergic transmission in cortex.</div><div class="NLM_p">A single intravenous (IV) dose of MK-801 (0.07 mg/kg) consistently and significantly changed the characteristics of the cortical EEG from a low amplitude, highly regular 1.8–2.0 Hz signal (δ oscillation) to a slower, higher amplitude, less synchronous signal of 0.5–1.6 Hz for up to 1 h post dose (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>). PPF was simultaneously disrupted in these animals (data not shown). <b>71</b>, also given IV, was capable of maximally reversing 80% of the disruptive effects of MK-801 on both cortical EEG and PPF. The effect of reversal peaked at 30 min post IV dose of <b>71</b> and gradually diminished over time.</div><figure id="fig13" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0013.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Timecourse of <b>71</b> (0.3 mg/kg, IV) effects on MK-801-induced changes in low frequency cortical oscillation activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Parallel neuropharmacokinetic studies were conducted to evaluate brain exposure of <b>71</b> over time (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>) and to estimate <b>71</b> in vivo potency in cortical EEG through use of pharmacokinetic/pharmacodynamic (PK/PD) modeling (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00397/suppl_file/jm7b00397_si_001.pdf" class="ext-link">Supporting Information</a>). This model identified a linear relationship between <b>71</b> C<sub>bu</sub> and reversal of the MK-801 effect. On the basis of the model, <b>71</b> was projected to provide a maximal reversal of 80% of the MK-801 induced local field potential disruption at steady state <i>C</i><sub>bu</sub> of 11 nM.</div><figure id="fig14" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0014.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Rat exposure (0.3 mg/kg, IV) of <b>71</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These studies indicate that specific inhibition of the PDE2A enzyme by <b>71</b> can significantly alleviate at least two measures of cortical disruption caused by NMDA antagonists at <i>C</i><sub>bu</sub> = 2.3–11 nM (<a class="ref internalNav" href="#tbl17" aria-label="Table 17">Table 17</a>). The corresponding calculated changes in brain cGMP at these <i>C</i><sub>bu</sub> levels show that low to moderate changes in cyclic nucleotides were also associated with the reversal of NMDA antagonist effects versus the maximal attainable brain cGMP increase.</div><div class="NLM_table-wrap" id="tbl17"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 17. Comparison of Calculated Brain cGMP Increases for <b>71</b> in Mouse vs Rat in Vivo Efficacy <i>C</i><sub>bu</sub><a class="ref internalNav" href="#t17fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0048.gif" alt="" id="GRAPHIC-d50e3005-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t17fn1"><div class="footnote" id="t17fn1"><sup>Table a</sup><p class="last"><i>C</i><sub>bu</sub> = unbound brain concentration; EEG = electroencephalogram; RAM = radial arm maze.</p></div></div><div></div></div><div class="NLM_p last">An explanation for the lower levels of cyclic nucleotide increases providing efficacy in these models is that as previously reported,<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(28)</a> PDE2A exists as an inactive dimer and the NMDA antagonists used in the in vivo models could specifically activate PDE2A in discrete circuits that are sensitive to PDE2A inhibition. As a result, in vivo brain cGMP measurements may represent inhibition of a less active form of PDE2A that is broadly distributed and whose inhibition is primarily responsible for the observed biochemical changes. Using a more conservative estimate of measured values for the average, steady state <i>C</i><sub>bu</sub> from the reversal of MK-801-induced changes in cortical EEG (11 nM or ca. 6 × PDE2A IC<sub>50</sub>) and a <i>C</i><sub>bu</sub>/<i>C</i><sub>pu</sub> from rat studies of 0.36, the estimated human dose of 108 mg/day is very much in line with the estimates from in vitro data of 77 mg/day (<a class="ref internalNav" href="#tbl11" aria-label="Table 11">Table 11</a>), demonstrating that <b>71</b> is a viable lead series for optimization toward a clinical candidate.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11336" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11336" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Using a combination of structure-based drug design and strategic application of parallel chemistry, two unique screening hits, <b>2</b> and <b>3</b>, were merged to generate a potent and exceptionally PDE2A-selective series which culminated in the discovery of the tool compound <b>71</b>. The radioligand <b>78</b> demonstrated binding to PDE2A in brain tissue in vitro, which was in line with its potency in an in vitro cell free system, building confidence in using the cell-free system to estimate target engagement in vivo. <i>C</i><sub>bu</sub>/<i>C</i><sub>pu</sub> was consistent in rodent and CSF levels in rat tracked with the <i>C</i><sub>bu</sub>. Compound <b>71</b> demonstrated in vivo activity as evidenced by biochemical increases in brain cGMP accumulation in rodent brain regions expressing highest levels of PDE2A enzyme. Additionally, behavioral and electrophysiological changes due to two different NMDA antagonists were reversed at exposures where <b>71</b> would selectively inhibit PDE2A without activity at any other target. These data show that selective PDE2A inhibition in brain can potentiate pharmacologically induced NMDA hypofunction in vivo and suggest a therapeutic role for brain penetrant PDE2A inhibitors in treating neurological and neuropychiatric disorders associated with NMDA hypofunction such as schizophrenia. Further characterization of this compound in translatable preclinical models of neuropsychiatric symptom domains should inform future clinical trial design. To support this research, <b>71</b> will be available for purchase from Millipore-Sigma (catalogue no. PZ0355).</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Experimental Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14300" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14300" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Research involving animals was performed in accordance with institutional guidelines as defined by Institutional Animal Care and Use Committee for U.S. institutions.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> PDE2-A3 Scintillation Proximity Assay</h3><div class="NLM_p last">Human PDE2A isoform sequences to be used for cloning were derived from NCBI accession entry NR_026572 for hPDE2A3, respectively. PDE2A isoform sequences were cloned into a pFastBac1 vector such that an amino terminal FLAG extension and appropriate protease cleavage sites would be available for subsequent purification steps. Full-length PDE2A3 enzyme was obtained from FLAG purification of sf21 insect cells using standard affinity purification procedures for this tag (anti-FLAG M2, Sigma-Aldrich) or by crude lysate methods.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> PDE2-A3 Assay Methodology</h3><div class="NLM_p last">Test compounds were solubilized in 100% dimethyl sulfoxide and diluted to the required concentrations in 15% dimethyl sulfoxide/distilled H<sub>2</sub>O at 5× final concentrations. Compounds were tested at eight concentrations ranging from 0.316 to 0.0001 μM in triplicate. The activity of the test substances on human PDE2A3 was determined using the [3H]cGMP scintillation proximity assay format using 384-well plates. The PDE scintillation proximity assay (SPA) yttrium silicate beads (PerkinElmer RPNQ0024) preferentially bind the linear nucleotide, GMP, compared to the cyclic nucleotide, cGMP. Using 3H-cGMP (PerkinElmer NET337001MC) as the substrate in this reaction allows the product, 3H-GMP, to be detected using a Wallac Microbeta scintillation counter. The enzyme concentration for each isoform was determined by enzyme titration experiments to be in the linear range of the assay. The Michaelis constant (<i>K</i><sub>m</sub>) of the enzyme was determined to be 12.8 μM for cGMP. The final substrate concentration used was at sub-<i>K</i><sub>m</sub> levels so that IC<sub>50</sub> values would approximate the <i>K</i><sub>i</sub> values. The reaction time was chosen with respect to the amount of time where 10–20% of substrate was hydrolyzed by the enzyme. The assay was validated using literature compounds as controls before testing the representative compounds of the present invention. The corresponding IC<sub>50</sub> values of the compounds for the inhibition of PDE activities were determined from the concentration–effect curves by means of nonlinear regression.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Phosphodiesterase Selectivity Assays</h3><div class="NLM_p last">The phosphodiesterase (PDE) assays measure the conversion of 3′, 5′-[<sup>3</sup>H] cAMP to 5′-[<sup>3</sup>H] AMP (for PDE 1B1, 3A1, 4D3, 7B, 8B, and 10A1) or 3′, 5′-[<sup>3</sup>H] cGMP to 5′-[<sup>3</sup>H] GMP (for PDE 5A1, 6 (bovine), 9A1, and 11A4) by the relevant PDE enzyme subtype. Yttrium silicate (YSi) scintillation proximity (SPA) beads bind selectively to 5′-[<sup>3</sup>H] AMP or 5′-[<sup>3</sup>H] GMP, with the magnitude of radioactive counts being directly related to PDE enzymatic activity. The assay was performed in white walled opaque bottom 384-well plates. Then 1 μL of compound in DMSO was added to each well. Enzyme solution was then added to each well in buffer (in mM: Trizma, 50 (pH7.5); MgCl<sub>2</sub>, 1.3 mM) containing Brij 35 (0.01% (v/v)). For PDE1B1, the assay buffer additionally included CaCl<sub>2</sub> (30 mM) and calmodulin (25 U/mL). Subsequently, 20 μL of 3′,5′-[<sup>3</sup>H] cGMP (125 nM) or 20 μL of 3′,5′-[<sup>3</sup>H] cAMP (50 nM) were added to each well to start the reaction and the plate was incubated for 30 min at 25 °C. The reaction was terminated by the addition of 20 μL of PDE YSi SPA beads (PerkinElmer). Following an additional 8 h incubation period, the plates were read on a MicroBeta radioactive plate counter (PerkinElmer) to determine radioactive counts per well.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Data Analysis</h3><div class="NLM_p last">Inhibition curves were plotted from individual experiments, and IC<sub>50</sub> values were determined using a four-parameter logistic fit. IC<sub>50</sub> is defined as the concentration of the test article that produced a 50% inhibition of a maximal response. All PDE selectivity data is in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00397/suppl_file/jm7b00397_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> PDE2A Brain Tissue Binding Assay</h3><div class="NLM_p last">Saturation binding experiments were conducting using membranes from dissected striatal regions of rat, dog, and monkey. Initial tissue concentration curve studies were conducted, and it was determined that 1.5 mg/mL for rat and 2.5 mg/mL for dog and monkey was ideal for each species, respectively. Frozen tissue was weighed into 50 mM Tris buffer (pH 7.4 at 4 °C) containing 2.0 mM MgCl<sub>2</sub>, homogenized using a Polytron, and then spun in a centrifuge at 40000<i>g</i> for 10 min. The pellet was resuspended in assay buffer (50 mM Tris buffer @ pH 7.5 containing 1.3 mM MgCl<sub>2</sub>). Incubations were initiated by the addition of 200 μL of predetermined tissue concentration to 25 μL of increasing concentrations of <b>78</b>, along with 25 μL of either DMSO buffer or 10 μM of <b>1</b> (a specific PDE2 inhibitor). After a 30 min incubation period at room temperature, assay samples were rapidly filtered through Unifilter-96 GF/BK PEI-coated filter plates and rinsed with ice-cold 50 mM Tris buffer (pH 7.4 at 4 °C). Membrane bound <b>78</b> levels were determined by liquid scintillation counting of the filterplates in Ecolume. Once the <i>K</i><sub>d</sub> was determined, time course studies were conducted to ensure parameters were linear and at equilibrium by using a 30 min incubation.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Behavioral Assays</h3><div class="NLM_p last">Male Long Evans rats from Charles River Laboratories (Kingston, NY) ranged between 200 and 225 g upon arrival and between 400 and 450 g during the study. Animals were individually housed in environmentally controlled quarters (light/dark: 0600 h/1800 h) for 1 week prior to initiation of experiments.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Spontanous Locomotor Activity</h3><div class="NLM_p last">Locomotor activity was measured in 48 custom-made automated activity chambers (30 cm × 30 cm) housed in sound-attenuating cabinets and equipped with photocells and a metal touchplate. A single 15 W bulb in each cabinet was controlled by a 24 h timer which allowed the behavioral chambers to be maintained on a 0400 h/1600 h light/dark cycle. Horizontal activity was measured as crossovers from one quadrant of the cage floor to another, while vertical locomotor activity (i.e., rears) was measured as the number of times an animal stood up on its hind legs against the walls of the chamber, making contact with the metal touchplate. Data were recorded, stored, and analyzed by a computer equipped with LabView software.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Radial Arm Maze</h3><div class="NLM_p">Animals were food-restricted (25–30 g rodent chow/day) beginning 7 days prior to the first day of exposure to the maze. The eight arm radial maze (Pathfinder Maze System, Lafayette Instrument Co., Lafayette, IN) contained a food cup at the end of each arm, the contents of which were not visible from the central platform. The task required that the animals enter each arm to retrieve the food pellets and use spatial cues in the room in order to remember which arms of the maze they have previously entered. Permanent visual cues existed within each test room.</div><div class="NLM_p">During training, one reinforcement pellet was placed in the food cup at the end of each arm. Animals were placed on the maze facing away from the experimenter, facing the same arm at the start of each trial. The timer was started, and each arm entry was recorded in sequence. An entry was defined as all four paws entering an arm of the maze. The animal was allowed to choose arms until all eight arms were entered and pellets were consumed, until 30 choices were made, or until 5 min had elapsed, which ever event occurred first. Entry into an arm previously chosen was counted as an error. If an animal failed to choose all eight arms in 5 min, the arms not chosen were also counted as errors. Animals were trained once a day five days per week (Monday–Friday), and the training criterion was defined as two or fewer errors on two consecutive training days.</div><div class="NLM_p last">Maze Testing: Once the training criterion was met by all subjects (approximately 15 days of training), drug testing was initiated. On Mondays and Thursdays, all animals were tested to identify those qualified for testing of experimental sybstances on Tuesdays and Fridays. No testing was performed on Wednesdays. Animals which committed two or fewer errors on qualifying days were randomly assigned to treatment groups and were subjected to drug testing by an experimenter who was blinded as to each animal’s treatment. After each qualifying day, animals to be tested were again randomly assigned to treatment groups and were tested the following day. This procedure was repeated until the number for each group equaled at least 10, which typically took between three and four test days.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Electrophysiology Assay: Cortical Delta Oscillation</h3><div id="sec4_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Animals and Surgical Procedures</h4><div class="NLM_p last">Male Sprague–Dawley rats (Harlan, USA; weighing 250–320 g) under urethane anesthesia @ 1.5 g/kg intraperitoneal (IP), were placed in a stereotaxic frame, where craniotomies were performed above the region of the medial prefrontal cortex (mPFC) and ipsilateral (CA)1/subiculum. Body temperature of the rat was maintained at 37 °C with an electrical heating pad (Harvard Apparatus, USA). The femoral vein was cannulated for administration of test drugs. After the conclusion of the experiments, animals were euthanized with an IV bolus of urethane. All surgical procedures were conducted in accordance with an approved animal use protocol in compliance with the Animal Welfare Act Regulations and with the Guide for the Care and Use of Laboratory Animals, National Institutes of Health guidelines.</div></div><div id="sec4_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Electrophysiological Recordings</h4><div class="NLM_p last">Unilateral hippocampal EEG was recorded by a metal, monopolar macro electrode (Rhodes Medical Instruments, Inc., model SNEX-300) placed in the mPFC region (coordinates: 3.4 mm anterior from the bregma, 0.6 mm lateral from the midline, and 5.0 mm ventral) as described previously (Kiss et al, 2011<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>). Field potentials were amplified, filtered (0.1–100 Hz), displayed, and digitized at 2000 Hz for on-line and off-line analysis (Spike2 program; Cambridge Electronic Design, Cambridge, UK). Electrically evoked responses distinguished in the EEG and quantitative EEG analysis were performed by means of waveform averages and fast Fourier transformation, respectively (Spike2 program). Power spectrum density of the spontaneous EEG was computed in the δ, or 0–4 Hz frequency range over the same time periods used to measure the PPF responses. The EEG activity in normal rats under urethane anesthesia during baseline activity is a synchronous, sinusoidal oscillation which ranges from 1.8 to 2.4 Hz (Hz). Following MK-801 administration, the cortical EEG shifts within the delta band to a less synchronous, higher amplitude signal of 0.5–1.8 Hz. Disruption of the cortical EEG following MK-801 injection was quantified by calculating the percentage of total power that occurred in the 0.5–1.8 Hz frequency range compared to the entire 0–4 Hz δ band.</div></div><div id="sec4_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Paired-Pulse Stimulus, Waveform Averages, Data Analysis, and Statistics</h4><div class="NLM_p last">Twisted, stainless steel, bipolar stimulating electrodes were placed in the CA1/subiculum (coordinates: 5.4 mm posterior from the bregma, 5.0 mm lateral and 8.0 mm ventral) (Kiss et al, 2011<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>). Paired-pulse stimulation consisted of two square-pulses, duration 0.1 ms, 0.6–2.5 mA, pair-pulse interval of 100 ms, interstimulus interval of 10 s generated continuously from a Master 8 stimulator (A.P.M.I., Jerusalem, Israel). The intensity of the stimulation was adjusted so that size of the P1 response was ∼100 μV.</div></div><div id="sec4_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Brain cGMP Measures</h4><div class="NLM_p last">Brain tissue measurements of cGMP accumulation following drug administration were carried out as previously described (Schmidt et al., 2008).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(29)</a> CD-1 mice were sacrificed by focused microwave irradiation of the brain. Regions of interest were isolated and homogenized in 0.5 N HCL followed by centrifugation. Supernatant concentrations of cyclic nucleotides were measured using enzyme immunoassay kits (Cayman Chemical, Ann Arbor, MI). Data were analyzed using a One-Way ANOVA followed by Fishers’ PLSD test with the criterion for significance set at <i>p</i> < 0.05.</div></div><div id="sec4_9_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Neuropharmacokinetic Studies in Wistar–Hannover or Sprague–Dawley Rats and/or DRC Mice</h4><div class="NLM_p last">The in-life portion of these studies were conducted at either Pfizer Inc. (Groton, CT) or Bioduro Inc. (Shanghai, China), while the bioanalytical portions of these studies were conducted at Pfizer Inc. (Groton, CT). Rats received single intravenous (IV) or subcutaneous (SC) doses of <b>71</b>. The IV dose was prepared as a solution in 5/5/90 DMSO/Cremaphor/saline or hydroxypropyl-β-cyclodextrin acidified while the SC dose was prepared as a solution in 20% SBE-BCD + 2ME 1 N HCl in a volume of 1 mL/kg. Blood samples were collected via cardiac puncture in ethylenediaminetetraacetic acid (EDTA) treated tubes at designated times between 2 min and 24 h, while whole brain and/or cerebrospinal fluid (CSF) samples were collected at the same time points as blood via terminal matrix samplings. Plasma was isolated after centrifugation and placed on wet ice, while CSF was collected into tubes via puncture of the cisterna magna and immediately placed on dry ice and brains were rinsed with saline and blotted dry before being placed on dry ice. Thawed whole brain samples were homogenized on ice with water and/or saline 4× the weight as the brain (1:4, w/v). All samples were stored at −80 °C prior to analysis.</div></div><div id="sec4_9_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Measurement of in Vitro Fractions Unbound</h4><div class="NLM_p">The in vitro unbound fractions of <b>71</b> were determined in mouse, rat, and human plasma and in rat brain tissue homogenate using a 96-well equilibrium dialysis method described by Kalvass et al., with the following exceptions at Pfizer Inc. (Groton, CT). Plasma samples were obtained from BioReclamation (Chestertown, MD) and kept frozen until they were thawed, and pH was adjusted to ∼7.4 prior to dialysis. Mouse, rat, and human plasma was spiked with 1 μM of <b>71</b>, and each matrix was dialyzed against an equal volume (150 μL) of phosphate buffer at 37 °C for 6 h. Following the incubations, equal volumes (50 μL) of plasma and buffer samples were collected and mixed with 50 μL of buffer or control plasma, respectively, for preparation of separate mixed matrix samples. Following the incubations, 15 μL of plasma or 45 μL of buffer samples were collected and mixed with 15 or 45 μL of buffer or control plasma, respectively, for preparation of mixed matrix samples. All samples were then precipitated with internal standard in MeCN (200 μL), vortexed, and centrifuged. Supernatants were analyzed using an LC–MS/MS assay.</div><div class="NLM_p last">Brain homogenates were prepared from freshly harvested rat brains following dilution with a 4-fold volume of phosphate buffer and spiked with 5 μM <b>71</b>. The homogenate was dialyzed against an equal volume (150 μL) of phosphate buffer at 37 °C for 6 h. Following the incubation, equal volumes (50 μL) of brain homogenate and buffer samples were collected and mixed with 50 μL of buffer or control homogenate, respectively, for preparation of mixed matrix samples. All samples were then precipitated with internal standard in MeCN (200 μL), vortexed, and centrifuged. Supernatants were analyzed using an LC–MS/MS assay. A dilution factor of 5 was applied to the calculation of brain fraction unbound. The brain fraction unbound obtained in rat was used in calculating the unbound fraction of drug in both rat and mouse brain.</div></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Computational Methods</h3><div class="NLM_p last">Dihedral angle scans were performed on truncated systems comprised of the phenyl pyrazole with and without a methyl at the N1 position, as well as the NH pyrazole tautomer. The dihedral angle was increased from 0° to 360° in increments of 10°, and each resultant structure was optimized at the B3LYP-D3/6-31+G** level of theory<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(30)</a> followed by single-point energy calculations at the M06-2X/cc-PVDZ level of theory<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(31)</a> in Jaguar (version 8.7, Schrödinger, LLC: New York, NY, 2015). Conformational strain energies were calculated as follows: (1) the tautomers (<b>40</b> and <b>42</b>) and <b>41</b> were overlaid with the bound conformation of Q5 from the X-ray co-crystal structure using ROCS (version 3.2.0.4: OpenEye Scientific Software, Santa Fe, NM. <a href="http://www.eyesopen.com" class="extLink">http://www.eyesopen.com</a>)<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(32)</a> to do a flexible molecular superposition, (2) the dihedral angle was adjusted to the optimal angle from the DFT scan (0° and 30° for the tautomers (<b>40</b> and <b>42</b>) and 40° for <b>41</b>) or constrained to the X-ray co-crystal structure angle (67°), and (3) the energies were calculated at the M06-2X/cc-PVDZ//B3LYP-D3/6-31+G** level of theory. Conformational energy penalties were estimated by subtracting the relative energy at the local minima dihedral angle for the tautomers (<b>40</b> and <b>42</b>) and <b>41</b> from their respective energies at the dihedral angle of the X-ray co-crystal structure, based on <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Protein X-ray Crystallography</h3><div class="NLM_p">The catalytic domain of human PDE2A was recombinantly expressed, purified, and co-crystallized with 3-isobutyl-1-methylxanthine (IBMX) as previously described.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Complexes with other inhibitors were obtained either by soaking (for <b>3</b>, <b>4</b>, and <b>39</b>) or by co-crystallization (for <b>1</b> and <b>56</b>). The reservoir solution was used to make a saturated solution of the desired inhibitor for soaking, and one or two crystals of the IBMX complex were soaked in this solution for 2–24 h. Co-crystals with <b>1</b> were obtained from the same conditions as the original co-crystals with IBMX, and <b>39</b> yielded the best cocrystals in drops that contained a different precipitant (20–25% PEG 8000).</div><div class="NLM_p">Crystals were flash-frozen in liquid nitrogen after being briefly dipped in a cryoprotectant solution consisting of the soaking/crystallization buffer supplemented with 25% glycerol.</div><div class="NLM_p">X-ray diffraction data were collected at 100 K with radiation of wavelength 1.0 Å at the Advanced Photon Source at Argonne National Laboratory, beamline 17ID, and were integrated and scaled with programs of the HKL2000 package.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(33)</a> Subsequent data manipulations, including refinement, were carried out using the CCP4 suite of programs.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(34)</a> All the structures were solved by molecular replacement using the IBMX complex structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ITU">3ITU</a>) as the search model. All-atom refinement was done either with Refmac5<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(35)</a> or autoBUSTER.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(36)</a> Details of data collection and refinement statistics are given in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00397/suppl_file/jm7b00397_si_001.pdf" class="ext-link">Supporting Information</a>.</div><div class="NLM_p last">Use of the IMCA-CAT beamline 17- ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman–Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357.″</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Chemistry Experimental Section</h3><div class="NLM_p">Experiments were generally carried out under inert atmosphere (nitrogen or argon), particularly in cases where oxygen- or moisture-sensitive reagents or intermediates were employed. Commercial solvents and reagents were generally used without further purification, including anhydrous solvents where appropriate (generally Sure-Seal products from the Aldrich Chemical Co., Milwaukee, Wisconsin). Mass spectrometry (MS) data is reported from liquid chromatography–mass spectrometry (LCMS) or atmospheric pressure chemical ionization (APCI) instrumentation. Chemical shifts for nuclear magnetic resonance (NMR) data are expressed in parts per million (ppm, δ) referenced to residual peaks from the deuterated solvents employed, or to tetramethylsilane standard with multiplicities given as s (singlet), br (broad), d (doublet), t (triplet), dt (doublet of triplets), q (quintet), m (multiplet). Compound purity is determined by high performance liquid chromatography (HPLC), and all final test compounds were >95% purity. All final compounds were assessed for purity by HPLC via the following general conditions. Column: Waters Atlantis dC18 4.6 × 50, 5 μ. Mobile phase A: 0.05% TFA in water (v/v). Mobile phase B: 0.05% TFA in MeCN (v/v). Gradient: 95.0% water/5.0% MeCN linear to 5% water/95% MeCN in 4.0 min, HOLD at 5% water/95% MeCN to 5.0 min. Flow: 2 mL/min.</div><div id="sec4_12_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 3-Isobutyl-4-(isoindolin-2-yl)-1-methyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>2</b>)</h4><div id="sec4_12_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> Step 1: 2-(1-Hydroxy-3-methylbutylidene)malononitrile (<b>7</b>)</h5><div class="NLM_p last">To a stirred solution of malononitrile (91.5 g, 1.38 mol) in anhydrous THF (2 L) was added sodium hydride (60% dispersion in mineral oil, 121 g, 3.04 mol) in portions below 10 °C. The resultant mixture was stirred for 1 h, at which point 3-methylbutanoyl chloride (<b>6</b>, 200 g, 1.08 mol) was added dropwise while maintaining an internal temperature below 10 °C. The resultant solution was stirred for 30 min at this temperature and was then allowed warm to rt where it was stirred overnight. The reaction mixture was acidified with 2 M aqueous HCl to pH 2–3 and was extracted with EtOAc (2 L × 3). The organic layer was washed with brine (1 L) and concentrated to give 157.3 g (76%) of the title compound as an amber liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.16 (s, 1H), 2.47 (d, 2H, <i>J</i> = 8 Hz), 2.12 (m, 1H), 1.04 (d, <i>J</i> = 6 Hz, 6 H).</div></div><div id="sec4_12_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> Step 2: 2-(1-Methoxy-3-methylbutylidene)malononitrile (<b>8</b>)</h5><div class="NLM_p last">Sodium bicarbonate (482 g, 6.03 mol) was added protionwise to a solution of compound <b>7</b> (100 g, 0.67 mol) in a mixture of dioxane (770 mL) and water (130 mL). Dimethyl sulfate (575 g, 4.15 mol) was added dropwise while cooling with an ice-bath. The resultant mixture was stirred at room temperature for 3 days. The mixture was filtered, and the cake was partitioned between water (1×) and EtOAc (2×). The filtrate was concentrated under reduced pressure to remove dioxane, and the aqueous residue was extracted with EtOAc (1 L × 4). The combined organic layers were washed with brine (300 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give crude product, which was purified by silica gel chromatography eluting with petroleum ether/EtOAc to afford 370 g (56%) of the title compound as a yellow liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.14 (s, 1H), 3.95 (s, 3H), 2.54 (d, <i>J</i> = 10 Hz, 2H), 2.02 (m, 1H), 1.05 (d, <i>J</i> = 9.2 Hz, 6 H).</div></div><div id="sec4_12_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> Step 3: 3-Isobutyl-4-isocyano-1-methyl-1<i>H</i>-pyrazol-5-amine (<b>9</b>)</h5><div class="NLM_p last">To a stirred solution of compound <b>8</b> (110 g, 0.67 mol) in ethanol (800 mL) was added methyl hydrazine (61.8 g, 1.34 mol), and the resultant mixture was heated at 65 °C for 2 days. The mixture was concentrated, and the residue was dissolved in EtOAc (300 mL), washed with water (100 mL) and brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude product was purified by silica gel chromatography eluting with petroleum ether/EtOAc to afford 130 g (35%) of the title compound as a yellow liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.58 (s, 3H), 2.46 (d, <i>J</i> = 7.2 Hz, 2H), 2.03 (m, 1H), 0.95 (d, <i>J</i> = 6.4 Hz, 6 H).</div></div><div id="sec4_12_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> Step 4: 5-Amino-3-isobutyl-1-methyl-1<i>H</i>-pyrazole-4-carboxamide (<b>10</b>)</h5><div class="NLM_p last">Compound <b>9</b> (147 g, 0.826 mol) was added to H<sub>2</sub>SO<sub>4</sub> (650 mL) in portions below 10 °C. After the addition, the resultant mixture was heated to 60 °C for 2 h. The reaction mixture was cooled to room temperature and poured into crushed ice. The mixture was carefully basified ammonium hydroxide to pH 9 while adding additional ice as needed. The mixture was left standing overnight then was filtered. The resultant solid was dissolved in EtOAc (1 L), washed with brine (200 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give 55 g of the title compound. The filtrate from above was extracted with EtOAc (3 L × 2). The organic layer was washed with brine (1 L), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give an additional 55 g of the title compound for a combined yield of 110 g (68%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.53 (brs, 2H), 5.28 (m, 2H), 3.48 (s, 3H), 2.45 (d, <i>J</i> = 9.6 Hz, 2H), 1.98 (m, 1H), 0.92 (d, <i>J</i> = 6.8 Hz, 6 H).</div></div><div id="sec4_12_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> Step 5: 3-Isobutyl-1-methyl-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>11</b>)</h5><div class="NLM_p last">A solution of compound <b>10</b> (55 g, 0.28 mol) in formic acid (500 mL) was heated to reflux overnight. The mixture was then concentrated under reduced pressure, and the residue was washed with MeOH (60 mL × 2) and dried under vacuum to afford 41 g (71%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.15 (s, 1H), 7.91 (s, 1H), 3.90 (s, 3H), 2.78 (d, <i>J</i> = 7.2 Hz, 2H), 2.17 (m, 1H), 0.92 (d, <i>J</i> = 6.8 Hz, 6H). LC/MS (M + H): 207.</div></div><div id="sec4_12_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> Step 6: 4-Chloro-3-isobutyl-1-methyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>12</b>)</h5><div class="NLM_p last">Compound <b>11</b> (5 g, 2.41 mmol) was suspended in POCl<sub>3</sub> (35 mL), and the mixture was heated at 110 °C for 4 h. After cooling to rt, excess POCl<sub>3</sub> was removed under reduced pressure. To the residue was added dichloromethane (50 mL) and ice-cold water (1 mL). The organic layer was separated and aqueous layer was extracted with dichloromethane (20 mL). The combined organic layer was dried over MgSO<sub>4</sub> and concentrated to give the crude title product, which was taken onto the next step without purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.72 (s, 1H), 4.11 (s, 3H), 2.99 (d, <i>J</i> = 8.0 Hz, 2H), 2.19 (m, 1H), 1.03 (d, <i>J</i> = 4.0 Hz, 6H). LC/MS = 225 (M + H).</div></div><div id="sec4_12_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> Step 7: 3-Isobutyl-4-(isoindolin-2-yl)-1-methyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>2</b>)</h5><div class="NLM_p last">To a solution of <b>12</b> (264 mg, 1.17 mmol) and isoindoline (340 mg, 2.86 mmol) in MeCN (5 mL) was added TEA (0.4 mL). The mixture was stirred overnight at room temperature. The solvent was removed in vacuo, and the residue was purified by silica gel chromatography eluting with 4:6 EtOAc/hexane to afford 271 mg (75%) of the title product. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.39 (s, 1H), 7.33 (m, 4H), 5.19 (s, 4H), 3.99 (s, 3H), 3.01 (d, <i>J</i> = 7.2 Hz, 2 H), 2.01 (m, 1H), 0.95 (d, <i>J</i> = 6.8 Hz, 6H). LC/MS = 308 (M + H).</div></div></div><div id="sec4_12_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 3-Isobutyl-4-(3-(4-methoxyphenoxy)azetidin-1-yl)-1-methyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>4</b>)</h4><div class="NLM_p last">To <b>12</b> (773 mg, 3.44 mmol) and 3-(4-methoxyphenoxy)azetidine (617 mg, 3.44 mmol) in THF (16 mL) and water (2 mL) was added K<sub>2</sub>CO<sub>3</sub> (435 mg, 0.915 mmol). The mixture was stirred at rt overnight and the organic phase was removed, dried over MgSO<sub>4</sub>, and concentrated. The crude residue was recrystallized from 2:8 EtOAc/heptane to afford 960 mg (76%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.39 (s, 1H), 6.86 (d, <i>J</i> = 8.0 Hz, 2H), 6.72 (d, <i>J</i> = 8.0 Hz, 2H), 5.05 (m, 1H), 4.77 (m, 2H), 4.42 (m, 2H), 3.96 (s, 3H), 3.78 (s, 3H), 2.76 (d, <i>J</i> = 8.0 Hz, 2H), 2.05 (m, 1H), 0.93 (d, <i>J</i> = 8.0 Hz, 6H). LC/MS = 368 (M + H).</div></div><div id="sec4_12_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 3-Isobutyl-5-(2-methoxyphenethoxy)-[1,2,4]triazolo[4,3-<i>a</i>]pyrazine (<b>3</b>)</h4><div id="sec4_12_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> Step 1: 5-Chloro-3-isobutyl-[1,2,4]triazolo[4,3-<i>a</i>]pyrazine (<b>29a</b>)</h5><div class="NLM_p last">To a solution of isovaleraldehyde (<b>18a</b>, 714 mg, 8.29 mmol) and 2-chloro-6-hydrazinylpyrazine (<b>28</b>, 1000 mg, 6.917 mmol) in dichloromethane (50 mL) was added (diacetoxyiodo)benzene (3.34 g, 10.4 mmol). The reaction solution was stirred at room temperature for 18 h. The reaction mixture was concentrated and purified by silica gel chromatography (heptane/EtOAc 0–100% gradient) to afford the title compound in 84% yield (1220 mg, 5.79 mmol). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.21 (s, 1H), 7.81 (s, 1H), 3.36 (d, <i>J</i> = 7.02 Hz, 2H), 2.32 (td, <i>J</i> = 6.83, 13.66 Hz, 1H), 1.07 (d, <i>J</i> = 6.63 Hz, 6H).</div></div><div id="sec4_12_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> Step 2: 3-Isobutyl-5-(2-methoxyphenethoxy)-[1,2,4]triazolo[4,3-<i>a</i>]pyrazine (<b>3</b>)</h5><div class="NLM_p last">To a flame-dried flask under a flow of nitrogen was added 2-(2-methoxyphenyl)ethan-1-ol (260 mg, 1.70 mmol). THF (5 mL) was added, followed by addition of sodium hydride (60% dispersion in mineral oil, 71 mg, 1.78 mmol). The reaction was stirred at room temperature for 5 min. 5-Chloro-3-isobutyl-[1,2,4]triazolo[4,3-<i>a</i>]pyrazine (300 mg, 1.42 mmol) dissolved in THF (2 mL) was added dropwise, and the reaction was stirred at room temperature for 2 h. The reaction was concentrated and the residue purified by silica gel chromatography (heptane/EtOAc 100%/0% to 0%/100% gradient). Fractions collected to give the title compound in 58% yield (465 mg, 0.827 mmol). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.88 (s, 1H), 7.28–7.32 (m, 1H), 7.23 (s, 1H), 7.22 (d, <i>J</i> = 7.02 Hz, 1H), 6.87–6.99 (m, 2H), 4.52 (t, <i>J</i> = 7.02 Hz, 2H), 3.86 (s, 3H), 3.27 (t, <i>J</i> = 7.22 Hz, 2H), 3.16 (d, <i>J</i> = 7.02 Hz, 2H), 2.23 (td, <i>J</i> = 6.68, 13.56 Hz, 1H), 0.99 (d, <i>J</i> = 6.63 Hz, 6H). LC/MS = 327.3 (M + H).</div></div></div><div id="sec4_12_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Library Synthesis Protocol: <a class="ref internalNav" href="#sch4" aria-label="Scheme 3">Scheme 3</a></h4><table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">1.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Prepare 0.40 M aldehyde <b>18</b> in 1,2-dichloroethane (DCE).</p></td></tr><tr class="li1"><td valign="top">2.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Prepare 0.40 M hydrazine <b>20</b> in DCE.</p></td></tr><tr class="li1"><td valign="top">3.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Prepare 0.20 M iodobenzene diacetate in 1,2-dichloroethane (DCE).</p></td></tr><tr class="li1"><td valign="top">4.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense 800 μL of 0.40 M aldehyde solution to the vials.</p></td></tr><tr class="li1"><td valign="top">5.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense 800 μL of 0.40 M hydrazine solution to the vials.</p></td></tr><tr class="li1"><td valign="top">6.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense 1250 μL of 0.20 M iodobenzene diacetate solution.</p></td></tr><tr class="li1"><td valign="top">7.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Cover with plastic sheets.</p></td></tr><tr class="li1"><td valign="top">8.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Vortex. Please make sure intermediates are in solution before proceeding.</p></td></tr><tr class="li1"><td valign="top">9.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Cover with plastic sheets.</p></td></tr><tr class="li1"><td valign="top">10.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Set in a fume hood for 2 h with the plastic sheets on.</p></td></tr><tr class="li1"><td valign="top">11.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Remove solvents.</p></td></tr><tr class="li1"><td valign="top">12.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense 1600 μL of DMSO to the vials.</p></td></tr><tr class="li1"><td valign="top">13.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Vortex until dissolved.</p></td></tr><tr class="li1"><td valign="top">14.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Purify by HPLC.</p></td></tr></table></div><div id="sec4_12_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Resynthesis of Library Compound <b>22</b>: 3-(3-(4-(Trifluoromethyl)phenyl)-1<i>H</i>-pyrazol-4-yl)-[1,2,4]triazolo[4,3-<i>a</i>]pyrazine</h4><div class="NLM_p last">To 2-hydrazinylpyrazine (<b>20</b>) (152 mg, 1.38 mmol), 5-(4-trifluoromethyl)phenyl)-1<i>H</i>-pyrazole-4-carbaldehyde (398 mg, 1.66 mmol), and diacetoxyiodobenzene (444 mg, 1.38 mmol) was added dichloromethane (5 mL). The reaction mixture was stirred at room temperature for 16 h. The reaction was then partitioned between dichloromethane and water. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by silica gel chromatography (EtOAc/methanol 0–10% gradient) to yield 45 mg (0.136 mmol, 9.9%) of the title compound. <sup>1</sup>H NMR (600 MHz, DMSO<sub>1</sub>) δ 9.46 (d, <i>J</i> = 1.32 Hz, 1H), 8.54 (br s, 1H), 8.19 (dd, <i>J</i> = 1.54, 4.61 Hz, 1H), 7.88 (d, <i>J</i> = 4.83 Hz, 1H), 7.75 (d, <i>J</i> = 7.91 Hz, 2H), 7.68 (br s, 2H). LC/MS = 331.2 (M + H).</div></div><div id="sec4_12_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Library Synthesis Protocol: <a class="ref internalNav" href="#sch5" aria-label="Scheme 4">Scheme 4</a></h4><div id="sec4_12_3_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> Step 1: S<sub>N</sub>Ar by R<sub>1</sub>OH</h5><table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">1.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Prepare 1.2 M stock solution of core template in anhydrous THF.</p></td></tr><tr class="li1"><td valign="top">2.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Prepare 1.2 M stock solution of corresponding alcohols in anhydrous THF.</p></td></tr><tr class="li1"><td valign="top">3.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Prepare 1.2 M stock solution of KO-<i>t</i>-Bu in THF.</p></td></tr><tr class="li1"><td valign="top">4.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense 500 μL (1.0  equiv, 600 μmol) of the corresponding alcohols solution from step 2 into an each single 6 mL tube in a 48-tube plate.</p></td></tr><tr class="li1"><td valign="top">5.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense 600 μL (1.2 equiv, 720 μmol) of KO-<i>t</i>-Bu solution from step 3 into the each test tube.</p></td></tr><tr class="li1"><td valign="top">6.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The tubes were closed, and the reaction mixture was stirred using Vortex at room temp for 30 s.</p></td></tr><tr class="li1"><td valign="top">7.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The new 48-tube plate was prepared for the template solution.</p></td></tr><tr class="li1"><td valign="top">8.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense 500 μL (1.0  equiv, 600 μmol) of the core template solution into an each single 6 mL tube in a 48-tube plate.</p></td></tr><tr class="li1"><td valign="top">9.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Open the tubes from step 6, transfer all the amount (1.1 mL) of the THF solution into the each test tube from step 8 portionwise, by 200 μL.</p></td></tr><tr class="li1"><td valign="top">10.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The tubes were closed, the reaction mixture was stirred using Vortex at room temp for 30 s<sup>–1</sup> min.</p></td></tr><tr class="li1"><td valign="top">11.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Prepare 0.7 M stock solution of AcOH in DCM.</p></td></tr><tr class="li1"><td valign="top">12.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense 900 μL (1.0  equiv, 630 μmol) of the AcOH solution from step 11 into the each test tube from step 10.</p></td></tr><tr class="li1"><td valign="top">13.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The reaction mixture was stirred using Vortex at room temp for 30 s.</p></td></tr><tr class="li1"><td valign="top">14.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The solution from step 13 was evaporated in Zymark at ∼40 °C for 4 h.</p></td></tr></table></div><div id="sec4_12_3_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> Step 2: Substitution by Hydrazine</h5><table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">15.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The tubes with the products from step A (by 600 μmol) were distributed to the 48-tubes plate.</p></td></tr><tr class="li1"><td valign="top">16.</td><td colspan="5" valign="top" class="paragraph"><p class="last">500 μL of EtOH were added into the each tube.</p></td></tr><tr class="li1"><td valign="top">17.</td><td colspan="5" valign="top" class="paragraph"><p class="last">500 μL of hydrazine monohydrate were added into the each tube (the ratio of hydrazine/EtOH = 1:1 is very important).</p></td></tr><tr class="li1"><td valign="top">18.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The tubes were closed, and the reaction mixture was stirred using Vortex at room temp.</p></td></tr><tr class="li1"><td valign="top">19.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The reaction mixture was stirred at 80 °C for 4–5 h.</p></td></tr><tr class="li1"><td valign="top">20.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The reaction mixture was cooled to room temperature.</p></td></tr><tr class="li1"><td valign="top">21.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The solution from step 20 was evaporated in Zymark at ∼50 °C for 4 h.</p></td></tr><tr class="li1"><td valign="top">22.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Two mL of EtOAc were added into the each tube.</p></td></tr><tr class="li1"><td valign="top">23.</td><td colspan="5" valign="top" class="paragraph"><p class="last">500 μL of 5% NaCl aq solution were added into the each tube.</p></td></tr><tr class="li1"><td valign="top">24.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The reaction mixture was stirred using Vortex for 20 s.</p></td></tr><tr class="li1"><td valign="top">25.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Allow the mixture to give two layers.</p></td></tr><tr class="li1"><td valign="top">26.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Transfer 2000 μL of top organic layer to Celite column.</p></td></tr><tr class="li1"><td valign="top">27.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Do not transfer any water layer (very important).</p></td></tr><tr class="li1"><td valign="top">28.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Filter through Celite, collect the fraction.</p></td></tr><tr class="li1"><td valign="top">29.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Again, 2 mL of EtOAc were added into the each tube with the water layer.</p></td></tr><tr class="li1"><td valign="top">30.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The reaction mixture was stirred using Vortex for 20 s.</p></td></tr><tr class="li1"><td valign="top">31.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Allow the mixture to give two layers.</p></td></tr><tr class="li1"><td valign="top">32.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Transfer 2000 μL of top organic layer to the same Celite column.</p></td></tr><tr class="li1"><td valign="top">33.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Do not transfer any water layer (very important).</p></td></tr><tr class="li1"><td valign="top">34.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Filter through Celite, collect the fraction.</p></td></tr><tr class="li1"><td valign="top">35.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Again, 2 mL of EtOAc were added into the each tube with the water layer.</p></td></tr><tr class="li1"><td valign="top">36.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The reaction mixture was stirred using Vortex for 20 s.</p></td></tr><tr class="li1"><td valign="top">37.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Allow the mixture to give two layers.</p></td></tr><tr class="li1"><td valign="top">38.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Transfer 2000 μL of top organic layer to the same Celite column.</p></td></tr><tr class="li1"><td valign="top">39.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Do not transfer any water layer (very important).</p></td></tr><tr class="li1"><td valign="top">40.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Filter through Celite, collect the fraction.</p></td></tr><tr class="li1"><td valign="top">41.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Fractions from steps 28, 34, and 40 were combined and evaporated in Zymark at ∼40 °C for 5 h.</p></td></tr></table></div><div id="sec4_12_3_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> Step 3: Hydrazone formation/Cyclization</h5><table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">42.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The tubes with the products from step B (by 600 μmol, really ∼100–150 μmol) were distributed to the 48-tube plate.</p></td></tr><tr class="li1"><td valign="top">43.</td><td colspan="5" valign="top" class="paragraph"><p class="last">500 μL of MeCN were added into the each tube.</p></td></tr><tr class="li1"><td valign="top">44.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Prepare 0.3 M stock solution of corresponding aldehydes in anhydrous MeCN.</p></td></tr><tr class="li1"><td valign="top">45.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense 500 μL (1.1–1.3  equiv, 150 μmol) of the aldehyde solution into an each single 6 mL tube in a 48-tube plate.</p></td></tr><tr class="li1"><td valign="top">46.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Ten μL of AcOH were added into the each tube.</p></td></tr><tr class="li1"><td valign="top">47.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The tubes were closed, and the reaction mixture was stirred using Vortex at room temp.</p></td></tr><tr class="li1"><td valign="top">48.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The reaction mixture was stirred at room temperature for 2 h.</p></td></tr><tr class="li1"><td valign="top">49.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Prepare 0.3 M stock solution of PhI(OAc)<sub>2</sub> (iodobenzene diacetate) in anhydrous MeCN.</p></td></tr><tr class="li1"><td valign="top">50.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Open the tubes, dispense 500 μL (1.2  equiv, 150 μmol) of the iodobenzene diacetate solution into the each test tube.</p></td></tr><tr class="li1"><td valign="top">51.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The tubes were closed, and the reaction mixture was stirred using Vortex at room temp.</p></td></tr><tr class="li1"><td valign="top">52.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The reaction mixture was stirred at 80 °C for 2 h.</p></td></tr></table></div></div><div id="sec4_12_3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Library Synthesis Protocol: <a class="ref internalNav" href="#sch6" aria-label="Scheme 5">Scheme 5</a></h4><div id="sec4_12_3_1_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> Step 1: Suzuki Reaction</h5><table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">1.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Prepare a solution of 5-iodo-1-methyl-1<i>H</i>-pyrazole <b>25</b> (0.1875 M, solution A) in DMF.</p></td></tr><tr class="li1"><td valign="top">2.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Prepare a solution of Pd(dppf)Cl<sub>2</sub> (0.0375 M, solution B) in DMF.</p></td></tr><tr class="li1"><td valign="top">3.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense requisite aryl boronate (225 μmol, 1.5 equiv) to 8 mL vials.</p></td></tr><tr class="li1"><td valign="top">4.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense Cs<sub>2</sub>CO<sub>3</sub> (97 mg, 300 μmol, 2.0 equiv) to each vial.</p></td></tr><tr class="li1"><td valign="top">5.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense 800 μL of solution A (150 μmol, 1.0 equiv) to 8 mL vials.</p></td></tr><tr class="li1"><td valign="top">6.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense 200 μL of solution B (7.5 μmol, 0.05 equiv) to each vial under nitrogen atmosphere.</p></td></tr><tr class="li1"><td valign="top">7.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The reaction solution was bubbled with nitrogen gas for about one min.</p></td></tr><tr class="li1"><td valign="top">8.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Cap the vials and shake at 60 °C for 16 h.</p></td></tr><tr class="li1"><td valign="top">9.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Spot check by LC-MS.</p></td></tr><tr class="li1"><td valign="top">10.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The mixture from the vials was filtered, and the filtrate was concentrated with a Speedvac.</p></td></tr><tr class="li1"><td valign="top">11.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The residue was purified by prep TLC (EtOAc/petroleum ether = 1:3) to give substituted pyrazoles <b>26</b>.</p></td></tr></table></div><div id="sec4_12_3_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> Step 2: Iodination</h5><table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">12.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense substituted pyrazoles <b>26</b> to 8 mL vials.</p></td></tr><tr class="li1"><td valign="top">13.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense NIS (<i>N</i>-iodosuccinimide, 23 mg, 105 μmol, 1.05 equiv) to each vial.</p></td></tr><tr class="li1"><td valign="top">14.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Cap the vials and shake at 30 °C for 16 h.</p></td></tr><tr class="li1"><td valign="top">15.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense another batch of NIS (13 mg, 50 μmol, 0.5 equiv) to each vial.</p></td></tr><tr class="li1"><td valign="top">16.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Cap the vials and shake at 80 °C for 16 h.</p></td></tr><tr class="li1"><td valign="top">17.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Spot check by LC-MS.</p></td></tr><tr class="li1"><td valign="top">18.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The solvent was evaporated off by Speedvac.</p></td></tr><tr class="li1"><td valign="top">19.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Water (1.5 mL) was added.</p></td></tr><tr class="li1"><td valign="top">20.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The mixture was extracted with EtOAc (1.5 mL × 3). See Library Synthesis Protocol: <a class="ref internalNav" href="#sch5" aria-label="Scheme 4">Scheme 4</a>, steps 14–24.</p></td></tr><tr class="li1"><td valign="top">21.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The organic layer was collected, washed with saturated brine (1.5 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and was filtered.</p></td></tr><tr class="li1"><td valign="top">22.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The filtrate was concentrated to give crude substituted iodopyrazoles <b>27</b>, which were used for the next step without further purification.</p></td></tr></table></div><div id="sec4_12_3_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> Step 3: Aldehyde Formation</h5><table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">23.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The solvent DMF was bubbled with CO (g) to saturation before using.</p></td></tr><tr class="li1"><td valign="top">24.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense Pd(OAc)<sub>2</sub> (1.1 mg, 5 μmol, 0.05 equiv) to 8 mL vials containing the crude substituted iodopyrazoles <b>27</b>.</p></td></tr><tr class="li1"><td valign="top">25.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense 1,1′-bis-diphenylphosphino-ferrocene (5.5 mg, 10 μmol, 0.1 equiv) to each vial.</p></td></tr><tr class="li1"><td valign="top">26.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense Et<sub>3</sub>N (35 μL, 250 μmol, 2.5 equiv) to each vial.</p></td></tr><tr class="li1"><td valign="top">27.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense 1 mL of DMF saturated with CO (g) to each vial.</p></td></tr><tr class="li1"><td valign="top">28.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense Et<sub>3</sub>SiH (35 μL, 200 μmol, 2.0 equiv) to each vial.</p></td></tr><tr class="li1"><td valign="top">29.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The reaction solution was bubbled with CO (g) for about one min at 0 °C.</p></td></tr><tr class="li1"><td valign="top">30.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Cap the vials and shake at 60 °C for 48 h.</p></td></tr><tr class="li1"><td valign="top">31.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Spot check by LC-MS.</p></td></tr><tr class="li1"><td valign="top">32.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The mixture was concentrated by Speedvac, and the residue was purified by prep TLC (EtOAc/petroleum ether = 1:1) to give title pyrazole aldehdyes</p></td></tr></table></div><div id="sec4_12_3_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> Steps 4/5: Hydrazone Formation/Cyclization</h5><table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">33.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense 2-hydrazinyl-6-propoxypyrazine (<b>17a</b>, 10 mg, 60 μmol, 1.0 equiv) to 8 mL vials containing the pyrazole aldehdyes</p></td></tr><tr class="li1"><td valign="top">34.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense 300 μL of EtOH to each vial.</p></td></tr><tr class="li1"><td valign="top">35.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Cap the vials and shake at 80 °C for 1 h.</p></td></tr><tr class="li1"><td valign="top">36.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The reaction mixture was cooled to room temperature.</p></td></tr><tr class="li1"><td valign="top">37.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense another 300 μL of EtOH to each vial.</p></td></tr><tr class="li1"><td valign="top">38.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Dispense (diacetoxyiodo)benzene (20 mg, 60 μmol, 1.0 equiv) to each vial.</p></td></tr><tr class="li1"><td valign="top">39.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Cap the vials and shake at 30 °C for 16 h.</p></td></tr><tr class="li1"><td valign="top">40.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Spot check by LC-MS.</p></td></tr><tr class="li1"><td valign="top">41.</td><td colspan="5" valign="top" class="paragraph"><p class="last">The reaction mixture was concentrated by Speedvac.</p></td></tr><tr class="li1"><td valign="top">42.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Purify by HPLC.</p></td></tr></table></div></div><div id="sec4_12_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> General Resynthesis Procedure for Compounds Prepared via <a class="ref internalNav" href="#sch5" aria-label="Scheme 4">Scheme 4</a> and <a class="ref internalNav" href="#sch6" aria-label="5">5</a> Library Synthesis Protocols: Compounds <b>30</b>–<b>39</b></h4><div id="sec4_12_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> Steps 1/2: Hydrazone Formation/Cyclization</h5><div class="NLM_p last">To a 2 dram vial was added 2-chloro-6-hydrazinylpyrazine (<b>28</b>, 1 equiv), the appropriate aldehyde (1.2 equiv), and dichloromethane (0.0875M). The reaction was stirred at room temperature for 5 min. (Diacetoxyiodo)benzene (1  equiv) was added, and the reaction was stirred at room temperature for 18 h. Dess–Martin periodinane (1 equiv) was added, and the reaction was allowed to stir at room temperature for 24 h. The reaction mixture was concentrated and subjected to a silica plug using 1:1 heptane/EtOAc then 100% EtOAc. The eluent from 100% EtOAc wash was collected and carried forward crude.</div></div><div id="sec4_12_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> Step 3: S<sub>N</sub>Ar by R<sub>1</sub>OH</h5><div class="NLM_p last">To a 2 dram vial was added the material isolated from step 1 in THF (0.0875M). To the reaction vessel was added the appropriate alcohol (R<sub>1</sub>OH, 6 equiv) followed by addition of sodium hydride (60% dispersion in mineral oil (3 equiv)). The reaction mixture was stirred at room temperature for 3 h. The reaction was diluted with a 2:1 mixture of saturated aqueous NH<sub>4</sub>Cl and water. The aqueous was extracted 3× with EtOAc. The organics were combined, dried over anhydrous magnesium sulfate, filtered, and concentrated. The samples were purified via reverse phase HPLC (methods A–D, below).</div></div></div><div id="sec4_12_4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Purification Conditions</h4><div id="sec4_12_4_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> Method A: Compounds <b>31</b>, <b>34</b>–<b>39</b></h5><div class="NLM_p last">Column: Waters XBridge C18 19 × 100, 5 μ. Mobile phase A: 0.03% NH<sub>4</sub>OH in water (v/v). Mobile phase B: 0.03% NH<sub>4</sub>OH in MeCN (v/v). Gradient: 80.0% H<sub>2</sub>O/20.0% MeCN linear to 40% H<sub>2</sub>O/60% MeCN in 10.5 min, 40% H<sub>2</sub>O/60% MeCN linear to 0% H<sub>2</sub>O/100% MeCN in 0.5 min, HOLD at 0% H<sub>2</sub>O/100% MeCN to 12.0 min. Flow: 25 mL/min.</div></div><div id="sec4_12_4_2_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> Method B: Compound <b>30</b></h5><div class="NLM_p last">Column: Waters XBridge C18 19 × 100, 5 μ. Mobile phase A: 0.03% NH<sub>4</sub>OH in water (v/v). Mobile phase B: 0.03% NH<sub>4</sub>OH in MeCN (v/v). Gradient: HOLD at 80.0% H<sub>2</sub>O/20.0% MeCN for 1.0 min, 80.0% H<sub>2</sub>O/20.0% MeCN linear to 60.0% H<sub>2</sub>O/40.0% MeCN in 6.75 min, linear to 0% H<sub>2</sub>O/100% MeCN to 7.0 min, HOLD at 0% H<sub>2</sub>O/100% MeCN from 7.0 to 8.0 min. Flow: 30 mL/min.</div></div><div id="sec4_12_4_2_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> Method C: Compound <b>33</b></h5><div class="NLM_p last">(Column: Waters Sunfire C18 19 × 100, 5 μ. Mobile phase A: 0.05% trifluoroacetic acid (TFA) in water (v/v). Mobile phase B: 0.05% TFA in MeCN (v/v). 90.0% H<sub>2</sub>O/10.0% MeCN linear to 50% H<sub>2</sub>O/50% MeCN in 8.5 min, 50% H<sub>2</sub>O/50% MeCN linear to 0% H<sub>2</sub>O/100% MeCN in 0.5 min, HOLD at 0% H<sub>2</sub>O/100% MeCN to 10.0 min. Flow: 25 mL/min.</div></div><div id="sec4_12_4_2_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> Method D: Compound <b>32</b></h5><div class="NLM_p last">(Column: Waters Sunfire C18 19 × 100, 5 μ. Mobile phase A: 0.05% TFA in water (v/v). Mobile phase B: 0.05% TFA in MeCN (v/v); 75.0% H<sub>2</sub>O/25.0% MeCN linear to 35% H<sub>2</sub>O/65% MeCN in 8.5 min, HOLD at 0% H<sub>2</sub>O/100% MeCN to 10.0 min. Flow: 25 mL/min.</div></div></div><div id="sec4_12_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Isolated Yield: <sup>1</sup>H NMR and MS Data for Resynthesized Library Compounds from <a class="ref internalNav" href="#sch5" aria-label="Schemes 4">Schemes 4</a> and <a class="ref internalNav" href="#sch6" aria-label="5">5</a></h4><div id="sec4_12_4_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i79" class="anchor-spacer"></div><h5 class="article-section__title" id="_i79"> 3-Isobutyl-5-propoxy-[1,2,4]triazolo[4,3-<i>a</i>]pyrazine (<b>30</b>)</h5><div class="NLM_p last">Yield 20.4 mg, 8.7%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.89 (s, 1H), 7.44 (s, 1H), 4.32 (t, <i>J</i> = 6.37 Hz, 2H), 3.14 (d, <i>J</i> = 7.03 Hz, 2H), 2.15 (td, <i>J</i> =<i>J</i> = 6.92, 13.40 Hz, 1H), 1.88 (qd, <i>J</i> = 7.08, 13.89 Hz, 2H), 1.06 (t, <i>J</i> = 7.47 Hz, 3H), 0.93 (d, <i>J</i> = 6.59 Hz, 6H). LC/MS = 235.2 (M + H).</div></div><div id="sec4_12_4_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i80" class="anchor-spacer"></div><h5 class="article-section__title" id="_i80"> 5-Propoxy-3-(3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrazol-4-yl)-[1,2,4]triazolo[4,3-<i>a</i>]pyrazine (<b>31</b>)</h5><div class="NLM_p last">Yield 1.5 mg, 8.8%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.04 (s, 1H), 8.25 (br s, 1H), 7.62 (br s, 2H), 7.51–7.59 (m, 2H), 7.45 (s, 1H), 3.98 (br s, 2H), 1.40 (br s, 2H), 0.59 (br s, 3H). LC/MS = 389.1 (M + H).</div></div><div id="sec4_12_4_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i81" class="anchor-spacer"></div><h5 class="article-section__title" id="_i81"> 5-(2-Methoxyphenethoxy)-3-(3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrazol-4-yl)-[1,2,4]triazolo[4,3-<i>a</i>]pyrazine (<b>32</b>)</h5><div class="NLM_p last">Yield 36.8 mg, 20.7%. <sup>1</sup>H NMR (400 MHz, cd<sub>3</sub>od) δ 8.91 (s, 1H), 8.05 (s, 1H), 7.54–7.60 (m, 2H), 7.47–7.54 (m, 2H), 7.36 (s, 1H), 7.02–7.20 (m, 1H), 6.85 (d, <i>J</i> = 8.22 Hz, 1H), 6.64–6.73 (m, 2H), 4.19 (t, <i>J</i> = 6.26 Hz, 2H), 3.76 (s, 3H), 2.78 (t, <i>J</i> = 6.26 Hz, 2H). LC/MS = 481.2 (M + H).</div></div><div id="sec4_12_4_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i82" class="anchor-spacer"></div><h5 class="article-section__title" id="_i82"> 5-Propoxy-3-(3-(<i>p</i>-tolyl)-1<i>H</i>-pyrazol-4-yl)-[1,2,4]triazolo[4,3-<i>a</i>]pyrazine (<b>33</b>)</h5><div class="NLM_p last">Yield 13.4 mg, 9.6%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.99 (s, 1H), 7.87 (s, 1H), 7.25 (d, <i>J</i> = 8.20 Hz, 2H), 7.13 (s, 1H), 7.04 (d, <i>J</i> = 7.80 Hz, 2H), 3.86 (t, <i>J</i> = 6.44 Hz, 2H), 2.28 (s, 3H), 1.52 (sxt, <i>J</i> = 7.02 Hz, 2H), 0.70 (t, <i>J</i> = 7.41 Hz, 3H). LC/MS = 335.2 (M + H).</div></div><div id="sec4_12_4_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83"> 3-(1-Methyl-5-(<i>p</i>-tolyl)-1<i>H</i>-pyrazol-4-yl)-5-propoxy-[1,2,4]triazolo[4,3-<i>a</i>]pyrazine (<b>34</b>)</h5><div class="NLM_p last">Yield 4.4 mg, 9.2%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.94 (s, 1H), 7.79 (s, 1H), 7.44 (s, 1H), 7.20–7.25 (m, 2H), 7.16–7.20 (m, 2H), 4.15 (t, <i>J</i> = 6.15 Hz, 2H), 3.84 (s, 3H), 2.28 (s, 3H), 1.60 (qd, <i>J</i> = 6.88, 13.62 Hz, 2H), 0.71 (t, <i>J</i> = 7.25 Hz, 3H). LC/MS = 349.2 (M + H).</div></div><div id="sec4_12_4_3_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i84" class="anchor-spacer"></div><h5 class="article-section__title" id="_i84"> 3-(1-Methyl-5-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrazol-4-yl)-5-propoxy-[1,2,4]triazolo[4,3-<i>a</i>]pyrazine (<b>35</b>)</h5><div class="NLM_p last">Yield 2.1 mg, 5.7%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.95 (s, 1H), 7.88 (s, 1H), 7.76 (d, <i>J</i> = 8.35 Hz, 2H), 7.61 (d, <i>J</i> = 7.91 Hz, 2H), 7.49 (s, 1H), 4.19 (t, <i>J</i> = 6.15 Hz, 2H), 3.88 (s, 3H), 3.31 (s, 7H), 1.57–1.69 (m, 2H), 0.73 (t, <i>J</i> = 7.47 Hz, 3H). LC/MS = 403.1 (M + H).</div></div><div id="sec4_12_4_3_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i85" class="anchor-spacer"></div><h5 class="article-section__title" id="_i85"> 3-(1-Methyl-5-phenyl-1<i>H</i>-pyrazol-4-yl)-5-propoxy-[1,2,4]triazolo[4,3-<i>a</i>]pyrazine (<b>36</b>)</h5><div class="NLM_p last">Yield 1.1 mg, 3.3%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.94 (s, 1H), 7.82 (s, 1H), 7.45 (s, 1H), 7.31–7.42 (m, 5H), 4.15 (t, <i>J</i> = 6.15 Hz, 2H), 3.85 (s, 3H), 1.54–1.64 (m, 2H), 0.71 (t, <i>J</i> = 7.47 Hz, 3H). LC/MS = 335.2 (M + H).</div></div><div id="sec4_12_4_3_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86"> 3-(1-Methyl-5-phenyl-1<i>H</i>-pyrazol-4-yl)-5-propoxy-[1,2,4]triazolo[4,3-<i>a</i>]pyrazine (<b>37</b>)</h5><div class="NLM_p last">Yield 2.6 mg, 9.8%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.95 (s, 1H), 7.82 (s, 1H), 7.46 (s, 1H), 7.42 (dd, <i>J</i> = 5.49, 8.57 Hz, 2H), 7.23 (t, <i>J</i> = 8.79 Hz, 2H), 4.17 (t, <i>J</i> = 6.15 Hz, 2H), 3.84 (s, 3H), 1.62 (qd, <i>J</i> = 7.01, 13.67 Hz, 2H), 0.72 (t, <i>J</i> = 7.47 Hz, 3H). LC/MS = 353.2 (M + H).</div></div><div id="sec4_12_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i87" class="anchor-spacer"></div><h5 class="article-section__title" id="_i87"> 3-(5-(4-Methoxyphenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)-5-propoxy-[1,2,4]triazolo[4,3-<i>a</i>]pyrazine (<b>38</b>)</h5><div class="NLM_p last">Yield 2.4 mg, 7.6%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.95 (s, 1H), 7.88 (s, 1H), 7.76 (d, <i>J</i> = 8.35 Hz, 2H), 7.61 (d, <i>J</i> = 7.91 Hz, 2H), 7.49 (s, 1H), 4.19 (t, <i>J</i> = 6.15 Hz, 2H), 3.88 (s, 3H), 1.63 (qd, <i>J</i> = 6.88, 13.62 Hz, 2H), 0.73 (t, <i>J</i> = 7.47 Hz, 3H). LC/MS = 365.2 (M + H).</div></div><div id="sec4_12_4_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i88" class="anchor-spacer"></div><h5 class="article-section__title" id="_i88"> 3-(5-(4-Ethylphenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)-5-propoxy-[1,2,4]triazolo[4,3-<i>a</i>]pyrazine (<b>39</b>)</h5><div class="NLM_p last">Yield 4.1 mg, 7.0%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.94 (s, 1H), 7.79 (s, 1H), 7.45 (s, 1H), 7.25 (d, <i>J</i> = 8.35 Hz, 2H), 7.22 (d, <i>J</i> = 8.35 Hz, 2H), 4.15 (t, <i>J</i> = 6.15 Hz, 2H), 3.84 (s, 3H), 2.58 (d, <i>J</i> = 7.47 Hz, 2H), 1.59 (d, <i>J</i> = 7.03 Hz, 2H), 1.15 (t, <i>J</i> = 7.47 Hz, 3H), 0.70 (t, <i>J</i> = 7.47 Hz, 3H). LC/MS = 363.2 (M + H).</div></div></div><div id="sec4_12_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Representative Synthesis of Compounds of General Structure <b>50</b></h4></div><div id="sec4_12_4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> (4,6-Dichloropyrimidin-5-yl)(5-(4-ethylphenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)methanone (<b>50a</b>)</h4><div id="sec4_12_4_5_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i91" class="anchor-spacer"></div><h5 class="article-section__title" id="_i91"> Step 1: 5-(4-Ethylphenyl)-1-methyl-1<i>H</i>-pyrazole (<b>46a</b>)</h5><div class="NLM_p last">A mixture of (1-methyl-1<i>H</i>-pyrazol-5-yl)boronic acid (42.8 g, 0.34 mol) and 1-bromo-4-ethylbenzene (63.0 g, 0.34 mol) in DME (1 L) and 2 M sodium carbonate (430 mL) was degassed and purged with nitrogen three times. Then Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (2.4 g, 3.4 mmol) was added, and the mixture was purged with nitrogen twice. The reaction mixture was heated to reflux and stirred under nitrogen for 3 h. The mixture was cooled, and DME was removed under reduced pressure. Water (500 mL) was added to the residue, then the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 300 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc/petroleum ether 1:100) to afford 32.0 g (51%) of the title compound as a yellow liquid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.50 (d, <i>J</i> = 1.6 Hz, 1H), 7.34 (d, <i>J</i> = 6.4 Hz, 2H), 7.28 (d, <i>J</i> = 8 Hz, 2H), 6.28 (d, <i>J</i> = 1.8 Hz, 1 H), 3.89 (s, 3H), 2.70 (q, <i>J</i> = 7.6 Hz, 2H), 1.28 (t, <i>J</i> = 7.6 Hz, 3H).</div></div><div id="sec4_12_4_5_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i92" class="anchor-spacer"></div><h5 class="article-section__title" id="_i92"> Step 2: 5-(4-Ethylphenyl)-1-methyl-1<i>H</i>-pyrazole-4-carbaldehyde (<b>47a</b>)</h5><div class="NLM_p last">Dimethylformamide (200 mL) was cooled to 0 °C and treated with POCl<sub>3</sub> (50 g, 0.323 mmol). After the addition, the mixture was warmed to room temperature and stirred for 1 h. To the solution was added <b>46a</b>, and the reaction mixture was heated to 120 °C with stirring overnight. The mixture was cooled to RT, at which point the POCl<sub>3</sub> and DMF were removed under reduced pressure. The residue was poured into ice–water (500 mL), and the mixture was carefully adjusted to pH = 8 with aqueous saturated sodium carbonate. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 × 200 mL). The combined organic layers were washed with brine, dried over Na<sub>s</sub>SO<sub>4</sub>, and filtered. The filtrate was concentrated under reduced pressure. Silica gel chromatography eluting with EtOAc/petroleum ether afforded 20.0 g (87%) of the title compound as a yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 9.60 (s, 1H), 8.03 (s, 1H), 7.37 (d, <i>J</i> = 8 Hz, 2H), 7.33 (d, <i>J</i> = 8 Hz, 2H), 3.81 (s, 3H), 2.74 (q, <i>J</i> = 7.6 Hz, 2H), 1.3 (t, <i>J</i> = 7.6 Hz, 3H).</div></div><div id="sec4_12_4_5_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i93" class="anchor-spacer"></div><h5 class="article-section__title" id="_i93"> Step 3: (4,6-Dichloropyrimidin-5-yl)(5-(4-ethylphenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)methanol (<b>49a</b>)</h5><div class="NLM_p last"><i>n</i>-Butyllithium (2.5 M in hexane, 94 mL, 0.234 mol) was added dropwise to a solution of diisopropylamine (33 mL, 0.234 mol) in THF (350 mL) at −70 °C. After stirring for 0.5 h, the solution was cooled to −90 °C and a solution of 4,6-dichloropyrimidine (34.8 g, 0.234 mol) in THF (200 mL) was added dropwise, maintaining the temperature between −70 to −90 °C, and the resultant solution was stirred for 1 h. To the mixture was added a solution of the aldehyde <b>47a</b> (25 g, 0.117 mol) in THF (200 mL) while maintaining an internal temperature between −70 and −90 °C. Stirring was continued at this temperature for 2 h following the addition. The reaction mixture was quenched with acetic acid (30 g), warmed to rt, and poured into water (600 mL). The organic phase was removed, and the aqueous phase was extracted with EtOAc (2 × 250 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by silica gel chromatography eluting with EtOAc/petroleum ether afford 27.5 g (65%) of the title compound as a yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 8.50 (s, 1H), 7.63 (s, 1H), 7.26 (d, <i>J</i> = 8 Hz, 2H), 7.12 (d, <i>J</i> = 7.2 Hz, 2H), 6.26 (s, 1H), 3.68 (s, 3H), 2.66 (q, <i>J</i> = 7.6 Hz, 2H), 1.25 (t, <i>J</i> = 7.6 Hz, 3H).</div></div><div id="sec4_12_4_5_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i94" class="anchor-spacer"></div><h5 class="article-section__title" id="_i94"> Step 4: (4,6-Dichloropyrimidin-5-yl)(5-(4-ethylphenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)methanone (<b>50a</b>)</h5><div class="NLM_p last">To a mixture of <b>49a</b> (27.0 g, 74.4 mmol) and CHCl<sub>3</sub> (600 mL) was added Dess–Martin periodinane (47.3 g, 112 mmol) in portions at room temperature. After the addition, the reaction mixture was stirred at room temperature for 1 h. The reaction mixture was then filtered, and the filtrate was washed sequentially with cold 0.5 M NaOH (700 mL) and brine. The solution was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. Silica gel chromatography eluting with EtOAc/petroleum ether afforded 18.1 g (67%) of the title compound as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 8.44 (s, 1 H), 8.18 (s, 1H), 7.12 (m, 4H), 3.69 (s, 3H), 2.61 (q, <i>J</i> = 7.6 Hz, 2H), 1.22 (t, <i>J</i> = 7.6 Hz, 3H). LC/MS = 361.0 (M + H).</div></div></div><div id="sec4_12_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> Library Protocol for Synthesis of Compounds in <a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a></h4><table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">1.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Amines (HNR<sub>1</sub>R<sub>2</sub>, 100 μmol each) were weighed into reaction vials (8 mL).</p></td></tr><tr class="li1"><td valign="top">2.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Diisopropyl ethylamine (DIEA) was added to each reaction vial (2 equiv, 200 μmol)</p></td></tr><tr class="li1"><td valign="top">3.</td><td colspan="5" valign="top" class="paragraph"><p class="last"><b>50a</b> (5.0 mmol) was solubilized in MeCN/DMF (0.333 M final concentration) and distributed to the reaction vials (300 ul, 0.1 mmol., 1.0 equiv).</p></td></tr><tr class="li1"><td valign="top">4.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Shake at rt for 4 h.</p></td></tr><tr class="li1"><td valign="top">5.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Add DIEA to each vial (2 equiv, 200 μmol), then add 50 μL of methyl hydrazine.</p></td></tr><tr class="li1"><td valign="top">6.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Shake reaction vials for 18 h overnight at 75 °C.</p></td></tr><tr class="li1"><td valign="top">7.</td><td colspan="5" valign="top" class="paragraph"><p class="last">After cooling to room temperature, remove reaction vial caps and evaporate solvent. Add 2 mL 1:1 DCE/MeOH and solubilize reaction solids.</p></td></tr><tr class="li1"><td valign="top">8.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Filter solution through a solid-phase extraction (SPE) frit.</p></td></tr><tr class="li1"><td valign="top">9.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Evaporate solvent again from reaction vials.</p></td></tr><tr class="li1"><td valign="top">10.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Solubilize reaction solids again with 2 mL 1:1 DCE/MeOH. Load onto a Biotage ISOLUTE SCX SPE. Elute with 5 mL of 1:1 DCE/MeOH, then switch to tared collection racks and elute with 6 mL of 1 N TEA in MeOH.</p></td></tr><tr class="li1"><td valign="top">11.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Evaporate down the samples.</p></td></tr><tr class="li1"><td valign="top">12.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Solubilize crude reaction mixtures in 1 mL DMSO and submit to HPLC purification</p></td></tr></table></div><div id="sec4_12_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> Preparative HPLC Purification Methods</h4><div id="sec4_12_4_97" class="NLM_sec NLM_sec_level_4"><div id="ac_i97" class="anchor-spacer"></div><h5 class="article-section__title" id="_i97">A </h5><div class="NLM_p last">Column: Waters XBridge C18 19 mm × 100 mm, 5 μ. Mobile phase A: 0.03% NH<sub>4</sub>OH in water (v/v). Mobile phase B: 0.03% NH<sub>4</sub>OH in MeCN (v/v).</div></div><div id="sec4_12_4_98" class="NLM_sec NLM_sec_level_4"><div id="ac_i98" class="anchor-spacer"></div><h5 class="article-section__title" id="_i98">B </h5><div class="NLM_p last">Column: Waters Sunfire C18 19 mm × 100 mm, 5 μ. Mobile phase A: 0.05% TFA in water (v/v). Mobile phase B: 0.05% TFA in MeCN (v/v).</div></div><div id="sec4_12_4_99" class="NLM_sec NLM_sec_level_4"><div id="ac_i99" class="anchor-spacer"></div><h5 class="article-section__title" id="_i99">C </h5><div class="NLM_p">Solvent Gradients for Compounds <b>52</b>–<b>59</b>.</div><table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">a.</td><td colspan="5" valign="top" class="paragraph"><p class="last"><b>52</b>: 80.0% H<sub>2</sub>O/20.0% MeCN linear to 45% H<sub>2</sub>O/55% MeCN in 8.5 min, 55% H<sub>2</sub>O/50% MeCN linear to 0% H<sub>2</sub>O/100% MeCN in 0.5 min, HOLD at 0% H<sub>2</sub>O/100% MeCN to 10.0 min. Flow: 25 mL/min.</p></td></tr><tr class="li1"><td valign="top">b.</td><td colspan="5" valign="top" class="paragraph"><p class="last"><b>53</b>: 95.0% H<sub>2</sub>O/5.0% MeCN linear to 5% H<sub>2</sub>O/95% MeCN in 8.5 min, HOLD at 0% H<sub>2</sub>O/100% MeCN to 10.0 min. Flow: 25 mL/min.</p></td></tr><tr class="li1"><td valign="top">c.</td><td colspan="5" valign="top" class="paragraph"><p class="last"><b>54</b>: 80.0% H<sub>2</sub>O/20.0% MeCN linear to 50% H<sub>2</sub>O/50% MeCN in 8.5 min, 50% H<sub>2</sub>O/50% MeCN linear to 0% H<sub>2</sub>O/100% MeCN in 0.5 min, HOLD at 0% H<sub>2</sub>O/100% MeCN to 10.0 min. Flow: 25 mL/min.</p></td></tr><tr class="li1"><td valign="top">d.</td><td colspan="5" valign="top" class="paragraph"><p class="last"><b>55</b>: 95.0% H<sub>2</sub>O/5.0% MeCN linear to 5% H<sub>2</sub>O/95% MeCN in 8.5 min, HOLD at 0% H<sub>2</sub>O/100% MeCN to 10.0 min. Flow: 25 mL/min.</p></td></tr><tr class="li1"><td valign="top">e.</td><td colspan="5" valign="top" class="paragraph"><p class="last"><b>56</b>: 80.0% H<sub>2</sub>O/20.0% MeCN linear to 50% H<sub>2</sub>O/50% MeCN in 8.5 min, 50% H<sub>2</sub>O/50% MeCN linear to 0% H<sub>2</sub>O/100% MeCN in 0.5 min, HOLD at 0% H<sub>2</sub>O/100% MeCN to 10.0 min. Flow: 25 mL/min.</p></td></tr><tr class="li1"><td valign="top">f.</td><td colspan="5" valign="top" class="paragraph"><p class="last"><b>57</b>: 95.0% H<sub>2</sub>O/5.0% MeCN linear to 5% H<sub>2</sub>O/95% MeCN in 8.5 min, HOLD at 0% H<sub>2</sub>O/100% MeCN to 10.0 min. Flow: 25 mL/min.</p></td></tr><tr class="li1"><td valign="top">g.</td><td colspan="5" valign="top" class="paragraph"><p class="last"><b>58</b>: 80.0% H<sub>2</sub>O/20.0% MeCN linear to 50% H<sub>2</sub>O/50% MeCN in 8.5 min, 50% H<sub>2</sub>O/50% MeCN linear to 0% H<sub>2</sub>O/100% MeCN in 0.5 min, HOLD at 0% H<sub>2</sub>O/100% MeCN to 10.0 min. Flow: 25 mL/min.</p></td></tr></table></div></div><div id="sec4_12_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> Assessment of Purity via Analytical Scale HPLC</h4><table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">i.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Column: Waters Atlantis C18 4.6 mm × 50 mm, 5 μm. Mobile phase A: 0.05% TFA in water (v/v). Mobile phase B: 0.05% TFA in MeCN (v/v).</p></td></tr><tr class="li1"><td valign="top">ii.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Gradient: 95.0% H<sub>2</sub>O/5.0% MeCN linear to 5.0% H<sub>2</sub>O/95.0% MeCN in 4.0 min, HOLD at 5.0% H<sub>2</sub>O/95.0% MeCN to 5.0 min. Flow: 2 mL/min.</p></td></tr><tr class="li1"><td valign="top">iii.</td><td colspan="5" valign="top" class="paragraph"><p class="last">MS conditions: MS mode ESI+; scan range 160–1000 Da (<a class="ref internalNav" href="#tbl18" aria-label="Table 18">Table 18</a>).</p></td></tr></table><div class="NLM_table-wrap" id="tbl18">Table 18<div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center">prep HPLC method</th><th class="colsep0 rowsep0" align="center" char=".">observed MS (M + H)</th><th class="colsep0 rowsep0" align="center" char=".">QC retention time (min)</th><th class="colsep0 rowsep0" align="center" char=".">isolated quantity (mg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char=".">374.2668</td><td class="colsep0 rowsep0" align="char" char=".">2.08</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char=".">404.276</td><td class="colsep0 rowsep0" align="char" char=".">2.18</td><td class="colsep0 rowsep0" align="char" char=".">30.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char=".">447.3123</td><td class="colsep0 rowsep0" align="char" char=".">2.12</td><td class="colsep0 rowsep0" align="char" char=".">24.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char=".">388.2807</td><td class="colsep0 rowsep0" align="char" char=".">2.13</td><td class="colsep0 rowsep0" align="char" char=".">12.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char=".">431.3308</td><td class="colsep0 rowsep0" align="char" char=".">1.82</td><td class="colsep0 rowsep0" align="char" char=".">18.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char=".">404.2774</td><td class="colsep0 rowsep0" align="char" char=".">2.37</td><td class="colsep0 rowsep0" align="char" char=".">20.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="char" char=".">417.3148</td><td class="colsep0 rowsep0" align="char" char=".">1.93</td><td class="colsep0 rowsep0" align="char" char=".">13.6</td></tr></tbody></table></div></div></div><div id="sec4_12_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> General Procedure A for Resynthesis of Compounds of Generic Structure <b>44</b> from <b>50</b></h4><div class="NLM_p">Step 1: <b>50</b> (1 equiv) dissolved in 20 volumes of MeCN (mL/g) cooled to 0 °C was treated with diisopropylethyl amine (1.05 equiv) and an amine (1.0 equiv). The solution was stirred and was allowed to slowly warm to 23 °C overnight. LC/MS showed the desired mass for M + H. The solvent was removed in vacuo, and the crude material could be taken directly into the next step or could be purified by silica gel chromatography.</div><div class="NLM_p last">Step 2: <b>51</b> (1 equiv) from the previous step was dissolved in pyridine (10 volumes), and methyl hydrazine (10 equiv) was added. The solution was heated to 85 °C for 16 h. After cooling to room temperature, the solvent was removed in vacuo and the crude material was purified by silica gel chromatography or precipitation from heptane. <b>Note: rotamers are often present with the azetidine, which can lead to more complicated</b><sup><b>1</b></sup><b>H NMR spectra and absence of protons or less accurate integration of protons in certain instances.</b></div></div><div id="sec4_12_4_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> Synthesis via General Procedure A of 4-(Azetidin-1-yl)-3-(5-(4-ethylphenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)-1-methyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>52</b>)</h4><div class="NLM_p last">Yield 92% over two steps, 1.26 g (92% yield). Precipitated from heptane. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.32 (s, 1H), 7.67 (s, 1H), 7.28 (d, <i>J</i> = 8.0 Hz, 2H), 7.18 (d, <i>J</i> = 8.0 Hz, 2H), 4.00 (s, 3H), 3.92 (s, 3H), 2.64 (q, <i>J</i> = 7.61 Hz, 3H), 2.26 (td, <i>J</i> = 7.71, 15.42 Hz, 4H), 1.23 (t, <i>J</i> = 7.61 Hz, 3H). LC/MS = 374.2 (M + H).</div></div><div id="sec4_12_4_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> 4-(Azetidin-1-yl)-1-methyl-3-(1-methyl-5-phenyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>68</b>)</h4><div id="sec4_12_4_9_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i104" class="anchor-spacer"></div><h5 class="article-section__title" id="_i104"> Step 1: 1-Methyl-5-phenyl-1<i>H</i>-pyrazole</h5><div class="NLM_p last">Prepared similarly to <b>46a</b>. Purified by silica gel chromatography (4:1 heptane/EtOAc) to afford 1.2 g, 67% yield, of the title compound. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.91 (s, 3H), 6.33(d, 1H, <i>J</i> = 2 Hz), 7.45 (m, 5H), 7.54 (d, 1H, <i>J</i> = 2 Hz). LC/MS = 159 (M + H).</div></div><div id="sec4_12_4_9_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i105" class="anchor-spacer"></div><h5 class="article-section__title" id="_i105"> Step 2: 1-Methyl-5-phenyl-1<i>H</i>-pyrazole-4-carbaldehyde</h5><div class="NLM_p last">Prepared similarly to <b>47a</b>. Purified by silica gel chromatography (20:1 to 5:1 petroleum ether/EtOAc) to afford 420 mg, 59% yield, of the title compound. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.85 (s, 3H), 7.46 (m, 2H), 7.59 (m, 3H), 8.08 (s, 1H), 9.64(s, 1H). LC/MS = 187 (M + H).</div></div><div id="sec4_12_4_9_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i106" class="anchor-spacer"></div><h5 class="article-section__title" id="_i106"> Step 3: (4,6-Dichloropyrimidin-5-yl)(1-methyl-5-phenyl-1<i>H</i>-pyrazol-4-yl)methanol</h5><div class="NLM_p last">Prepared similarly to <b>49a</b>. Purification by silica gel chromatography (1:3 heptane/EtOAc) afforderd 59 mg, 32% yield, of the title compound. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.62 (s, 3H), 6.19 (s, 1H), 7.20 (m, 2H), 7.33 (m, 3H), 7.58 (s, 1H), 8.45 (s, 1H). LC/MS = 335 (M + H).</div></div><div id="sec4_12_4_9_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i107" class="anchor-spacer"></div><h5 class="article-section__title" id="_i107"> Step 4: (4,6-Dichloropyrimidin-5-yl)(1-methyl-5-phenyl-1<i>H</i>-pyrazol-4-yl)methanone</h5><div class="NLM_p last">Prepared similarly to <b>50a</b>. Crude material was triturated with EtOAc to afford 16 g, 80% yield, of the title compound. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.71 (s, 3H), 7.23 (m, 2H), 7.37 (m, 3H), 8.19 (s, 1H), 8.49 (s, 1H). LC/MS = 333 (M + H).</div></div><div id="sec4_12_4_9_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i108" class="anchor-spacer"></div><h5 class="article-section__title" id="_i108"> Steps 5/6: 4-(Azetidin-1-yl)-1-methyl-3-(1-methyl-5-phenyl-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>68</b>)</h5><div class="NLM_p last">Prepared according to general procedure A. Purified by silica gel chromatography (EtOAc/MeOH, 200:1 to 50:1); 75 mg, 82% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.31 (s, 1H), 7.68 (s, 1H), 7.35 (m, 4H), 4.12 (d, <i>J</i> = 7.03 Hz, 1H), 3.98 (s, 3H), 3.95–3.85 (br s, 3H, azetidine N-CH<sub>2</sub> protons), 3.92 (s, 3H), 2.25 (quin, <i>J</i> = 7.71 Hz, 2H)). LC/MS = 346.1 (M + H).</div></div></div><div id="sec4_12_4_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> 4-(Azetidin-1-yl)-1-methyl-3-(1-methyl-5-(<i>p</i>-tolyl)-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>69</b>)</h4><div id="sec4_12_4_9_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i110" class="anchor-spacer"></div><h5 class="article-section__title" id="_i110"> Step 1: 5-(4-Methylphenyl)-1-methyl-1<i>H</i>-pyrazole</h5><div class="NLM_p last">Used same method as for <b>46a</b>. Purified by silica gel chromatography (100:1 petroleum ether/EtOAc) to afford 55.0 g, 73% yield, of the title compound as a yellow liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.42 (s, 3H), 3.89 (s, 3H), 6.29 (d, <i>J</i> = 1.8 Hz, 1H), 7.29 (br AB quartet, <i>J</i><sub>AB</sub> = 8 Hz, 4H), 7.52 (d, <i>J</i> = 2.0 Hz, 1H).</div></div><div id="sec4_12_4_9_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i111" class="anchor-spacer"></div><h5 class="article-section__title" id="_i111"> Step 2: 1-Methyl-5-(<i>p</i>-tolyl)-1<i>H</i>-pyrazole-4-carbaldehyde</h5><div class="NLM_p last">Used same method as for <b>47a</b>. Purification by silica gel chromatography (100:1 to 30:1 petroleum ether/EtOAc) afforded 28.2 g, 81% yield, of the title compound as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.46 (s, 3H), 3.81 (s, 3H), 7.33 (quartet, <i>J</i> = 8, 17 Hz, 4H), 8.04 (s, 1H), 9.60 (s, 1H).</div></div><div id="sec4_12_4_9_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i112" class="anchor-spacer"></div><h5 class="article-section__title" id="_i112"> Step 3: (4,6-Dichloropyrimidin-5-yl)(1-methyl-5-(<i>p</i>-tolyl)-1<i>H</i>-pyrazol-4-yl)methanol</h5><div class="NLM_p last">Used same method as for <b>49a</b>. Purification by recrystallization of crude material from EtOAc afforded 82.0 g, 78% yield, of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, CDCI<sub>3</sub>) 2.39 (s, 3H), 3.72 (s, 3H), 6 26 (s, 1H), 7.17 (br dd, <i>J</i> = 8, 32 Hz, 4H), 7.66 (s, 1H), 8.55 (s, 1H).</div></div><div id="sec4_12_4_9_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i113" class="anchor-spacer"></div><h5 class="article-section__title" id="_i113"> Step 4: (4,6-Dichloropyrimidin-5-yl)(1-methyl-5-(<i>p</i>-tolyl)-1<i>H</i>-pyrazol-4-yl)methanone</h5><div class="NLM_p last">Used same method as for <b>50a</b>. Purification of the crude product by recrystallization from MeOH afforded 31.3 g, 53% yield, of the title compound as a pale-yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.49 (s, 1H), 8.15 (s, 1H), 7.07–7.15 (br AB quartet, <i>J</i>, A = 8 Hz, <i>J</i>, B = 8 Hz, 4H), 3.69 (s, 3H), 2.33 (s, 3H). LC/MS = 346.9 (M + H).</div></div><div id="sec4_12_4_9_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i114" class="anchor-spacer"></div><h5 class="article-section__title" id="_i114"> Steps 5 and 6: Prepared According to General Procedure A. 4-(Azetidin-1-yl)-1-methyl-3-(1-methyl-5-(<i>p</i>-tolyl)-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>69</b>)</h5><div class="NLM_p last">Final compound purified via silica gel chromatography (Gradient: 0 to 30% MeOH in dichloromethane) to provide 200 mg (97% yield, two steps) of the title compound as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.32 (s, 1H), 7.67 (s, 1H), 7.20 (br dd, <i>J</i> = 8.1, 33 Hz, 4H), 3.99 (s, 3H), 3.91 (s, 3H), 3.75–4.04 (br m, 4H), 2.34 (br s, 3H), 2.21–2.30 (m, 2H). LC/MS = 360.5 (M + H).</div></div></div><div id="sec4_12_4_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> 4-(Azetidin-1-yl)-3-(5-(4-cyclopropylphenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)-1-methyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>70</b>)</h4><div id="sec4_12_4_9_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i116" class="anchor-spacer"></div><h5 class="article-section__title" id="_i116"> Step 1: 5-(4-Cyclopropylphenyl)-1-methyl-1<i>H</i>-pyrazole</h5><div class="NLM_p last">Used same procedure as for <b>46a</b>. Purification by silica gel chromatography (4:1 heptane/EtOAc) afforded 350 mg, 31% yield of the title compound. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.52 (s, 1H), 7.34 (d, <i>J</i> = 12 Hz, 2H), 7.18 (d, <i>J</i> = 8 Hz, 2H), 6.29 (s, 1H), 3.90 (s, 3H), 1.97 (m, 1H), 1.05 (m, 2H), 0.78 (m, 2H). LC/MS = 199 (M + H).</div></div><div id="sec4_12_4_9_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i117" class="anchor-spacer"></div><h5 class="article-section__title" id="_i117"> Step 2: 5-(4-Cyclopropylphenyl)-1-methyl-1<i>H</i>-pyrazole-4-carbaldehyde</h5><div class="NLM_p last">Used the same procedure as for <b>47a</b>. The final product was purified by silica gel chromatography eluted with petroleum ether/EtOAc (20:1–5:1) to afford 390 mg, 98% yield, of the title compound as an oil. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 9.61 (s, 1H), 8.05 (s, 1H), 7.25 (d, <i>J</i> = 12 Hz, 2H), 7.15 (d, <i>J</i> = 8 Hz, 2H,), 3.82 (s, 3H), 1.96 (m, 1H), 1.05 (m, 2H), 0.81 (m, 2H). LC/MS = 227 (M + H).</div></div><div id="sec4_12_4_9_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i118" class="anchor-spacer"></div><h5 class="article-section__title" id="_i118"> Step 3: (5-(4-Cyclopropylphenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)(4,6-dichloropyrimidin-5-yl)methanol</h5><div class="NLM_p last">Used same procedure as for <b>49a</b>. Purification by silica gel chromatography afforded 120 mg, 18% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.56 (s, 1H), 7.64 (s, 1H), 7.25 (d, <i>J</i> = 12 Hz, 2H), 7.12 (d, <i>J</i> = 8 Hz, 2H), 6.26 (s, 1H), 3.83 (s, 3H), 1.97 (m, 1H), 1.08 (m, 2H), 0.75 (m, 2H). LC/MS = 377 (M + H).</div></div><div id="sec4_12_4_9_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i119" class="anchor-spacer"></div><h5 class="article-section__title" id="_i119"> Step 4: (5-(4-Cyclopropylphenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)(4,6-dichloropyrimidin-5-yl)methanone</h5><div class="NLM_p last">Used same procedure as for <b>50a</b>. Purification of crude material by triturating with EtOAc afforded 14 g, 70% yield, of the title compound. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.45 (s, 1H), 8.14 (s, 1H), 7.07 (d, <i>J</i> = 8 Hz, 2H), 6.96 (d, <i>J</i> = 8 Hz, 2H), 3.67 (s, 3H), 1.84 (m, 1H), 1.00 (m, 2H), 0.66 (m, 2H). LC/MS = 372.9 (M + H).</div></div><div id="sec4_12_4_9_4_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i120" class="anchor-spacer"></div><h5 class="article-section__title" id="_i120"> Steps 5 and 6: 4-(Azetidin-1-yl)-3-(5-(4-cyclopropylphenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)-1-methyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>70</b>)</h5><div class="NLM_p last">Synthesized using general procedure A. Purification by silica gel chromatography (200:1 to 50:1 EtOAc/MeOH) afforded a solid, 57 mg (0.148 mmol), 79% yield over two steps. Note: more complicated spectra due to rotamers. Integrations may not be accurate. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.27 (s, 1H), 7.62 (s, 1H), 7.19 (d, <i>J</i> = 8.2 Hz, 2H), 6.99 (d, <i>J</i> = 8.2 Hz, 2H), 4.08 (m, 1H), 3.95 (s, 3H), 3.92–3.75 (br m, 3H), 3.86 (s, 3H), 2.22 (m, 2H), 1.8 (m, 2H), 1.21 (t, <i>J</i> = 7.12 Hz, 1.25 H), 0.95 (m, 1.9 H), 0.66 (m, 1.9 H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 157.9, 154.8, 153.9, 145.0, 142.8, 140.1, 135.9, 129.3, 125.8, 125.7, 113.7, 100.9, 37.8, 33.8, 17.0, 15.2, 9.6. LC/MS = 386.1 (M + H).</div></div></div><div id="sec4_12_4_9_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121"> 4-(Azetidin-1-yl)-1-methyl-3-(1-methyl-5-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>71</b>)</h4><div id="sec4_12_4_9_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i122" class="anchor-spacer"></div><h5 class="article-section__title" id="_i122"> Step 1: 1-Methyl-5-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrazole</h5><div class="NLM_p last">Prepared similarly to <b>46a</b>. Purified by silica gel chromatography (4:1 heptane/EtOAc) to afford 1.4 g, 55% yield, of the title compound as an oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.76 (d, <i>J</i> =12 Hz, 2H,), 7.57 (m, 3H), 6.39(d, <i>J</i> = 4 Hz, 1H,), 3.94 (s, 3H). LC/MS = 227 (M + H).</div></div><div id="sec4_12_4_9_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i123" class="anchor-spacer"></div><h5 class="article-section__title" id="_i123"> Step 2: 1-Methyl-5-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrazole-4-carbaldehyde</h5><div class="NLM_p last">Prepared similarly to <b>47a</b>. Purification by silica gel chromatography (20:1 to 5:1 petroleum ether/EtOAc afforded 390 mg, 58% yield, of the title compound as a solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) 9.68 (s, 1H) 8.09 (s, 1H), 7.86 (d, 2H, <i>J</i> = 8 Hz), 7.61 (d, 2H, <i>J</i> = 8 Hz), 3.86 (s, 3H). LC/MS = 255 (M + H).</div></div><div id="sec4_12_4_9_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i124" class="anchor-spacer"></div><h5 class="article-section__title" id="_i124"> Step 3: (4,6-Dichloropyrimidin-5-yl)(1-methyl-5-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrazol-4-yl)methanol</h5><div class="NLM_p last">Prepared similarly to <b>49a</b>. Purification by silica gel chromatography (1:1 heptane/EtOAc) afforded 120 mg, 38% yield, of the title compound as a solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) 8.51 (s, 1H), 7.65 (d, 2H, <i>J</i> = 8 Hz), 7.54 (s, 1H), 7.39 (d, 2H, <i>J</i> = 8 Hz), 6.14 (s, 1H), 3.66 (s, 3H). LC/MS = 403 (M + H).</div></div><div id="sec4_12_4_9_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i125" class="anchor-spacer"></div><h5 class="article-section__title" id="_i125"> Step 4: (4,6-Dichloropyrimidin-5-yl)(1-methyl-5-phenyl-1<i>H</i>-pyrazol-4-yl)methanone</h5><div class="NLM_p last">(4,6-Dichloropyrimidin-5-yl)(1-methyl-5-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrazol-4-yl)methanol (48.0 g, 0.119 mol) was dissolved in acetone (1 L). CrO<sub>3</sub> (31.7 g, 0.317 mol) was added. The reaction mixture was stirred at room temperature for 1 h. The solvent was evaporated. EtOAc and water were added to the residue. The organic layer was separated, washed with water, dried, and passed through a layer of silica gel. The residue was evaporated to a slurry. The formed crystals were filtered off and washed with ether. This afforded 35.0 g, 73% yield, of the title compound. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.59 (s, 1H), 8.07 (s, 1H), 7.70 (d, <i>J</i> = 8 Hz, 2H), 7.48 (d, <i>J</i> = 8 Hz, 2H), 3.77 (s, 3H). LC/MS = 401 (M + H).</div></div><div id="sec4_12_4_9_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i126" class="anchor-spacer"></div><h5 class="article-section__title" id="_i126"> Steps 5 and 6: 4-(Azetidin-1-yl)-1-methyl-3-(1-methyl-5-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>71</b>)</h5><div class="NLM_p last">Synthesized using general procedure A. Purification by silica gel chromatography (100:1 to 20:1 EtOAc/MeOH) afforded a solid, 4.1 g (9.92 mmol), 86% yield over two steps as a solid. <sup>1</sup>H NMR (400 MHz,CDCl<sub>3</sub>) δ 7.63 (d, <i>J</i> = 8.00 Hz, 1H), 7.52 (d, <i>J</i> = 8.00 Hz, 1H), 3.98 (s, 3H), 3.92 (s, 3H), 3.89 (brs, ca. 4H), 2.27 (quin, <i>J</i> = 7.71 Hz, 2H). LC/MS = 414.4 (M + H).</div></div></div><div id="sec4_12_4_9_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127"> 4-(Azetidin-1-yl)-1-(methyl-t3)-3-(1-methyl-5-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>78</b>)</h4><div id="sec4_12_4_9_8_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i128" class="anchor-spacer"></div><h5 class="article-section__title" id="_i128"> Step 1: 4-(Azetidin-1-yl)-3-(1-methyl-5-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>77</b>)</h5><div class="NLM_p last">(4-(Azetidin-1-yl)-6-chloropyrimidin-5-yl)(1-methyl-5-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrazol-4-yl)methanone (intermediate prepared in the synthesis of <b>71</b>) (999 mg, 2.37 mmol) was dissolved in THF (10 mL), was cooled to 0 °C, and hydrazine (23.7 mmol, 23.7 mL, 1 M in THF) was added. The solution was allowed to slowly warm to room temperature and was stirred for 16 h. The solvent was removed in vacuo, and the residue was purified by silica gel chromatography (heptane/EtOAc/MeOH, 100:9:1) to afford 529 mg, 56% yield, of the title compound as a solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 13.54 (s, 1 H), 8.18 (s, 1 H), 7.60–7.87 (m, 5 H), 3.89 (s, 3 H), 3.78 (br s, 3 H), 2.19 (s, 2 H). LC/MS = 400.1, 402.3.</div></div><div id="sec4_12_4_9_8_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i129" class="anchor-spacer"></div><h5 class="article-section__title" id="_i129"> Step 2: 4-(Azetidin-1-yl)-1-(methyl-t3)-3-(1-methyl-5-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>78</b>)</h5><div class="NLM_p">A solution of 4-(azetidin-1-yl)-3-(1-methyl-5-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (see above) (3.4 mg, 8.5 μmol, 2.7 equiv) in 0.2 mL of DMF was treated with NaH (60% dispersion in mineral oil, 5.2 mg, 130 μmol, 42 equiv) and stirred for 5 min at room temperature. The solution was transferred by syringe to a freshly opened 5 cc ampule containing 250 mCi of tritiated methyl iodide (80 Ci/mmol, 3.1 μmol, 1  equiv, purchased from American Radiolabeled Chemicals, Inc., St. Louis, MO 63146) in 0.25 mL of DMF. After 15 min, the reaction was diluted with EtOAc, washed twice with H<sub>2</sub>O, concentrated in vacuo, and reconstituted in EtOAc. Liquid scintillation counting (LSC) of the solution indicated the presence of 240 mCi of nonvolatile radioactivity, which was determined to be chemically and radiochemically impure <b>78</b> by HPLC (see HPLC method A below) and radio-TLC (see Radio TLC below).</div><div class="NLM_p last">Half of the crude product solution, 120 mCi, was concentrated and purified by normal phase flash cartridge chromatography (Thomson SINGLE StEP 4.7 g amine flash column, EtOAc eluant) to afford 105 mCi of radiochemically pure <b>78</b>. Remaining chemical impurities were removed by reconstitution of the product in 1 mL of 20% MeCN/80% aq 0.1% formic acid and purification by reverse phase flash cartridge chromatography (Thomson SINGLE StEP 5.5 g C18 flash column, 1 mL fractions, 20% MeCN/80% aqueous 0.1% formic acid for 60 mL then linear gradient to 50% MeCN/50% aq 0.1% formic acid at 130 mL). The product fractions were combined, partially concentrated to remove MeCN, neutralized with satd aq NaHCO<sub>3</sub>, and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, concentrated in vacuo, and the resulting residue was dissolved in EtOH for storage. LSC analysis of the EtOH solution indicated isolation of 55 mCi of <b>78</b>, which was found to be chemically and radiochemically pure by HPLC (see HPLC method B below) and have a specific activity of 82 Ci/mmol by MS (see MS method below).</div></div></div><div id="sec4_12_4_9_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i130" class="anchor-spacer"></div><h4 class="article-section__title" id="_i130"> HPLC Method A</h4><div class="NLM_p last">Column: Zorbax SB-CN 4.6 mm × 150 mm, 5 μm. Column temperature: ambient. Flow rate: 1 mL/min. Detection: UV @ 210 nm, 254 nm and radiochemical by β-RAM. Mobile phase A: 0.1% aq methanesulfonic acid. Mobile phase B: MeCN. Run time: 10 min. Gradient: initial 90% A, 7 min 10% A, 7.1 min 90% A. Radio-TLC: Thomson Amine plate eluting with EtOAc and AR-2000 radiometric detection.</div></div><div id="sec4_12_4_9_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131"> HPLC Method B</h4><div class="NLM_p last">Column: Atlantis C18 2.1 mm × 50 mm, 5 μm. Column temperature: ambient. Flow rate: 1 mL/min. Detection: UV @ 210 nm and radiochemical by β-RAM. Mobile phase A: MeCN. Mobile phase B: H<sub>2</sub>O/MeCN/formic acid (98/2/0.1). Run time: 10 min.</div></div><div id="sec4_12_4_9_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132"> MS Method Information</h4><div class="NLM_p last">Flow rate: 1 mL/min. Mobile phase: H<sub>2</sub>O/MeCN/formic acid (98/2/0.1). Ionization source: ESI+. Scan range: 300–500.</div></div><div id="sec4_12_4_9_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i133" class="anchor-spacer"></div><h4 class="article-section__title" id="_i133"> 4-(Azetidin-1-yl)-1-methyl-3-(1-methyl-5-(5-(trifluoromethyl)pyridin-2-yl)-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>72</b>)</h4><div id="sec4_12_4_9_12_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i134" class="anchor-spacer"></div><h5 class="article-section__title" id="_i134"> Step 1: 2-(1-Methyl-1<i>H</i>-pyrazol-5-yl)-5-(trifluoromethyl)pyridine</h5><div class="NLM_p last">A mixture of (1-methyl-1<i>H</i>-pyrazol-5-yl)boronic acid (1.00 g, 7.94 mmol), 2-bromo-5-(trifluoromethyl)pyridine (1.79 g, 7.94 mmol), bis(triphenylphosphine)palladium (II) dichloride (279 mg, 0.397 mmol), and sodium carbonate (3.37 g, 31.8 mmol) in dimethoxy ethane (30 mL), and water (3 mL) was heated at 90 °C overnight. THE mixture was cooled to RT, and the solvent was removed under vacuum. The residue was dissolved in water and extracted twice with EtOAc. The combined extracts were washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. Silica gel chromatography eluting with an EtOAc/heptanes gradient afforded 630 mg (35%) of the title compound. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.89 (br d, <i>J</i> = 2 Hz, 1H), 8.19–8.23 (m, 1H), 7.94 (br d, <i>J</i> = 8.2 Hz, 1H), 7.58 (d, <i>J</i> = 2.0 Hz, 1H), 6.60 (d, <i>J</i> = 2.2 Hz, 1H), 3.95 (s, 3H).</div></div><div id="sec4_12_4_9_12_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i135" class="anchor-spacer"></div><h5 class="article-section__title" id="_i135"> Step 2: 2-(4-Iodo-1-methyl-1<i>H</i>-pyrazol-5-yl)-5-(trifluoromethyl)pyridine</h5><div class="NLM_p last">To 2-(1-methyl-1<i>H</i>-pyrazol-5-yl)-5-(trifluoromethyl)pyridine (390 mg, 1.72 mmol) in acetic acid (4 mL) was added <i>N</i>-iodosuccinimide. The mixture was heated to 70 °C for 1 h. The solvent was removed under vacuum, and the crude material was chromatographed over silica gel to afford 524 mg (86%) of the title compound as a white crystalline solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.83 (br d, <i>J</i> = 2 Hz, 1H), 8.17 (br dd, <i>J</i> = 8, 2 Hz, 1H), 8.00 (br d, <i>J</i> = 8 Hz, 1H), 7.66 (s, 1H), 3.89 (s, 3H). LC/MS = 353. Eight (M + H).</div></div></div><div id="sec4_12_4_9_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i136" class="anchor-spacer"></div><h4 class="article-section__title" id="_i136"> 4-(Azetidin-1-yl)-6-chloropyrimidine-5-carbaldehyde (<b>61</b>)</h4><div class="NLM_p">A solution of 4,6-dichloropyrimidine-5-carbaldehyde (3.083 g, 17.17 mmol) and DIPEA (2.2 g, 2.85 mL, 17.2 mmol) in chloroform (1.4 mL) cooled to 0 °C was treated with azetidine (1.0 g, 1.2 mL, 17 mmol) and then was allowed to warm slowly to room temperature where it was stirred for 16 h. The resulting reaction mixture was filtered to remove a precipitate that had formed, the solution was evaporated, and the residue was purified by silica gel chromatography eluting with a EtOAc/heptane gradient. This afforded 2.2 g of the title compound (11.1 mmol, 64% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 10.25 (s, 1H), 8.27 (s, 1H), 8.06 (s, 1H), 4.25–4.10 (br s., 4H), 2.31–2.42 (m, 2H).</div><div id="sec4_12_4_9_13_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i137" class="anchor-spacer"></div><h5 class="article-section__title" id="_i137"> Step 3: (4-(Azetidin-1-yl)-6-chloropyrimidin-5-yl)(1-methyl-5-(5-(trifluoromethyl)pyridin-2-yl)-1<i>H</i>-pyrazol-4-yl)methanol</h5><div class="NLM_p last">To a solution of 2-(4-iodo-1-methyl-1<i>H</i>-pyrazol-5-yl)-5-(trifluoromethyl)pyridine (50 mg, 0.14 mmol) in THF at −78 °C was added slowly dropwise nBuLi (0.074 mL of a 2.5 M solution in hexanes). The mixture was stirred for 1 h, and then a solution of 4-(azetidin-1-yl)-6-chloropyrimidine-5-carbaldehyde in THF (1 mL) was added. After 1.5 h, the mixture was diluted with water, warmed to rt, and extracted with EtOAc. After washing with brine, the organic material was dried over MgSO<sub>4</sub>, filtered, and concentrated. Silica gel chromatography eluting with 5:1:94 MeOH/Et<sub>3</sub>N/dichloromethane afforded 40 mg (66%) of the title compound. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.89 (br d, <i>J</i> = 2 Hz, 1H), 8.19–8.23 (m, 1H), 7.94 (br d, <i>J</i> = 8.2 Hz, 1H), 7.58 (d, <i>J</i> = 2.0 Hz, 1H), 6.60 (d, <i>J</i> = 2.2 Hz, 1H), 3.95 (s, 3H).</div></div><div id="sec4_12_4_9_13_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i138" class="anchor-spacer"></div><h5 class="article-section__title" id="_i138"> Step 4: (4-(Azetidin-1-yl)-6-chloropyrimidin-5-yl)(1-methyl-5-(5-(trifluoromethyl)pyridin-2-yl)-1<i>H</i>-pyrazol-4-yl)methanone</h5><div class="NLM_p last">To (4-(azetidin-1-yl)-6-chloropyrimidin-5-yl)(1-methyl-5-(5-(trifluoromethyl)pyridin-2-yl)-1<i>H</i>-pyrazol-4-yl)methanol (30 mg, 0.071 mmol) in dichloromethane (2 mL) in an ice bath was added Dess–Martin periodinane (33 mg, 0.078 mmol) After stirring for 1 h, the ice bath was removed, and the mixture was stirred overnight. The mixture was diluted with dichloromethane and quenched with satd NaHCO<sub>3</sub> (1 mL) and 1 M sodium thiosulfate (1 mL). The organic portion was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated. Silica gel chromatography (95% EtOAc, 2.5% MeOH, 2.5% TEA) with a 0–100% heptane gradient to afforded 29 mg (97%) of the title compound, containing minor impurities according to <sup>1</sup>H NMR analysis. The material was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.72 (br s, 1H), 8.00–8.13 (m, 3H), 7.89 (d, <i>J</i> = 8. Two Hz, 1H), 3.99–4.07 (m, 4H), 3.78 (s, 3H), 2.30–2.39 (m, 2H). LC/MS = 423.1, 425.2 (M + H).</div></div><div id="sec4_12_4_9_13_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i139" class="anchor-spacer"></div><h5 class="article-section__title" id="_i139"> Step 5: 4-(Azetidin-1-yl)-1-methyl-3-(1-methyl-5-(5-(trifluoromethyl)pyridin-2-yl)-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>72</b>)</h5><div class="NLM_p last">Prepared using the second step of general procedure A. Purification by silica gel chromatography, 0–10% MeOH in EtOAc, afforded 2.6 mg, 7.5% yield, of the title compound. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.77–8.79 (m, 1H), 8.17 (s, 1H), 8.12–8.16 (m, 1H), 7.85 (d, <i>J</i> = 8.2 Hz, 1H), 7.80 (s, 1H), 3.98 (s, 3H), 3.94 (s, 3H), 3.79–4.04 (br m, 4H), 2.25–2.34 (m, 2H). LC/MS = 415.0 (M + H).</div></div></div><div id="sec4_12_4_9_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i140" class="anchor-spacer"></div><h4 class="article-section__title" id="_i140"> 4-(Azetidin-1-yl)-3-(5-(5-cyclopropylpyridin-2-yl)-1-methyl-1<i>H</i>-pyrazol-4-yl)-1-methyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>73</b>)</h4><div id="sec4_12_4_9_14_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i141" class="anchor-spacer"></div><h5 class="article-section__title" id="_i141"> Step 1: 5-Cyclopropyl-2-(1-methyl-1<i>H</i>-pyrazol-5-yl)pyridine</h5><div class="NLM_p last">Used same procedure as for 2-(1-methyl-1<i>H</i>-pyrazol-5-yl)-5-(trifluoromethyl)pyridine (above), obtained 1140 mg, 5.72 mmol, 46% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.45 (d, <i>J</i> = 2.15 Hz, 1H), 7.53–7.57 (m, 1H), 7.46–7.50 (m, 1H), 7.45 (d, <i>J</i> = 2.15 Hz, 2H), 6.58 (d, <i>J</i> = 2.15 Hz, 1H), 4.07 (s, 3H), 1.98 (tt, <i>J</i> = 5.05, 8.51 Hz, 1H), 1.03–1.10 (m, 2H), 0.74–0.80 (m, 2H). LC/MS = 200.0 (M + H).</div></div><div id="sec4_12_4_9_14_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i142" class="anchor-spacer"></div><h5 class="article-section__title" id="_i142"> Step 2: 5-Cyclopropyl-2-(4-iodo-1-methyl-1<i>H</i>-pyrazol-5-yl)pyridine</h5><div class="NLM_p last">Used same procedure as for 2-(4-iodo-1-methyl-1<i>H</i>-pyrazol-5-yl)-5-(trifluoromethyl)pyridine (above) which yielded 1.3 g (4 mmol, 84% yield) of a brown oil. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.51 (t, <i>J</i> = 1.56 Hz, 1H), 7.56–7.59 (m, 2H), 7.54–7.56 (m, 1H), 3.85–3.89 (m, 3H), 2.03 (tt, <i>J</i> = 5.05, 8.42 Hz, 1H), 1.05–1.15 (m, 2H), 0.77–0.86 (m, 2H). LC/MS = 325.9 (M + H).</div></div><div id="sec4_12_4_9_14_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i143" class="anchor-spacer"></div><h5 class="article-section__title" id="_i143"> Step 3: (4-(Azetidin-1-yl)-6-chloropyrimidin-5-yl)(5-(5-cyclopropylpyridin-2-yl)-1-methyl-1<i>H</i>-pyrazol-4-yl)methanol</h5><div class="NLM_p last">A solution of 5-cyclopropyl-2-(4-iodo-1-methyl-1<i>H</i>-pyrazol-5-yl)pyridine (430 mg, 1.32 mmol) in THF (10 mL) at −78 °C was treated dropwise with <i>n</i>-BuLi (1.45 mmol, 2.5 M in heptanes). After stirring for 1 h a solution of the aldehyde <b>61</b> (261 mg, 1.32 mmol) in THF (4 mL) was added and the resulting orange solution was stirred for an additional 1.5 h. Water was added to quench the reaction, the mixture was warmed to room temperature, and the aqueous mixture was extracted with EtOAc (1 × 50 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, was filtered, solvent was evaporated, and the crude material was purified by silica gel chromatography eluting with 5:1:94 MeOH/Et<sub>3</sub>N/dichloromethane to afford the title compound, 167 mg (0.421 mmol, 32% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.36 (d, <i>J</i> = 2.15 Hz, 1H), 7.83 (s, 1H), 7.49 (s, 1H), 7.37 (dd, <i>J</i> = 2.34, 8.20 Hz, 1H), 7.24 (d, <i>J</i> = 8.00 Hz, 1H), 6.28 (s, 1H), 4.22 (td, <i>J</i> = 7.76, 10.25 Hz, 2H), 3.91 (td, <i>J</i> = 7.81, 10.35 Hz, 2H), 3.74 (s, 3H), 2.10–2.22 (m, 2H), 1.90–2.00 (m, 1H), 1.02–1.11 (m, 2H), 0.72–0.80 (m, 2H). LC/MS = 397.1 (M + H).</div></div><div id="sec4_12_4_9_14_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i144" class="anchor-spacer"></div><h5 class="article-section__title" id="_i144"> Step 4: (4-(Azetidin-1-yl)-6-chloropyrimidin-5-yl)(5-(5-cyclopropylpyridin-2-yl)-1-methyl-1<i>H</i>-pyrazol-4-yl)methanone)</h5><div class="NLM_p last">Prepared similarly to <b>50a</b>. Isolated 120 mg (0.42 mmol) of the title compound (72% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.39 (d, <i>J</i> = 1.76 Hz, 1H), 8.02 (s, 1H), 7.93 (s, 1H), 7.31–7.45 (m, 2H), 4.01 (br s, 4H), 3.73 (s, 3H), 2.30 (s, 2H), 1.90–2.02 (m, 1H), 1.03–1.14 (m, 2H), 0.74–0.82 (m, 2H). LC/MS = 395 (M + H).</div></div><div id="sec4_12_4_9_14_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i145" class="anchor-spacer"></div><h5 class="article-section__title" id="_i145"> Step 5: 4-(Azetidin-1-yl)-3-(5-(5-cyclopropylpyridin-2-yl)-1-methyl-1<i>H</i>-pyrazol-4-yl)-1-methyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>73</b>)</h5><div class="NLM_p last">Prepared using the second step of general procedure A. Purified by silica gel chromatography, using solvent A (90% EtOAc, 5% MeOH, 5% Et<sub>3</sub>N), and solvent B (heptane) with gradient 0–100% A. 50 mg (0.129 mmol, 42% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.49 (d, <i>J</i> = 2.15 Hz, 1H), 8.12 (s, 1H), 7.67 (s, 1H), 7.23 (dd, <i>J</i> = 2.34, 8.20 Hz, 1H), 7.08 (d, <i>J</i> = 8.20 Hz, 1H), 4.03 (s, 3H), 3.94 (s, 3H), 3.84 (br s, 3H), 2.19 (quin, <i>J</i> = 7.76 Hz, 2H), 1.87–2.05 (m, 1H), 0.97–1.10 (m, 2H), 0.67–0.88 (m, 2H). LC/MS = 387.2 (M + H).</div></div></div><div id="sec4_12_4_9_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i146" class="anchor-spacer"></div><h4 class="article-section__title" id="_i146"> 4-(Azetidin-1-yl)-3-(5-(5-cyclopropylpyrimidin-2-yl)-1-methyl-1<i>H</i>-pyrazol-4-yl)-1-methyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>74</b>)</h4><div id="sec4_12_4_9_15_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i147" class="anchor-spacer"></div><h5 class="article-section__title" id="_i147"> Step 1: 5-Cyclopropyl-2-(1-methyl-1<i>H</i>-pyrazol-5-yl)pyrimidine</h5><div class="NLM_p last">(1-Methyl-1<i>H</i>-pyrazol-5-yl)boronic acid (195 mg, 1.55 mmol), 2-chloro-5-cyclopropylpyrimidine (240 mg, 1.55 mmol), sodium carbonate (658 mg, 6.21 mmol), water (1 mL), and 1,2-dimethoxyethane (DME, 10 mL) were mixed and purged with nitrogen, then Cl<sub>2</sub>Pd(PPh<sub>3</sub>)<sub>2</sub> (55 mg, 0.078 mmol) was added and the mixture was heated at reflux for 16 h. Additional portions of boronic acid (50 mg, 0.4 mmol) and Cl<sub>2</sub>Pd(PPh<sub>3</sub>)<sub>2</sub> (10 mg, 0.014 mmol) were added, and heating was continued for 3 days. After cooling to room temperature, DME was evaporated, and the mixture was diluted with water and was extracted with EtOAc (2 × 200 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The crude mixture was purified by silica gel chromatography to afford the title compound (159 mg, 0.794 mmol, 51% yield) as a pale-yellow oil. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.57 (s, 2H), 7.46 (d, <i>J</i> = 2.15 Hz, 1H), 6.96 (d, <i>J</i> = 2.1 Hz, 1H), 4.25 (s, 3H), 1.88–2.01 (m, 1H), 1.05–1.16 (m, 2H), 0.77–0.94 (m, 2H). LC/MS = 200.9 (M + H).</div></div><div id="sec4_12_4_9_15_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i148" class="anchor-spacer"></div><h5 class="article-section__title" id="_i148"> Step 2: 5-Cyclopropyl-2-(4-iodo-1-methyl-1<i>H</i>-pyrazol-5-yl)pyrimidine</h5><div class="NLM_p last">5-Cyclopropyl-2-(1-methyl-1<i>H</i>-pyrazol-5-yl)pyrimidine (800 mg, 4.4 mmol) in acetic acid (20 mL) was treated with <i>N</i>-iodosuccinimide (1.090 g, 4.62 mmol) at room temperature then was heated at 85 °C for 1 h. After cooling to room temperature, the solvent was evaporated, the residue was dissolved in methylene chloride (2 mL) and was purified by silica gel chromatography (1:1 heptane/EtOAc) to afford to 1.3 g (3.99 mmol, 91% yield) of the title compound as a beige solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.66 (s, 2H), 7.56 (s, 1H), 4.06 (s, 3H), 1.95–2.05 (m, 1H), 1.15 (dd, <i>J</i> = 1.95, 8.39 Hz, 2H), 0.86–0.95 (m, 2H). LC/MS = 326.9 (M + H).</div></div><div id="sec4_12_4_9_15_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i149" class="anchor-spacer"></div><h5 class="article-section__title" id="_i149"> Step 3: (4-(Azetidin-1-yl)-6-chloropyrimidin-5-yl)(5-(5-cyclopropylpyrimidin-2-yl)-1-methyl-1<i>H</i>-pyrazol-4-yl)methanol</h5><div class="NLM_p last">A solution of 5-cyclopropyl-2-(4-iodo-1-methyl-1<i>H</i>-pyrazol-5-yl)pyrimidine (485 mg, 1.49 mmol) in THF (10 mL) cooled to −78 °C was treated dropwise with <i>i</i>-PrMgCl (1.49 mmol, 0.74 mL, 2 M in THF). After stirring for 1 h, the aldehyde <b>61</b> (294 mg, 1.49 mmol) in THF (1 mL) was added, and the reaction solution was stirred for 1.5 h. Water was added to quench the reaction, the mixture was warmed to room temperature, and the aqueous mixture was extracted with EtOAc (1 × 50 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The crude material was purified by silica gel chromatography eluting with 5% of MeOH and 1% of Et<sub>3</sub>N in dichloromethane to afford 370 mg (0.93 mmol, 62% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.58 (s, 2H), 8.01 (s, 1H), 7.32 (s, 1H), 6.43 (s, 1H), 4.27–4.37 (m, 2H), 4.13 (s, 3H), 4.01–4.11 (m, 2H), 2.21 (quin, <i>J</i> = 7.76 Hz, 2H), 1.91–2.02 (m, 1H), 1.09–1.18 (m, 2H), 0.84–0.91 (m, 2H). LC/MS = 398.1 (M + H).</div></div><div id="sec4_12_4_9_15_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i150" class="anchor-spacer"></div><h5 class="article-section__title" id="_i150"> Step 4: (4-(Azetidin-1-yl)-6-chloropyrimidin-5-yl)(5-(5-cyclopropylpyrimidin-2-yl)-1-methyl-1<i>H</i>-pyrazol-4-yl)methanone</h5><div class="NLM_p last">(4-(Azetidin-1-yl)-6-chloropyrimidin-5-yl)(5-(5-cyclopropylpyrimidin-2-yl)-1-methyl-1<i>H</i>-pyrazol-4-yl)methanol (370 mg, 0.932 mmol) in methylene chloride (10 mL) at 0 °C was treated portion wise with Dess–Martin periodinane (435 mg, 1.02 mmol). After 1 h, the reaction mixture was allowed to warm to room temperature and was stirred for 16 h. The reaction mixture was diluted with methylene chloride and quenched with saturated sodium bicarbonate (1 mL) and saturated sodium thiosulfate (1 mL), and the organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the solvent evaporated. The crude material was purified by silica gel chromatography using solvent mix A (95% EtOAc, 2.5% MeOH, 2.5% Et<sub>3</sub>N) in heptane with a 0–100% gradient to give 267 mg (0.674 mmol) of the title compound (72% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.48 (s, 2H), 8.05 (s, 1H), 7.95 (s, 1H), 4.82 (s, 3H), 4.00–4.23 (m, 4H), 3.86 (s, 3H), 2.33 (td, <i>J</i> = 7.71, 15.42 Hz, 2H), 1.86–2.01 (m, 1H), 1.10–1.19 (m, 2H), 0.76–0.96 (m, 2H). LC/MS = 396.1 (M + H).</div></div><div id="sec4_12_4_9_15_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i151" class="anchor-spacer"></div><h5 class="article-section__title" id="_i151"> Step 5: 4-(Azetidin-1-yl)-3-(5-(5-cyclopropylpyrimidin-2-yl)-1-methyl-1<i>H</i>-pyrazol-4-yl)-1-methyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>74</b>)</h5><div class="NLM_p last">(4-(Azetidin-1-yl)-6-chloropyrimidin-5-yl)(5-(5-cyclopropylpyrimidin-2-yl)-1-methyl-1<i>H</i>-pyrazol-4-yl)methanone (267 mg, 0.674 mmol) in 1,4-dioxane (2.25 mL) at room temperature was treated with methyl hydrazine (95 mg, 109 Na<sub>2</sub>SO<sub>4</sub>, 2.0 mmol), and the solution was stirred for 1 h. The solvent was evaporated, and the residue was purified by silica gel chromatography using a gradient 100%A:0%B to 0%A:100%B, A (heptane):B (90% EtOAc, 5% MeOH, 5% Et<sub>3</sub>N), to afford the title compound in 64% yield, 167 mg (0.431 mmol). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.41 (s, 2H), 8.16 (s, 1H), 7.67 (s, 1H), 4.21 (s, 3H), 4.03–4.10 (br m, 2H, a-azetidine N), 3.89 (s, 3H), 2.15 (quin, <i>J</i> = 7.76 Hz, 2H), 1.81–1.90 (m, 1H), 1.01–1.09 (m, 1H), 0.98–1.11 (m, 2H), 0.73–0.80 (m, 2H). LC/MS = 388.1 (M + H).</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i152"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00397">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31166" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31166" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00397" class="ext-link">10.1021/acs.jmedchem.7b00397</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">PDE2A protein X-ray crystal structure data collection and refinement statistics; BAY-60-7550 (<b>1</b>) brain exposure in mice; derivation of estimated human dose equation; number of replicates and standard error of the mean (SEM) for PDE2A IC<sub>50</sub> data and compound purity by HPLC; impact of pyrazole methylation on dihedral angles; kinase inhibition data for <b>71</b>; CEREP selectivity data for <b>71</b> dosed at 10 μM; PDE selectivity data for <b>1</b>, <b>2</b>, <b>3</b>, <b>4</b>, <b>39</b>, <b>52</b>, and <b>71</b>; rat IV pharmacokinetic data for <b>71</b> from <a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>; PK/PD modeling of <b>71</b> in MK-801 disruption of cortical delta oscillation in rat (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00397/suppl_file/jm7b00397_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00397/suppl_file/jm7b00397_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00397/suppl_file/jm7b00397_si_001.pdf">jm7b00397_si_001.pdf (0.99 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00397/suppl_file/jm7b00397_si_002.csv">jm7b00397_si_002.csv (2.49 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00397" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65052" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65052" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Helal</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9091-2091" title="Orcid link">http://orcid.org/0000-0002-9091-2091</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e5868d978c96cb8fcb8d80898489a595838c9f8097cb868a88"><span class="__cf_email__" data-cfemail="4023283229336e2a6e28252c212c003026293a25326e232f2d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric P. Arnold</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tracey L. Boyden</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng Chang</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas A. Chappie</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberly F. Fennell</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael D. Forman</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mihaly Hajos</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John F. Harms</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William E. Hoffman</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John M. Humphrey</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhijun Kang</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robin J. Kleiman</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bethany L. Kormos</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Che-Wah Lee</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiemin Lu</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Noha Maklad</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura McDowell</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scot Mente</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rebecca E. O’Connor</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jayvardhan Pandit</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Piotrowski</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne W. Schmidt</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Schmidt</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hirokazu Ueno</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick R. Verhoest</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edward X. Yang</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d50e7044-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i162">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24407" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24407" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Stephen Jenkinson for the generation of the PDE selectivity data, Lois Chenard for generation of compounds in <a class="ref internalNav" href="#tbl10" aria-label="Table 10">Table 10</a>, Justin Bellenger for the HPLC purification of compounds in <a class="ref internalNav" href="#tbl10" aria-label="Table 10">Table 10</a>, and Kevin Parris and Artem Evdokimov for their help with final refinement of the x-ray structures.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i163" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i163"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i164" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i164"> Abbreviations Used</h2><tr><td class="NLM_term"><i>C</i><sub>b</sub></td><td class="NLM_def"><p class="first last">brain concentration</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>bu</sub></td><td class="NLM_def"><p class="first last">brain unbound concentration</p></td></tr><tr><td class="NLM_term">clogD</td><td class="NLM_def"><p class="first last">calculated logarithm of the partition coefficient at a specific pH</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>p</sub></td><td class="NLM_def"><p class="first last">plasma concentration</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>pu</sub></td><td class="NLM_def"><p class="first last">unbound plasma concentration</p></td></tr><tr><td class="NLM_term">cp<i>K</i><sub>a</sub></td><td class="NLM_def"><p class="first last">calculated logarithm of the acid dissociation constant</p></td></tr><tr><td class="NLM_term">DIS</td><td class="NLM_def"><p class="first last">diversity introduction step</p></td></tr><tr><td class="NLM_term">DM</td><td class="NLM_def"><p class="first last">diversity monomer</p></td></tr><tr><td class="NLM_term">EEG</td><td class="NLM_def"><p class="first last">electroencephalogram</p></td></tr><tr><td class="NLM_term"><i>F</i><sub>ub</sub></td><td class="NLM_def"><p class="first last">fraction unbound in brain</p></td></tr><tr><td class="NLM_term"><i>F</i><sub>up</sub></td><td class="NLM_def"><p class="first last">fraction unbound in plasma</p></td></tr><tr><td class="NLM_term">HLM Cl<sub>int</sub></td><td class="NLM_def"><p class="first last">human liver microsome intrinsic clearance (mL/min/kg)</p></td></tr><tr><td class="NLM_term">k<i>D</i></td><td class="NLM_def"><p class="first last">dissociation constant</p></td></tr><tr><td class="NLM_term">LipE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency = logIC<sub>50</sub> – clogP</p></td></tr><tr><td class="NLM_term">MDR BA/AB</td><td class="NLM_def"><p class="first last">ratio of basil to apical/apical to basil flux in cell overexpressing the multidrug resistant 1 transporter</p></td></tr><tr><td class="NLM_term">mPFC</td><td class="NLM_def"><p class="first last">medial prefrontal cortex</p></td></tr><tr><td class="NLM_term">PFC</td><td class="NLM_def"><p class="first last">prefrontal cortex</p></td></tr><tr><td class="NLM_term">PPF</td><td class="NLM_def"><p class="first last">paired pulse facilitation</p></td></tr><tr><td class="NLM_term">RAM</td><td class="NLM_def"><p class="first last">radial arm maze</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i165">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04034" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04034" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 36 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><div class="note"><p class="first last">For a recent review of PDE10A inhibitors, see:</p></div><span class="NLM_contrib-group">Chappie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span> </span><span class="NLM_article-title">Current Landscape of Phosphodiesterase 10A (PDE10A) Inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7299</span><span class="NLM_x">–</span> <span class="NLM_lpage">7331</span><span class="refDoi"> DOI: 10.1021/jm3004976</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3004976" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2gsbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7299-7331&author=T.+A.+Chappieauthor=C.+J.+Helalauthor=X.+Hou&title=Current+Landscape+of+Phosphodiesterase+10A+%28PDE10A%29+Inhibition&doi=10.1021%2Fjm3004976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Current Landscape of Phosphodiesterase 10A (PDE10A) Inhibition</span></div><div class="casAuthors">Chappie, Thomas A.; Helal, Christopher J.; Hou, Xinjun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7299-7331</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  No abstr. required for Perspectives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolfNGPFFnnOrVg90H21EOLACvtfcHk0lgzl3PDZAe2mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2gsbrF&md5=b50361a522ec669cad0a65b2d33d5dfb</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm3004976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3004976%26sid%3Dliteratum%253Aachs%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26atitle%3DCurrent%2520Landscape%2520of%2520Phosphodiesterase%252010A%2520%2528PDE10A%2529%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7299%26epage%3D7331%26doi%3D10.1021%2Fjm3004976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harms, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx-LaFrance, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suiciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span> </span><span class="NLM_article-title">Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920)(I) for the Treatment of Schizophrenia</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5188</span><span class="NLM_x">–</span> <span class="NLM_lpage">5196</span><span class="refDoi"> DOI: 10.1021/jm900521k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900521k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5188-5196&author=P.+R.+Verhoestauthor=D.+S.+Chapinauthor=M.+Cormanauthor=K.+Fonsecaauthor=J.+F.+Harmsauthor=X.+Houauthor=E.+S.+Marrauthor=F.+S.+Mennitiauthor=F.+Nelsonauthor=R.+O%E2%80%99Connorauthor=J.+Panditauthor=C.+Proulx-LaFranceauthor=A.+W.+Schmidtauthor=C.+J.+Schmidtauthor=J.+A.+Suiciakauthor=S.+Liras&title=Discovery+of+a+Novel+Class+of+Phosphodiesterase+10A+Inhibitors+and+Identification+of+Clinical+Candidate+2-%5B4-%281-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl%29-phenoxymethyl%5D-quinoline+%28PF-2545920%29%28I%29+for+the+Treatment+of+Schizophrenia&doi=10.1021%2Fjm900521k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm900521k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900521k%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DCorman%26aufirst%3DM.%26aulast%3DFonseca%26aufirst%3DK.%26aulast%3DHarms%26aufirst%3DJ.%2BF.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DMarr%26aufirst%3DE.%2BS.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DProulx-LaFrance%26aufirst%3DC.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DSuiciak%26aufirst%3DJ.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520Phosphodiesterase%252010A%2520Inhibitors%2520and%2520Identification%2520of%2520Clinical%2520Candidate%25202-%255B4-%25281-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl%2529-phenoxymethyl%255D-quinoline%2520%2528PF-2545920%2529%2528I%2529%2520for%2520the%2520Treatment%2520of%2520Schizophrenia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5188%26epage%3D5196%26doi%3D10.1021%2Fjm900521k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx-Lafrance, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claffey, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuttle, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanase-Frawley, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span> </span><span class="NLM_article-title">Design and Discovery of 6-[(3<i>S</i>,4<i>S</i>)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-d]pyrimidin-4-one (PF-04447943) a Selective Brain Penetrant PDE9A Inhibitor for the Treatment of Cognitive Disorders</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9045</span><span class="NLM_x">–</span> <span class="NLM_lpage">9054</span><span class="refDoi"> DOI: 10.1021/jm3007799</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3007799" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9045-9054&author=P.+R.+Verhoestauthor=K.+R.+Fonsecaauthor=X.+Houauthor=C.+Proulx-Lafranceauthor=M.+Cormanauthor=C.+J.+Helalauthor=M.+M.+Claffeyauthor=J.+B.+Tuttleauthor=K.+J.+Coffmanauthor=S.+Liuauthor=F.+R.+Nelsonauthor=R.+J.+Kleimanauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=M.+A.+Vanase-Frawleyauthor=S.+Liras&title=Design+and+Discovery+of+6-%5B%283S%2C4S%29-4-methyl-1-%28pyrimidin-2-ylmethyl%29pyrrolidin-3-yl%5D-1-%28tetrahydro-2H-pyran-4-yl%29-1%2C5-dihydro-4H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-one+%28PF-04447943%29+a+Selective+Brain+Penetrant+PDE9A+Inhibitor+for+the+Treatment+of+Cognitive+Disorders&doi=10.1021%2Fjm3007799"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm3007799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007799%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DProulx-Lafrance%26aufirst%3DC.%26aulast%3DCorman%26aufirst%3DM.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26aulast%3DTuttle%26aufirst%3DJ.%2BB.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DVanase-Frawley%26aufirst%3DM.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DDesign%2520and%2520Discovery%2520of%25206-%255B%25283S%252C4S%2529-4-methyl-1-%2528pyrimidin-2-ylmethyl%2529pyrrolidin-3-yl%255D-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C5-dihydro-4H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2520%2528PF-04447943%2529%2520a%2520Selective%2520Brain%2520Penetrant%2520PDE9A%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Cognitive%2520Disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9045%26epage%3D9054%26doi%3D10.1021%2Fjm3007799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Claffey, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fors, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundesmann, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanase-Frawley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDougall-Murphy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span> </span><span class="NLM_article-title">Application of Structure-Based Drug Design and Parallel Chemistry to Identify Selective, Brain Penetrant, In Vivo Active Phosphodiesterase 9A Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9055</span><span class="NLM_x">–</span> <span class="NLM_lpage">9068</span><span class="refDoi"> DOI: 10.1021/jm3009635</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3009635" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVejsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9055-9068&author=M.+M.+Claffeyauthor=C.+J.+Helalauthor=P.+R.+Verhoestauthor=Z.+Kangauthor=K.+S.+Forsauthor=S.+Jungauthor=J.+Zhongauthor=M.+W.+Bundesmannauthor=X.+Houauthor=S.+Luiauthor=R.+J.+Kleimanauthor=M.+Vanase-Frawleyauthor=A.+W.+Schmidtauthor=F.+Mennitiauthor=C.+J.+Schmidtauthor=W.+E.+Hoffmanauthor=M.+Hajosauthor=L.+McDowellauthor=R.+E.+O%E2%80%99Connorauthor=M.+MacDougall-Murphyauthor=K.+R.+Fonsecaauthor=S.+L.+Beckerauthor=F.+R.+Nelsonauthor=S.+Liras&title=Application+of+Structure-Based+Drug+Design+and+Parallel+Chemistry+to+Identify+Selective%2C+Brain+Penetrant%2C+In+Vivo+Active+Phosphodiesterase+9A+Inhibitors&doi=10.1021%2Fjm3009635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Structure-Based Drug Design and Parallel Chemistry to Identify Selective, Brain Penetrant, In Vivo Active Phosphodiesterase 9A Inhibitors</span></div><div class="casAuthors">Claffey, Michelle M.; Helal, Christopher J.; Verhoest, Patrick R.; Kang, Zhijun; Bundesmann, Mark W.; Hou, Xinjun; Lui, Shenping; Kleiman, Robin J.; Vanase-Frawley, Michelle; Schmidt, Anne W.; Menniti, Frank; Schmidt, Christopher J.; Hoffman, William E.; Hajos, Mihaly; McDowell, Laura; O'Connor, Rebecca E.; MacDougall-Murphy, Mary; Fonseca, Kari R.; Becker, Stacey L.; Nelson, Frederick R.; Liras, Spiros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9055-9068</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase 9A inhibitors have shown activity in preclin. models of cognition with potential application as novel therapies for treating Alzheimer's disease.  Our clin. candidate, PF-04447943 (2), demonstrated acceptable CNS permeability in rats with modest asymmetry between central and peripheral compartments (free brain/free plasma = 0.32; CSF/free plasma = 0.19) yet had physicochem. properties outside the range assocd. with traditional CNS drugs.  To address the potential risk of restricted CNS penetration with 2 in human clin. trials, we sought to identify a preclin. candidate with no asymmetry in rat brain penetration and that could advance into development.  Merging the medicinal chem. strategies of structure-based design with parallel chem., a novel series of PDE9A inhibitors was identified that showed improved selectivity over PDE1C.  Optimization afforded preclin. candidate 19 that demonstrated free brain/free plasma ≥1 in rat and reduced microsomal clearance along with the ability to increase cyclic guanosine monophosphosphate levels in rat CSF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphK4OmJAu-pbVg90H21EOLACvtfcHk0lgIS3cb6YfDMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVejsrvJ&md5=5e3aea9b0bfd660973c1e5fd56b6d933</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm3009635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009635%26sid%3Dliteratum%253Aachs%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DKang%26aufirst%3DZ.%26aulast%3DFors%26aufirst%3DK.%2BS.%26aulast%3DJung%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DJ.%26aulast%3DBundesmann%26aufirst%3DM.%2BW.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DLui%26aufirst%3DS.%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DMenniti%26aufirst%3DF.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DHoffman%26aufirst%3DW.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DMcDowell%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%2BE.%26aulast%3DMacDougall-Murphy%26aufirst%3DM.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DApplication%2520of%2520Structure-Based%2520Drug%2520Design%2520and%2520Parallel%2520Chemistry%2520to%2520Identify%2520Selective%252C%2520Brain%2520Penetrant%252C%2520In%2520Vivo%2520Active%2520Phosphodiesterase%25209A%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9055%26epage%3D9068%26doi%3D10.1021%2Fjm3009635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Boess, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Staay, F.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Staveren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vente, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prickaerts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blokland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, G.</span><span> </span><span class="NLM_article-title">Inhibition of Phosphodiesterase 2 Increases Neuronal cGMP, Synaptic Plasticity and Memory Performance</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1081</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2004.07.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2Fj.neuropharm.2004.07.040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1081-1092&author=F.+G.+Boessauthor=M.+Hendrixauthor=F.-J.+van+der+Staayauthor=C.+Erbauthor=R.+Schreiberauthor=W.+van+Staverenauthor=J.+de+Venteauthor=J.+Prickaertsauthor=A.+Bloklandauthor=G.+Koenig&title=Inhibition+of+Phosphodiesterase+2+Increases+Neuronal+cGMP%2C+Synaptic+Plasticity+and+Memory+Performance&doi=10.1016%2Fj.neuropharm.2004.07.040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2004.07.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2004.07.040%26sid%3Dliteratum%253Aachs%26aulast%3DBoess%26aufirst%3DF.%2BG.%26aulast%3DHendrix%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BStaay%26aufirst%3DF.-J.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DSchreiber%26aufirst%3DR.%26aulast%3Dvan%2BStaveren%26aufirst%3DW.%26aulast%3Dde%2BVente%26aufirst%3DJ.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DKoenig%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520Phosphodiesterase%25202%2520Increases%2520Neuronal%2520cGMP%252C%2520Synaptic%2520Plasticity%2520and%2520Memory%2520Performance%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D47%26spage%3D1081%26epage%3D1092%26doi%3D10.1016%2Fj.neuropharm.2004.07.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Masood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajjhussein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, C.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. M.</span><span> </span><span class="NLM_article-title">Anxiolytic Effects of Phosphodiesterase-2 Inhibitors Associated with Increased cGMP Signaling</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x">, </span> <span class="NLM_fpage">690</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span><span class="refDoi"> DOI: 10.1124/jpet.109.156729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1124%2Fjpet.109.156729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=19684253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlKnu7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=2009&pages=690-699&author=A.+Masoodauthor=Y.+Huangauthor=H.+Hajjhusseinauthor=L.+Xiaoauthor=H.+Liauthor=W.+Wangauthor=A.+Hamzaauthor=C.-G.+Zhanauthor=J.+M.+O%E2%80%99Donnell&title=Anxiolytic+Effects+of+Phosphodiesterase-2+Inhibitors+Associated+with+Increased+cGMP+Signaling&doi=10.1124%2Fjpet.109.156729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Anxiolytic effects of phosphodiesterase-2 inhibitors associated with increased cGMP signaling</span></div><div class="casAuthors">Masood, Anbrin; Huang, Ying; Hajjhussein, Hassan; Xiao, Lan; Li, Hao; Wang, Wei; Hamza, Adel; Zhan, Chang-Guo; O'Donnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">690-699</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE)-2 is a component of the nitric-oxide synthase (NOS)/guanylyl cyclase signaling pathway in the brain.  Given recent evidence that pharmacol. induced changes in NO-cGMP signaling can affect anxiety-related behaviors, the effects of the PDE2 inhibitors (2-(3,4-dimethoxybenzyl)-7-det-5-methylimidazo-[5,1-f][1,2,4]triazin-4(3H)-one) (Bay 60-7550) and 3-(8-methoxy-1-methyl-2-oxo-7-phenyl-2,3-dihydro-1H-benzo[e]-[1,4]diazepin-5-yl)benzamide (ND7001), as well as modulators of NO, were assessed on cGMP signaling in neurons and on the behavior of mice in the elevated plus-maze, hole-board, and open-field tests, well established procedures for the evaluation of anxiolytics.  Bay 60-7550 (1 μM) and ND7001 (10 μM) increased basal and N-methyl-D-aspartate- or detanonoate-stimulated cGMP in primary cultures of rat cerebral cortical neurons; Bay 60-7550, but not ND7001, also increased cAMP.  Increased cGMP signaling, either by administration of the PDE2 inhibitors Bay 60-7550 (0.5, 1, and 3 mg/kg) or ND7001 (1 mg/kg), or the NO donor detanonoate (0.5 mg/kg), antagonized the anxiogenic effects of restraint stress on behavior in the three tests.  These drugs also produced anxiolytic effects on behavior in nonstressed mice in the elevated plus-maze and hole-board tests; these effects were antagonized by the guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (20 mg/kg).  By contrast, the NOS inhibitor Nω-nitro-L-arginine Me ester (50 mg/kg), which reduces cGMP signaling, produced anxiogenic effects similar to restraint stress.  Overall, the present behavioral and neurochem. data suggest that PDE2 may be a novel pharmacol. target for the development of drugs for the treatment of anxiety disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjfkIU0E1A7LVg90H21EOLACvtfcHk0lgBjsn3CC_7XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlKnu7rP&md5=168305397ab25ef6b2c20ede9b287ff0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.156729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.156729%26sid%3Dliteratum%253Aachs%26aulast%3DMasood%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DHajjhussein%26aufirst%3DH.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DHamza%26aufirst%3DA.%26aulast%3DZhan%26aufirst%3DC.-G.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26atitle%3DAnxiolytic%2520Effects%2520of%2520Phosphodiesterase-2%2520Inhibitors%2520Associated%2520with%2520Increased%2520cGMP%2520Signaling%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D331%26spage%3D690%26epage%3D699%26doi%3D10.1124%2Fjpet.109.156729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="note"><p class="first last">All reported PDE2A IC<sub>50</sub> values are the geometric mean of at least three independent IC<sub>50</sub> determinations unless otherwise noted. The PDE2A3 human splice variant was used for enzyme inhibition studies. PDE1, 3–11 IC<sub>50</sub> values/% inhibition are the geometric mean of four independent assays. See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00397/suppl_file/jm7b00397_si_001.pdf" class="ext-link">Supporting Information</a> for full data tables.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand Efficiency: a Useful Metric for Lead Selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+Efficiency%3A+a+Useful+Metric+for+Lead+Selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eaR-4VEG3AK0rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520Efficiency%253A%2520a%2520Useful%2520Metric%2520for%2520Lead%2520Selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span> </span><span class="NLM_article-title">Role of Physicochemical Properties and Ligand Lipophilicity Efficiency in Addressing Drug Safety Risks</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span><span class="refDoi"> DOI: 10.1016/S0065-7743(10)45023-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2FS0065-7743%2810%2945023-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=380-391&author=M.+P.+Edwardsauthor=D.+A.+Price&title=Role+of+Physicochemical+Properties+and+Ligand+Lipophilicity+Efficiency+in+Addressing+Drug+Safety+Risks&doi=10.1016%2FS0065-7743%2810%2945023-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0065-7743%2810%2945023-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-7743%252810%252945023-X%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26atitle%3DRole%2520of%2520Physicochemical%2520Properties%2520and%2520Ligand%2520Lipophilicity%2520Efficiency%2520in%2520Addressing%2520Drug%2520Safety%2520Risks%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D380%26epage%3D391%26doi%3D10.1016%2FS0065-7743%2810%2945023-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremaine, L.</span><span> </span><span class="NLM_article-title"><i>In vitro</i> and in vivo Approaches to Characterize Transporter-Mediated Disposition in Drug Discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">873</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span><span class="refDoi"> DOI: 10.1517/17460441.2014.922540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1517%2F17460441.2014.922540" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=873-890&author=B.+Fengauthor=M.+V.+Varmaauthor=C.+Costalesauthor=H.+Zhangauthor=L.+Tremaine&title=In+vitro+and+in+vivo+Approaches+to+Characterize+Transporter-Mediated+Disposition+in+Drug+Discovery&doi=10.1517%2F17460441.2014.922540"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1517%2F17460441.2014.922540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2014.922540%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DCostales%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DTremaine%26aufirst%3DL.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520Approaches%2520to%2520Characterize%2520Transporter-Mediated%2520Disposition%2520in%2520Drug%2520Discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2014%26volume%3D9%26spage%3D873%26epage%3D890%26doi%3D10.1517%2F17460441.2014.922540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Reneerkens, O. A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hage, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blokland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbusch, H. W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prickaerts, J.</span><span> </span><span class="NLM_article-title">Inhibition of Phoshodiesterase Type 2 or Type 10 Reverses Object Memory Deficits Induced by Scopolamine or MK-801</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">236</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/j.bbr.2012.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2Fj.bbr.2012.08.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=2013&pages=16-22&author=O.+A.+H.+Reneerkensauthor=K.+Ruttenauthor=E.+Bollenauthor=T.+Hageauthor=A.+Bloklandauthor=H.+W.+M.+Steinbuschauthor=J.+Prickaerts&title=Inhibition+of+Phoshodiesterase+Type+2+or+Type+10+Reverses+Object+Memory+Deficits+Induced+by+Scopolamine+or+MK-801&doi=10.1016%2Fj.bbr.2012.08.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2012.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2012.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DReneerkens%26aufirst%3DO.%2BA.%2BH.%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DBollen%26aufirst%3DE.%26aulast%3DHage%26aufirst%3DT.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DSteinbusch%26aufirst%3DH.%2BW.%2BM.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520Phoshodiesterase%2520Type%25202%2520or%2520Type%252010%2520Reverses%2520Object%2520Memory%2520Deficits%2520Induced%2520by%2520Scopolamine%2520or%2520MK-801%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2013%26volume%3D236%26spage%3D16%26epage%3D22%26doi%3D10.1016%2Fj.bbr.2012.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span> </span><span class="NLM_article-title">X-ray Crystal Structure of Phosphodiesterase 2 in Complex with a Highly Selective, Nanomolar Inhibitor Reveals a Binding-Induced Pocket Important for Selectivity</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">11708</span><span class="NLM_x">–</span> <span class="NLM_lpage">11711</span><span class="refDoi"> DOI: 10.1021/ja404449g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja404449g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=11708-11711&author=J.+Zhuauthor=Q.+Yangauthor=D.+Daiauthor=Q.+Huang&title=X-ray+Crystal+Structure+of+Phosphodiesterase+2+in+Complex+with+a+Highly+Selective%2C+Nanomolar+Inhibitor+Reveals+a+Binding-Induced+Pocket+Important+for+Selectivity&doi=10.1021%2Fja404449g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fja404449g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja404449g%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DDai%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DQ.%26atitle%3DX-ray%2520Crystal%2520Structure%2520of%2520Phosphodiesterase%25202%2520in%2520Complex%2520with%2520a%2520Highly%2520Selective%252C%2520Nanomolar%2520Inhibitor%2520Reveals%2520a%2520Binding-Induced%2520Pocket%2520Important%2520for%2520Selectivity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D11708%26epage%3D11711%26doi%3D10.1021%2Fja404449g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleo, M. D.</span><span> </span><span class="NLM_article-title">Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1345</span><span class="NLM_x">–</span> <span class="NLM_lpage">1410</span><span class="refDoi"> DOI: 10.1021/tx200168d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200168d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1345-1410&author=A.+F.+Stepanauthor=D.+P.+Walkerauthor=J.+Baumanauthor=D.+A.+Priceauthor=T.+A.+Baillieauthor=A.+S.+Kalgutkarauthor=M.+D.+Aleo&title=Structural+Alert%2FReactive+Metabolite+Concept+as+Applied+in+Medicinal+Chemistry+to+Mitigate+the+Risk+of+Idiosyncratic+Drug+Toxicity%3A+A+Perspective+Based+on+the+Critical+Examination+of+Trends+in+the+Top+200+Drugs+Marketed+in+the+United+States&doi=10.1021%2Ftx200168d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States</span></div><div class="casAuthors">Stepan, Antonia F.; Walker, Daniel P.; Bauman, Jonathan; Price, David A.; Baillie, Thomas A.; Kalgutkar, Amit S.; Aleo, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1345-1410</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Because of a preconceived notion that eliminating reactive metabolite (RM) formation with new drug candidates could mitigate the risk of idiosyncratic drug toxicity, the potential for RM formation is routinely examd. as part of lead optimization efforts in drug discovery.  Likewise, avoidance of "structural alerts" is almost a norm in drug design.  However, there is a growing concern that the perceived safety hazards assocd. with structural alerts and/or RM screening tools as standalone predictors of toxicity risks may be over exaggerated.  In addn., the multifactorial nature of idiosyncratic toxicity is now well recognized based upon observations that mechanisms other than RM formation (e.g., mitochondrial toxicity and inhibition of bile salt export pump (BSEP)) also can account for certain target organ toxicities.  Hence, fundamental questions arise such as: When is a mol. that contains a structural alert (RM pos. or neg.) a cause for concern.  Could the mol. in its parent form exert toxicity.  Can a low dose drug candidate truly mitigate metab.-dependent and -independent idiosyncratic toxicity risks.  In an effort to address these questions, we have retrospectively examd. 68 drugs (recalled or assocd. with a black box warning due to idiosyncratic toxicity) and the top 200 drugs (prescription and sales) in the United States in 2009 for trends in physiochem. characteristics, daily doses, presence of structural alerts, evidence for RM formation as well as toxicity mechanism(s) potentially mediated by parent drugs.  Collectively, our anal. revealed that a significant proportion (∼78-86%) of drugs assocd. with toxicity contained structural alerts and evidence indicating that RM formation as a causative factor for toxicity has been presented in 62-69% of these mols.  In several cases, mitochondrial toxicity and BSEP inhibition mediated by parent drugs were also noted as potential causative factors.  Most drugs were administered at daily doses exceeding several hundred milligrams.  There was no obvious link between idiosyncratic toxicity and physicochem. properties such as mol. wt., lipophilicity, etc.  Approx. half of the top 200 drugs for 2009 (prescription and sales) also contained one or more alerts in their chem. architecture, and many were found to be RM-pos.  Several instances of BSEP and mitochondrial liabilities were also noted with agents in the top 200 category.  However, with relatively few exceptions, the vast majority of these drugs are rarely assocd. with idiosyncratic toxicity, despite years of patient use.  The major differentiating factor appeared to be the daily dose; most of the drugs in the top 200 list are administered at low daily doses.  In addn., competing detoxication pathways and/or alternate nonmetabolic clearance routes provided suitable justifications for the safety records of RM-pos. drugs in the top 200 category.  Thus, while RM elimination may be a useful and pragmatic starting point in mitigating idiosyncratic toxicity risks, our anal. suggests a need for a more integrated screening paradigm for chem. hazard identification in drug discovery.  Thus, in addn. to a detailed assessment of RM formation potential (in relationship to the overall elimination mechanisms of the compd.(s)) for lead compds., effects on cellular health (e.g., cytotoxicity assays), BSEP inhibition, and mitochondrial toxicity are the recommended suite of assays to characterize compd. liabilities.  However, the prospective use of such data in compd. selection will require further validation of the cellular assays using marketed agents.  Until we gain a better understanding of the pathophysiol. mechanisms assocd. with idiosyncratic toxicities, improving pharmacokinetics and intrinsic potency as means of decreasing the dose size and the assocd. "body burden" of the parent drug and its metabolites will remain an overarching goal in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3IhczIcvVDLVg90H21EOLACvtfcHk0lgCpVuMTCOf4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D&md5=632b73f755738e49eb233bc8dca1fbcc</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Ftx200168d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200168d%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DStructural%2520Alert%252FReactive%2520Metabolite%2520Concept%2520as%2520Applied%2520in%2520Medicinal%2520Chemistry%2520to%2520Mitigate%2520the%2520Risk%2520of%2520Idiosyncratic%2520Drug%2520Toxicity%253A%2520A%2520Perspective%2520Based%2520on%2520the%2520Critical%2520Examination%2520of%2520Trends%2520in%2520the%2520Top%2520200%2520Drugs%2520Marketed%2520in%2520the%2520United%2520States%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1345%26epage%3D1410%26doi%3D10.1021%2Ftx200168d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Zhang, K. Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neiman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milburn, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollag, G.</span><span> </span><span class="NLM_article-title">A Glutamine Switch Mechanism for Nucleotide Selectivity by Phosphodiesterases</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span><span class="refDoi"> DOI: 10.1016/j.molcel.2004.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2Fj.molcel.2004.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=15260978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD2cXms1ektLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=279-286&author=K.+Y.+J.+Zhangauthor=G.+L.+Cardauthor=Y.+Suzukiauthor=D.+R.+Artisauthor=D.+Fongauthor=S.+Gilletteauthor=D.+Hsiehauthor=J.+Neimanauthor=B.+L.+Westauthor=C.+Zhangauthor=M.+V.+Milburnauthor=S.-H.+Kimauthor=J.+Schlessingerauthor=G.+Bollag&title=A+Glutamine+Switch+Mechanism+for+Nucleotide+Selectivity+by+Phosphodiesterases&doi=10.1016%2Fj.molcel.2004.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases</span></div><div class="casAuthors">Zhang, Kam Y. J.; Card, Graeme L.; Suzuki, Yoshihisa; Artis, D. Richard; Fong, Daniel; Gillette, Sam; Hsieh, Davin; Neiman, Joshua; West, Brian L.; Zhang, Chao; Milburn, Michael V.; Kim, Sung-Hou; Schlessinger, Joseph; Bollag, Gideon</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">279-286</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) comprise a family of enzymes that modulate the immune response, inflammation, and memory, among many other functions.  There are three types of PDEs: cAMP-specific, cGMP-specific, and dual-specific.  Here we describe the mechanism of nucleotide selectivity on the basis of high-resoln. co-crystal structures of the cAMP-specific PDE4B and PDE4D with AMP, the cGMP-specific PDE5A with GMP, and the apo-structure of the dual-specific PDE1B.  These structures show that an invariant glutamine functions as the key specificity determinant by a "glutamine switch" mechanism for recognizing the purine moiety in cAMP or cGMP.  The surrounding residues anchor the glutamine residue in different orientations for cAMP and for cGMP.  The PDE1B structure shows that in dual-specific PDEs a key histidine residue may enable the invariant glutamine to toggle between cAMP and cGMP.  The structural understanding of nucleotide binding enables the design of new PDE inhibitors that may treat diseases in which cyclic nucleotides play a crit. role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorRXGTDdAa1bVg90H21EOLACvtfcHk0lgCpVuMTCOf4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXms1ektLs%253D&md5=32fab6a75031a67290ec5eda2c3e080b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2004.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2004.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%2BY.%2BJ.%26aulast%3DCard%26aufirst%3DG.%2BL.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DFong%26aufirst%3DD.%26aulast%3DGillette%26aufirst%3DS.%26aulast%3DHsieh%26aufirst%3DD.%26aulast%3DNeiman%26aufirst%3DJ.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DMilburn%26aufirst%3DM.%2BV.%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DBollag%26aufirst%3DG.%26atitle%3DA%2520Glutamine%2520Switch%2520Mechanism%2520for%2520Nucleotide%2520Selectivity%2520by%2520Phosphodiesterases%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D15%26spage%3D279%26epage%3D286%26doi%3D10.1016%2Fj.molcel.2004.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Shah, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louise-May, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span> </span><span class="NLM_article-title">Chemotypes Sensitivity and Predictivity of in vivo Outcomes for Cytotoxic Assays in THLE and HepG2 Cell Lines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2753</span><span class="NLM_x">–</span> <span class="NLM_lpage">2757</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.04.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2Fj.bmcl.2014.04.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=24794102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntlOhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2753-2757&author=F.+Shahauthor=S.+Louise-Mayauthor=N.+Greene&title=Chemotypes+Sensitivity+and+Predictivity+of+in+vivo+Outcomes+for+Cytotoxic+Assays+in+THLE+and+HepG2+Cell+Lines&doi=10.1016%2Fj.bmcl.2014.04.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Chemotypes sensitivity and predictivity of in vivo outcomes for cytotoxic assays in THLE and HepG2 cell lines</span></div><div class="casAuthors">Shah, Falgun; Louise-May, Shirley; Greene, Nigel</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2753-2757</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In the present study, we demonstrate the utility of in vitro ATP depletion assays in both THLE and HepG2 cells for predicting the toxicol. outcome in Exploratory Toxicol. Studies across 446 Pfizer proprietary compds.  Our results suggest a higher likelihood of selecting suitable compds. for in vivo safety studies by using cytotoxicity assays in multiple cell-lines over a single cell line.  In addn., we demonstrate that different cell-lines have different sensitivities to compds. depending on their ionization state, i.e., acid, base or neutral.  HepG2 cells are more sensitive for basic compds., whereas THLE cells have a relatively higher sensitivity for the acidic and neutral compds.  These in vitro cytotoxicity assays when combined with physicochem. properties (c Log P >3 and topol. polar surface area (TPSA) <75 Å2), are the most effective means to prioritize compds. having a lower probability of causing adverse events in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro0b4p6N8hM7Vg90H21EOLACvtfcHk0lhLgMCano1iXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntlOhtbo%253D&md5=883eeb3b4ef422581ca7bd653105b7f1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.04.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.04.039%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DF.%26aulast%3DLouise-May%26aufirst%3DS.%26aulast%3DGreene%26aufirst%3DN.%26atitle%3DChemotypes%2520Sensitivity%2520and%2520Predictivity%2520of%2520in%2520vivo%2520Outcomes%2520for%2520Cytotoxic%2520Assays%2520in%2520THLE%2520and%2520HepG2%2520Cell%2520Lines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2753%26epage%3D2757%26doi%3D10.1016%2Fj.bmcl.2014.04.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, R.</span><span> </span><span class="NLM_article-title">In Vivo Site-Directed Radiotracers: Mini-Review</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">–</span> <span class="NLM_lpage">815</span><span class="refDoi"> DOI: 10.1016/j.nucmedbio.2008.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2Fj.nucmedbio.2008.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=19026942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=805-815&author=S.+Patelauthor=R.+Gibson&title=In+Vivo+Site-Directed+Radiotracers%3A+Mini-Review&doi=10.1016%2Fj.nucmedbio.2008.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo site-directed radiotracers: a mini-review</span></div><div class="casAuthors">Patel, Shil; Gibson, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">805-815</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review on the process for developing reversible, monovalent site-specific radiotracers in drug design.  It is concerned with the characteristics of radiotracers such as binding, lipophilicity, and binding specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYUEhMFA7d7bVg90H21EOLACvtfcHk0lhLgMCano1iXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL&md5=869985e0741d52a76cb546972097e2a8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DGibson%26aufirst%3DR.%26atitle%3DIn%2520Vivo%2520Site-Directed%2520Radiotracers%253A%2520Mini-Review%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D805%26epage%3D815%26doi%3D10.1016%2Fj.nucmedbio.2008.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chappie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaddan, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zasadny, K.</span><span> </span><span class="NLM_article-title">Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4568</span><span class="NLM_x">–</span> <span class="NLM_lpage">4579</span><span class="refDoi"> DOI: 10.1021/jm400312y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400312y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4568-4579&author=L.+Zhangauthor=A.+Villalobosauthor=E.+M.+Beckauthor=T.+Bocanauthor=T.+A.+Chappieauthor=L.+Chenauthor=S.+Grimwoodauthor=S.+D.+Heckauthor=C.+J.+Helalauthor=X.+Houauthor=J.+M.+Humphreyauthor=J.+Luauthor=M.+B.+Skaddanauthor=T.+J.+McCarthyauthor=P.+R.+Verhoestauthor=T.+T.+Wagerauthor=K.+Zasadny&title=Design+and+Selection+Parameters+to+Accelerate+the+Discovery+of+Novel+Central+Nervous+System+Positron+Emission+Tomography+%28PET%29+Ligands+and+Their+Application+in+the+Development+of+a+Novel+Phosphodiesterase+2A+PET+Ligand&doi=10.1021%2Fjm400312y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand</span></div><div class="casAuthors">Zhang, Lei; Villalobos, Anabella; Beck, Elizabeth M.; Bocan, Thomas; Chappie, Thomas A.; Chen, Laigao; Grimwood, Sarah; Heck, Steven D.; Helal, Christopher J.; Hou, Xinjun; Humphrey, John M.; Lu, Jiemin; Skaddan, Marc B.; McCarthy, Timothy J.; Verhoest, Patrick R.; Wager, Travis T.; Zasadny, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4568-4579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To accelerate the discovery of novel small mol. central nervous system (CNS) positron emission tomog. (PET) ligands, we aimed to define a property space that would facilitate ligand design and prioritization, thereby providing a higher probability of success for novel PET ligand development.  Toward this end, we built a database consisting of 62 PET ligands that have successfully reached the clinic and 15 radioligands that failed in late-stage development as neg. controls.  A systematic anal. of these ligands identified a set of preferred parameters for physicochem. properties, brain permeability, and nonspecific binding (NSB).  These preferred parameters have subsequently been applied to several programs and have led to the successful development of novel PET ligands with reduced resources and timelines.  This strategy is illustrated here by the discovery of the novel phosphodiesterase 2A (PDE2A) PET ligand 4-(3-[18F]fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine, [18F]PF-05270430 (5).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTCG9TZE0X-bVg90H21EOLACvtfcHk0lhLgMCano1iXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D&md5=ee7ce04829d7456a632c02c331c4edfa</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm400312y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400312y%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBocan%26aufirst%3DT.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHeck%26aufirst%3DS.%2BD.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DMcCarthy%26aufirst%3DT.%2BJ.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DZasadny%26aufirst%3DK.%26atitle%3DDesign%2520and%2520Selection%2520Parameters%2520to%2520Accelerate%2520the%2520Discovery%2520of%2520Novel%2520Central%2520Nervous%2520System%2520Positron%2520Emission%2520Tomography%2520%2528PET%2529%2520Ligands%2520and%2520Their%2520Application%2520in%2520the%2520Development%2520of%2520a%2520Novel%2520Phosphodiesterase%25202A%2520PET%2520Ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4568%26epage%3D4579%26doi%3D10.1021%2Fjm400312y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Stephenson, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coskran, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelms, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamowicz, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muravnick, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, D.</span><span> </span><span class="NLM_article-title">Immunohistochemical Localization of Phosphodiesterase 2A in Multiple Mammalian Species</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">949</span><span class="refDoi"> DOI: 10.1369/jhc.2009.953471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1369%2Fjhc.2009.953471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=19506089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOgtrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2009&pages=933-949&author=D.+T.+Stephensonauthor=T.+M.+Coskranauthor=M.+B.+Wilhelmsauthor=W.+O.+Adamowiczauthor=M.+M.+O%E2%80%99Donnellauthor=K.+B.+Muravnickauthor=F.+S.+Mennitiauthor=R.+J.+Kleimanauthor=D.+Morton&title=Immunohistochemical+Localization+of+Phosphodiesterase+2A+in+Multiple+Mammalian+Species&doi=10.1369%2Fjhc.2009.953471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Immunohistochemical localization of phosphodiesterase 2A in multiple mammalian species</span></div><div class="casAuthors">Stephenson, Diane T.; Coskran, Tim M.; Wilhelms, Margaret B.; Adamowicz, Wendy O.; O'Donnell, Michele M.; Muravnick, Kathleen B.; Menniti, Frank S.; Kleiman, Robin J.; Morton, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">933-949</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) comprise a family of enzymes that regulate the levels of cyclic nucleotides, key second messengers that mediate a diverse array of functions.  PDE2A is an evolutionarily conserved cGMP-stimulated cAMP and cGMP PDE.  In the present study, the regional and cellular distribution of PDE2A in tissues of rats, mice, cynomolgus monkeys, dogs, and humans was evaluated by immunohistochem.  A polyclonal antibody directed to the C-terminal portion of PDE2A specifically detected PDE2A by Western blotting and by immunohistochem.  The pattern of PDE2A immunoreactivity (ir) was consistent across all species.  Western blot anal. demonstrated that PDE2A was most abundant in the brain relative to peripheral tissues.  PDE2A ir was heterogeneously distributed within brain and was selectively expressed in particular peripheral tissues.  In the brain, prominent immunoreactivity was apparent in components of the limbic system, including the isocortex, hippocampus, amygdala, habenula, basal ganglia, and interpeduncular nucleus.  Cytoplasmic PDE2A staining was prominent in several peripheral tissues, including the adrenal zona glomerulosa, neurons of enteric ganglia, endothelial cells in all organs, lymphocytes of spleen and lymph nodes, and pituitary.  These studies suggest that PDE2A is evolutionarily conserved across mammalian species and support the hypothesis that the enzyme plays a fundamental role in signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVQCCm4loO7Vg90H21EOLACvtfcHk0lj3zufGl-A_og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOgtrrJ&md5=ce1dfa99cc99c02f31ab8071a9e438fd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1369%2Fjhc.2009.953471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1369%252Fjhc.2009.953471%26sid%3Dliteratum%253Aachs%26aulast%3DStephenson%26aufirst%3DD.%2BT.%26aulast%3DCoskran%26aufirst%3DT.%2BM.%26aulast%3DWilhelms%26aufirst%3DM.%2BB.%26aulast%3DAdamowicz%26aufirst%3DW.%2BO.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DM.%2BM.%26aulast%3DMuravnick%26aufirst%3DK.%2BB.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DMorton%26aufirst%3DD.%26atitle%3DImmunohistochemical%2520Localization%2520of%2520Phosphodiesterase%25202A%2520in%2520Multiple%2520Mammalian%2520Species%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2009%26volume%3D57%26spage%3D933%26epage%3D949%26doi%3D10.1369%2Fjhc.2009.953471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Padovan-Neto, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammut, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakroborty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dec, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threlfell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudrakola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harms, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. R.</span><span> </span><span class="NLM_article-title">Facilitation of Corticostriatal Transmission Following Pharmacological Inhibition of Striatal Phosphodiesterase 10A: Role of Nitric Oxide-Soluble Guanylyl Cyclase-cGMP Signaling Pathways</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">5781</span><span class="NLM_x">–</span> <span class="NLM_lpage">5791</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1238-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1523%2FJNEUROSCI.1238-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=25855188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvFKqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=5781-5791&author=F.+E.+Padovan-Netoauthor=S.+Sammutauthor=S.+Chakrobortyauthor=A.+M.+Decauthor=S.+Threlfellauthor=P.+W.+Campbellauthor=V.+Mudrakolaauthor=J.+F.+Harmsauthor=C.+J.+Schmidtauthor=A.+R.+West&title=Facilitation+of+Corticostriatal+Transmission+Following+Pharmacological+Inhibition+of+Striatal+Phosphodiesterase+10A%3A+Role+of+Nitric+Oxide-Soluble+Guanylyl+Cyclase-cGMP+Signaling+Pathways&doi=10.1523%2FJNEUROSCI.1238-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways</span></div><div class="casAuthors">Padovan-Neto, Fernando E.; Sammut, Stephen; Chakroborty, Shreaya; Dec, Alexander M.; Threlfell, Sarah; Campbell, Peter W.; Mudrakola, Vishnu; Harms, John F.; Schmidt, Christopher J.; West, Anthony R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5781-5791</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The striatum contains a rich variety of cyclic nucleotide phosphodiesterases (PDEs), which play a crit. role in the regulation of cAMP and cGMP signaling.  The dual-substrate enzyme PDE10A is the most highly expressed PDE in striatal medium-sized spiny neurons (MSNs) with low micromolar affinity for both cyclic nucleotides.  Previously, we have shown that systemic and local administration of the selective PDE10A inhibitor TP-10 potently increased the responsiveness of MSNs to cortical stimulation.  However, the signaling mechanisms underlying PDE10A inhibitor-induced changes in corticostriatal transmission are only partially understood.  The current studies assessed the resp. roles of cAMP and cGMP in the above effects using sol. guanylyl cyclase (sGC) or adenylate cyclase (AC) specific inhibitors.  Cortically evoked spike activity was monitored in urethane-anesthetized rats using in vivo extracellular recordings performed proximal to a microdialysis probe during local infusion of vehicle, the selective sGC inhibitor ODQ, or the selective AC inhibitor SQ 22536.  Systemic administration of TP-10 (3.2 mg/kg) robustly increased cortically evoked spike activity in a manner that was blocked following intrastriatal infusion of ODQ (50 μm).  The effects of TP-10 on evoked activity were due to accumulation of cGMP, rather than cAMP, as the AC inhibitor SQ was without effect.  Consistent with these observations, studies in neuronal NO synthase (nNOS) knock-out (KO) mice confirmed that PDE10A operates downstream of nNOS to limit cGMP prodn. and excitatory corticostriatal transmission.  Thus, stimulation of PDE10A acts to attenuate corticostriatal transmission in a manner largely dependent on effects directed at the NO-sGC-cGMP signaling cascade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBBIU11UPbv7Vg90H21EOLACvtfcHk0lj3zufGl-A_og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvFKqt7k%253D&md5=5dc33171f0b3548b195e3cb3e9591a61</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1238-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1238-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DPadovan-Neto%26aufirst%3DF.%2BE.%26aulast%3DSammut%26aufirst%3DS.%26aulast%3DChakroborty%26aufirst%3DS.%26aulast%3DDec%26aufirst%3DA.%2BM.%26aulast%3DThrelfell%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DP.%2BW.%26aulast%3DMudrakola%26aufirst%3DV.%26aulast%3DHarms%26aufirst%3DJ.%2BF.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DWest%26aufirst%3DA.%2BR.%26atitle%3DFacilitation%2520of%2520Corticostriatal%2520Transmission%2520Following%2520Pharmacological%2520Inhibition%2520of%2520Striatal%2520Phosphodiesterase%252010A%253A%2520Role%2520of%2520Nitric%2520Oxide-Soluble%2520Guanylyl%2520Cyclase-cGMP%2520Signaling%2520Pathways%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D5781%26epage%3D5791%26doi%3D10.1523%2FJNEUROSCI.1238-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Frank, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberg, M. E.</span><span> </span><span class="NLM_article-title">CREB: A Mediator of Long-Term Memory from Mollusks to Mammals</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1016/0092-8674(94)90394-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2F0092-8674%2894%2990394-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1994&pages=5-8&author=D.+A.+Frankauthor=M.+E.+Greenberg&title=CREB%3A+A+Mediator+of+Long-Term+Memory+from+Mollusks+to+Mammals&doi=10.1016%2F0092-8674%2894%2990394-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2894%2990394-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252894%252990394-8%26sid%3Dliteratum%253Aachs%26aulast%3DFrank%26aufirst%3DD.%2BA.%26aulast%3DGreenberg%26aufirst%3DM.%2BE.%26atitle%3DCREB%253A%2520A%2520Mediator%2520of%2520Long-Term%2520Memory%2520from%2520Mollusks%2520to%2520Mammals%26jtitle%3DCell%26date%3D1994%26volume%3D79%26spage%3D5%26epage%3D8%26doi%3D10.1016%2F0092-8674%2894%2990394-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Stephenson, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coskran, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span> </span><span class="NLM_article-title">The Distribution of Phosphodiesterase 2A in the Rat Brain</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2012.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2Fj.neuroscience.2012.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=23000621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1ahur7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2012&pages=145-155&author=D.+T.+Stephensonauthor=T.+M.+Coskranauthor=M.+P.+Kellyauthor=R.+J.+Kleimanauthor=D.+Mortonauthor=S.+M.+O%E2%80%99Neillauthor=C.+J.+Schmidtauthor=R.+J.+Weinbergauthor=F.+S.+Menniti&title=The+Distribution+of+Phosphodiesterase+2A+in+the+Rat+Brain&doi=10.1016%2Fj.neuroscience.2012.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The distribution of phosphodiesterase 2A in the rat brain</span></div><div class="casAuthors">Stephenson, D. T.; Coskran, T. M.; Kelly, M. P.; Kleiman, R. J.; Morton, D.; O'Neill, S. M.; Schmidt, C. J.; Weinberg, R. J.; Menniti, F. S.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">145-155</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The phosphodiesterases (PDEs) are a superfamily of enzymes that regulate spatio-temporal signaling by the intracellular second messengers cAMP and cGMP.  PDE2A is expressed at high levels in the mammalian brain.  To advance our understanding of the role of this enzyme in regulation of neuronal signaling, we here describe the distribution of PDE2A in the rat brain.  PDE2A mRNA was prominently expressed in glutamatergic pyramidal cells in cortex, and in pyramidal and dentate granule cells in the hippocampus.  Protein concd. in the axons and nerve terminals of these neurons; staining was markedly weaker in the cell bodies and proximal dendrites.  In addn., in both hippocampus and cortex, small populations of non-pyramidal cells, presumed to be interneurons, were strongly immunoreactive.  PDE2A mRNA was expressed in medium spiny neurons in neostriatum.  Little immunoreactivity was obsd. in cell bodies, whereas dense immunoreactivity was found in the axon tracts of these neurons and their terminal regions in globus pallidus and substantia nigra pars reticulata.  Immunostaining was dense in the medial habenula, but weak in other diencephalic regions.  In midbrain and hindbrain, immunostaining was restricted to discrete regions of the neuropil or clusters of cell bodies.  These results suggest that PDE2A may modulate cortical, hippocampal and striatal networks at several levels.  Preferential distribution of PDE2A into axons and terminals of the principal neurons suggests roles in regulation of axonal excitability or transmitter release.  The enzyme is also in forebrain interneurons, and in mid- and hindbrain neurons that may modulate forebrain networks and circuits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxNSYsU1HXSrVg90H21EOLACvtfcHk0ljWbXB4lNmQZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ahur7F&md5=3bb5ae07b9fcae2a917cc4aed4fef4a1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2012.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2012.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DStephenson%26aufirst%3DD.%2BT.%26aulast%3DCoskran%26aufirst%3DT.%2BM.%26aulast%3DKelly%26aufirst%3DM.%2BP.%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DMorton%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DS.%2BM.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DWeinberg%26aufirst%3DR.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26atitle%3DThe%2520Distribution%2520of%2520Phosphodiesterase%25202A%2520in%2520the%2520Rat%2520Brain%26jtitle%3DNeuroscience%26date%3D2012%26volume%3D226%26spage%3D145%26epage%3D155%26doi%3D10.1016%2Fj.neuroscience.2012.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Fernandez-Fernandez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbrock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroker, K. S.</span><span> </span><span class="NLM_article-title">Inhibition of PDE2A, but Not PDE9A, Modulates Presynaptic Short-Term Plasticity Measured by Paired-Pulse Facilitation in the CA1 Region of the Hippocampus</span> <span class="citation_source-journal">Synapse (Hoboken, NJ, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1002/syn.21840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1002%2Fsyn.21840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=26178667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1elu7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2015&pages=484-496&author=D.+Fernandez-Fernandezauthor=H.+Rosenbrockauthor=K.+S.+Kroker&title=Inhibition+of+PDE2A%2C+but+Not+PDE9A%2C+Modulates+Presynaptic+Short-Term+Plasticity+Measured+by+Paired-Pulse+Facilitation+in+the+CA1+Region+of+the+Hippocampus&doi=10.1002%2Fsyn.21840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus</span></div><div class="casAuthors">Fernandez-Fernandez, Diego; Rosenbrock, Holger; Kroker, Katja S.</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">484-496</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) inhibitors are currently considered promising therapeutic targets for treatment of cognitive impairment in diseases such as Schizophrenia and Alzheimer's disease.  Inhibitors of PDE2A and PDE9A have emerged as potential candidates shown to improve synaptic plasticity and memory function in animals.  However, the functional relevance of their putative different localization in the neuron is not understood.  Thus, this study aims at elucidating potential presynaptic effects of PDE2A inhibition in comparison to the inhibition of PDE9A.  For this purpose, we used paired-pulse facilitation (PPF), a model of short-term synaptic plasticity related to presynaptic function.  First, we performed a series of expts. to validate the model in acute rat hippocampal slices using several ref. substances including calcium channel blockers, glutamatergic receptor antagonists, and GPCR agonists.  Second, we analyzed the effect of PDE2A and PDE9A inhibition and their role regulating the influence that the second messengers cAMP and cGMP exert on basal transmission.  Our results show that the interplay between the adenylyl cyclase activator forskolin, the sol. guanylyl cyclase activator BAY 41-8543 and the PDE2A inhibitor PF-999 reveals a primarily presynaptic mechanism of action of PDE2A inhibition.  On the contrary, inhibition of PDE9A did not alter PPF under similar conditions.  In conclusion, these data provide new evidence supporting a role of PDE2A modulating short-term synaptic plasticity.  Moreover, this function of PDE2A is suggested to rely on an active modulation of the cAMP hydrolysis as a response to changes in cGMP levels at the presynaptic level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMx3KC2TNDKrVg90H21EOLACvtfcHk0ljWbXB4lNmQZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1elu7vI&md5=990c6e54c53f4d8a08ae91d2fbdcef83</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fsyn.21840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.21840%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez-Fernandez%26aufirst%3DD.%26aulast%3DRosenbrock%26aufirst%3DH.%26aulast%3DKroker%26aufirst%3DK.%2BS.%26atitle%3DInhibition%2520of%2520PDE2A%252C%2520but%2520Not%2520PDE9A%252C%2520Modulates%2520Presynaptic%2520Short-Term%2520Plasticity%2520Measured%2520by%2520Paired-Pulse%2520Facilitation%2520in%2520the%2520CA1%2520Region%2520of%2520the%2520Hippocampus%26jtitle%3DSynapse%2520%2528Hoboken%252C%2520NJ%252C%2520U.%2520S.%2529%26date%3D2015%26volume%3D69%26spage%3D484%26epage%3D496%26doi%3D10.1002%2Fsyn.21840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Suvarna, N. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. M.</span><span> </span><span class="NLM_article-title">Hydrolysis of <i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-Aspartate Receptor-Stimulated cAMP and cGMP by PDE4 and PDE2 Phosphodiesterases in Primary Neuronal Cultures of Rat Cerebral Cortex and Hippocampus</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span><span class="refDoi"> DOI: 10.1124/jpet.302.1.249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1124%2Fjpet.302.1.249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=12065724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD38Xlt1Sns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2002&pages=249-256&author=N.+U.+Suvarnaauthor=J.+M.+O%E2%80%99Donnell&title=Hydrolysis+of+N-Methyl-d-Aspartate+Receptor-Stimulated+cAMP+and+cGMP+by+PDE4+and+PDE2+Phosphodiesterases+in+Primary+Neuronal+Cultures+of+Rat+Cerebral+Cortex+and+Hippocampus&doi=10.1124%2Fjpet.302.1.249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus</span></div><div class="casAuthors">Suvarna, Neesha U.; O'Donnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">249-256</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Stimulation of N-methyl-D-aspartate (NMDA) receptors on neurons activates both cAMP and cGMP signaling pathways.  Expts. were carried out to det. which phosphodiesterase (PDE) families are involved in the hydrolysis of the cyclic nucleotides formed via this mechanism, using primary neuronal cultures prepd. from rat cerebral cortex and hippocampus.  The nonselective PDE inhibitor 3-isobutyl-1-methylxanthine (IBMX) potentiated the ability of NMDA to increase cAMP and cGMP.  However, among the family-selective inhibitors, only the PDE4 inhibitor rolipram enhanced the ability of NMDA to increase cAMP in the neurons.  In contrast, only the PDE2 inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) enhanced the ability of NMDA to increase cGMP.  Neither adenosine nor an adenosine deaminase inhibitor mimicked the effect of EHNA; this suggests that EHNA's inhibition of PDE2, not its effects on adenosine metab., mediates its effects on NMDA-stimulated cGMP concns.  The PDE inhibitor-augmented effects of NMDA on cAMP and cGMP formation were antagonized by 5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine maleate (MK-801), verifying NMDA receptor mediation.  In contrast, only NMDA-mediated cGMP formation was affected by altering either nitric oxide signaling or guanylyl cyclase; this suggests that NMDA-induced changes in cAMP are not secondary to altered cGMP concns.  Overall, the present findings indicate that cAMP and cGMP formed in neurons as a result of NMDA receptor stimulation are hydrolyzed by PDE4 and PDE2, resp.  Selective inhibitors of the two PDE families will differentially affect the functional consequences of activation of these two signaling pathways by NMDA receptor stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8KrZylzTUKLVg90H21EOLACvtfcHk0lgpRI4nQ6B2Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xlt1Sns78%253D&md5=5b7864065cd635b4b32718baa6a726fa</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fjpet.302.1.249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.302.1.249%26sid%3Dliteratum%253Aachs%26aulast%3DSuvarna%26aufirst%3DN.%2BU.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26atitle%3DHydrolysis%2520of%2520N-Methyl-d-Aspartate%2520Receptor-Stimulated%2520cAMP%2520and%2520cGMP%2520by%2520PDE4%2520and%2520PDE2%2520Phosphodiesterases%2520in%2520Primary%2520Neuronal%2520Cultures%2520of%2520Rat%2520Cerebral%2520Cortex%2520and%2520Hippocampus%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D302%26spage%3D249%26epage%3D256%26doi%3D10.1124%2Fjpet.302.1.249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Hajjhussein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suvarna, N. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gremillion, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandler, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. M.</span><span> </span><span class="NLM_article-title">Changes in NMDA Receptor-Induced Cyclic Nucleotide Synthesis Regulate the Age-Dependent Increase in PDE4A Expression in Primary Cortical Cultures</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1149</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><span class="refDoi"> DOI: 10.1016/j.brainres.2007.02.090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2Fj.brainres.2007.02.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=17407767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvFGmu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1149&publication_year=2007&pages=58-68&author=H.+Hajjhusseinauthor=N.+U.+Suvarnaauthor=C.+Gremillionauthor=L.+J.+Chandlerauthor=J.+M.+O%E2%80%99Donnell&title=Changes+in+NMDA+Receptor-Induced+Cyclic+Nucleotide+Synthesis+Regulate+the+Age-Dependent+Increase+in+PDE4A+Expression+in+Primary+Cortical+Cultures&doi=10.1016%2Fj.brainres.2007.02.090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Changes in NMDA receptor-induced cyclic nucleotide synthesis regulate the age-dependent increase in PDE4A expression in primary cortical cultures</span></div><div class="casAuthors">Hajjhussein, Hassan; Suvarna, Neesha U.; Gremillion, Carmen; Chandler, L. Judson; O'Donnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1149</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">58-68</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">NMDA receptor-induced cAMP and cGMP are selectively hydrolyzed by PDE4 and PDE2, resp., in rat primary cerebral cortical and hippocampal cultures.  Because cAMP levels regulate the expression of PDE4 in rat primary cortical cultures, we examd. the manner in which NMDA receptor activity regulates the age-dependent increase in the expression of PDE4A obsd. in vivo and in vitro.  Inhibiting the activity of NR2B subunit with ifenprodil blocked NMDA receptor-induced cGMP synthesis and increased NMDA receptor-induced cAMP levels in a manner that reduced PDE4 activity.  Therefore, NR1/NR2B receptor-induced cGMP signaling is involved in an acute cross-talk regulation of NR1/NR2A receptor-induced cAMP levels, mediated by PDE4.  Chronic inhibition of NMDA receptor activity with MK-801 reduced PDE4A1 and PDE4A5 expression and activity in a time-dependent manner; this effect was reversed by adding the PKA activator dbr-cAMP.  Inhibiting GABA receptors with bicuculline increased NMDA receptor-induced cAMP synthesis and PDE4A expression in cultures treated between DIV 16 and DIV 21 but not in cultures treated between DIV 8 and DIV 13.  This effect was due to a high tone of NMDA receptor-induced cGMP in younger cultures, which neg. regulated the expression of PDE4A by a PKG-mediated process.  The present results are consistent with behavioral data showing that both PDE4 and PDE2 are involved in NMDA receptor-mediated memory processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrihRRUfgxxGbVg90H21EOLACvtfcHk0lhHNl9c6cSaAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvFGmu7c%253D&md5=f7da05d9846bad0e9295c7062bc2fe2c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2007.02.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2007.02.090%26sid%3Dliteratum%253Aachs%26aulast%3DHajjhussein%26aufirst%3DH.%26aulast%3DSuvarna%26aufirst%3DN.%2BU.%26aulast%3DGremillion%26aufirst%3DC.%26aulast%3DChandler%26aufirst%3DL.%2BJ.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26atitle%3DChanges%2520in%2520NMDA%2520Receptor-Induced%2520Cyclic%2520Nucleotide%2520Synthesis%2520Regulate%2520the%2520Age-Dependent%2520Increase%2520in%2520PDE4A%2520Expression%2520in%2520Primary%2520Cortical%2520Cultures%26jtitle%3DBrain%2520Res.%26date%3D2007%26volume%3D1149%26spage%3D58%26epage%3D68%26doi%3D10.1016%2Fj.brainres.2007.02.090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Roberts, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castner, S. A.</span><span> </span><span class="NLM_article-title">Prevention of Ketamine-Induced Working Memory Impairments by AMPA Potentiators in a Nonhuman Primate Model of Cognitive Dysfunction</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span><span class="refDoi"> DOI: 10.1016/j.bbr.2010.03.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2Fj.bbr.2010.03.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=20347881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFWrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2010&pages=41-48&author=B.+M.+Robertsauthor=D.+E.+Holdenauthor=C.+L.+Shafferauthor=P.+A.+Seymourauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=G.+V.+Williamsauthor=S.+A.+Castner&title=Prevention+of+Ketamine-Induced+Working+Memory+Impairments+by+AMPA+Potentiators+in+a+Nonhuman+Primate+Model+of+Cognitive+Dysfunction&doi=10.1016%2Fj.bbr.2010.03.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction</span></div><div class="casAuthors">Roberts, Brooke M.; Holden, Daniel E.; Shaffer, Christopher L.; Seymour, Patricia A.; Menniti, Frank S.; Schmidt, Christopher J.; Williams, Graham V.; Castner, Stacy A.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">212</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-48</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Working memory impairments are a core aspect of schizophrenia, yet current medicines do not address such cognitive dysfunction.  We have developed a model of these working memory deficits by acutely disrupting glutamatergic synaptic transmission by administration of the N-methyl-3-aspartate (NMDA) antagonist ketamine in the nonhuman primate.  The current studies evaluated the effect of pos. allosteric modulators ("potentiators") of the α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors on the working memory and behavioral effects of ketamine.  AMPA receptors mediate fast excitatory synaptic transmission throughout the brain and play a crit. role in the activity-dependent regulation of NMDA receptors.  We find that pos. modulation of AMPA receptors with LY451646 (0.1-1.0 mg/kg, SC) and structurally distinct PF-4778574 (0.01 mg/kg, SC) robustly ameliorates ketamine-induced working memory impairments without altering behavioral effects of acute ketamine we consider related to pos.- and neg.-like symptoms.  These results support AMPA receptor potentiators as a potential adjunctive treatment for cognitive impairment assocd. with schizophrenia (CIAS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ3Id6D1EeSrVg90H21EOLACvtfcHk0lhHNl9c6cSaAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFWrsb8%253D&md5=a7e67cfd3027b0013e4ab448503219dc</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2010.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2010.03.039%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DB.%2BM.%26aulast%3DHolden%26aufirst%3DD.%2BE.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DWilliams%26aufirst%3DG.%2BV.%26aulast%3DCastner%26aufirst%3DS.%2BA.%26atitle%3DPrevention%2520of%2520Ketamine-Induced%2520Working%2520Memory%2520Impairments%2520by%2520AMPA%2520Potentiators%2520in%2520a%2520Nonhuman%2520Primate%2520Model%2520of%2520Cognitive%2520Dysfunction%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2010%26volume%3D212%26spage%3D41%26epage%3D48%26doi%3D10.1016%2Fj.bbr.2010.03.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Kawashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takita, M.</span><span> </span><span class="NLM_article-title">Cooperativity Between Hippocampal-Prefrontal Short-Term Plasticity Through Associative Long-Term Potentiation</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1109</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span><span class="refDoi"> DOI: 10.1016/j.brainres.2006.06.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2Fj.brainres.2006.06.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=16859647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVShtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1109&publication_year=2006&pages=37-44&author=H.+Kawashimaauthor=Y.+Izakiauthor=A.+A.+Graceauthor=M.+Takita&title=Cooperativity+Between+Hippocampal-Prefrontal+Short-Term+Plasticity+Through+Associative+Long-Term+Potentiation&doi=10.1016%2Fj.brainres.2006.06.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Cooperativity between hippocampal-prefrontal short-term plasticity through associative long-term potentiation</span></div><div class="casAuthors">Kawashima, Hitoshi; Izaki, Yoshinori; Grace, Anthony A.; Takita, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1109</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-44</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The hippocampal-medial prefrontal cortex (mPFC) pathway provides highly convergent input to the mPFC in rats and shows two types of short-term plasticity in terms of paired-pulse facilitation (PPF) of the field potential under urethane anesthesia.  We now report that stimulating either the dorsal or ventral subregions of the posterior hippocampus elicited PPF (by about 335 and 120%, resp.) of field potentials recorded in the mPFC at 100 ms interpulse interval.  This PPF-like interaction occurred when projections were stimulated in the ventral-dorsal order (by about 200% of the single-pulsed response), but not vice versa.  When weak long-term potentiation (LTP) of the dorsal projection was evoked simultaneously with strong LTP of the ventral projection, an associative effect was revealed (about + 55%), although the magnitudes of LTP in each projection were not correlated.  Even when the impermutable PPF-like facilitation was further enhanced (by about + 120%), the enhancement was not correlated with either form of LTP, but exhibited the interaction of changes in the dorsal PPF, rather than in the heterotopic priming effect through the ventral projection.  Moreover, this change was correlated with the assocd. LTP ratio of dorsal to ventral projection LTP (i.e., LTP associativity).  Larger increases in LTP associativity correlated with greater impermutable PPF-like facilitation; in addn., there was hardly attenuation of the response to the dorsal projection by subsequent electrolytic lesions of the ventral subregion.  These results indicate that the mPFC functionally integrates discrete sources of hippocampal information via cooperativity between short- and long-term plasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMS4E25Z8AAbVg90H21EOLACvtfcHk0ljAEewjcP11tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVShtLg%253D&md5=812e28913413526255e35b7cbb6c8f79</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2006.06.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2006.06.034%26sid%3Dliteratum%253Aachs%26aulast%3DKawashima%26aufirst%3DH.%26aulast%3DIzaki%26aufirst%3DY.%26aulast%3DGrace%26aufirst%3DA.%2BA.%26aulast%3DTakita%26aufirst%3DM.%26atitle%3DCooperativity%2520Between%2520Hippocampal-Prefrontal%2520Short-Term%2520Plasticity%2520Through%2520Associative%2520Long-Term%2520Potentiation%26jtitle%3DBrain%2520Res.%26date%3D2006%26volume%3D1109%26spage%3D37%26epage%3D44%26doi%3D10.1016%2Fj.brainres.2006.06.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Kiss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span> </span><span class="NLM_article-title">Delta Oscillation and Short-Term Plasticity in the Rat Medial Prefrontal Cortex: Modelling NMDA Hypofunction of Schizophrenia</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1017/S1461145710000271</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1017%2FS1461145710000271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=20334724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=29-42&author=T.+Kissauthor=W.+E.+Hoffmannauthor=M.+Hajos&title=Delta+Oscillation+and+Short-Term+Plasticity+in+the+Rat+Medial+Prefrontal+Cortex%3A+Modelling+NMDA+Hypofunction+of+Schizophrenia&doi=10.1017%2FS1461145710000271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Delta oscillation and short-term plasticity in the rat medial prefrontal cortex: modelling NMDA hypofunction of schizophrenia</span></div><div class="casAuthors">Kiss, Tamas; Hoffmann, William E.; Hajos, Mihaly</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-42</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Dysfunction of the prefrontal cortex (PFC) is considered to be an important factor contributing to a decrease in cognitive performance of schizophrenia patients.  The medial PFC (mPFC) is innervated by the hippocampus/subiculum, and the subiculum-mPFC pathway is known to be involved in various cognitive processes.  Glutamate-contg. subicular axons innervate cortical pyramidal neurons and interneurons where AMPA and NMDA receptors are implicated in synaptic transmission.  In our expts., properties of subiculum-mPFC interactions were studied using pathway stimulation and local field potential (LFP) recordings of the mPFC in urethane-anesthetized rats.  Changes in paired-pulse facilitation (PPF) and LFP oscillations, effects of the NMDA receptor antagonist MK-801, and the AMPAkine LY451395 were evaluated.  Effects of disruption of the thalamo-cortical loop with local microinjection of lidocaine into the mediodorsal thalamic nucleus (MD) were also studied.  Our findings demonstrate that both systemic administration of MK-801 and local MD lidocaine microinjection produce similar changes in LFP oscillations and redn. in PPF.  Specifically, it was obsd. that MK-801 (0.05 mg/kg i.v.) and intra-thalamic lidocaine changed regular, 2 Hz delta oscillation to a less regular 0.5-1.5 Hz delta rhythm.  Concurrently, PPF in response to elec. stimulation of the subiculum was significantly attenuated.  Administration of the AMPAkine LY451395 (0.01 mg/kg i.v.) reversed the MK-801- and lidocaine-induced changes, and was itself blocked by the AMPA receptor antagonist CP-465022.  Anal. of our findings suggests a crit. role of cortical interneurons in NMDA/AMPA receptor-mediated changes in thalamo-cortical oscillations and PPF, and contributes to our understanding of the NMDA hypofunction model of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5APr_ncoDP7Vg90H21EOLACvtfcHk0lhgW4_h0h3iBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLnO&md5=5cf78907f9690c37011f8d3e39f7b110</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1017%2FS1461145710000271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145710000271%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26atitle%3DDelta%2520Oscillation%2520and%2520Short-Term%2520Plasticity%2520in%2520the%2520Rat%2520Medial%2520Prefrontal%2520Cortex%253A%2520Modelling%2520NMDA%2520Hypofunction%2520of%2520Schizophrenia%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2011%26volume%3D14%26spage%3D29%26epage%3D42%26doi%3D10.1017%2FS1461145710000271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fennell, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillman, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span> </span><span class="NLM_article-title">Mechanism for the allosteric regulation of phosphodiesterase 2A deduced from the X-ray structure of a near full-length construct</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">18225</span><span class="NLM_x">–</span> <span class="NLM_lpage">18230</span><span class="refDoi"> DOI: 10.1073/pnas.0907635106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1073%2Fpnas.0907635106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=19828435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVags7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=18225-18230&author=J.+Panditauthor=M.+D.+Formanauthor=K.+F.+Fennellauthor=K.+S.+Dillmanauthor=F.+S.+Menniti&title=Mechanism+for+the+allosteric+regulation+of+phosphodiesterase+2A+deduced+from+the+X-ray+structure+of+a+near+full-length+construct&doi=10.1073%2Fpnas.0907635106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism for the allosteric regulation of phosphodiesterase 2A deduced from the X-ray structure of a near full-length construct</span></div><div class="casAuthors">Pandit, Jayvardhan; Forman, Michael D.; Fennell, Kimberly F.; Dillman, Keith S.; Menniti, Frank S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">18225-18230, S18225/1-S18225/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We report the x-ray crystal structure of a phosphodiesterase (PDE) that includes both catalytic and regulatory domains.  PDE2A (215-900) crystd. as a dimer in which each subunit had an extended organization of regulatory GAF-A and GAF-B and catalytic domains connected by long α-helixes.  The subunits cross at the GAF-B/catalytic domain linker, and each side of the dimer contains in series the GAF-A and GAF-B of one subunit and the catalytic domain of the other subunit.  A dimer interface extends over the entire length of the mol.  The substrate binding pocket of each catalytic domain is occluded by the H-loop.  We deduced from comparisons with structures of isolated, ligand-bound catalytic subunits that the H-loop swings out to allow substrate access.  However, in dimeric PDE2A (215-900), the H-loops of the two catalytic subunits pack against each other at the dimer interface, necessitating movement of the catalytic subunits to allow for H-loop movement.  Comparison of the unliganded GAF-B of PDE2A (215-900) with previous structures of isolated, cGMP-bound GAF domains indicates that cGMP binding induces a significant shift in the GAF-B/catalytic domain linker.  We propose that cGMP binding to GAF-B causes movement, through this linker region, of the catalytic domains, such that the H-loops no longer pack at the dimer interface and are, instead, free to swing out to allow substrate access.  This increase in substrate access is proposed as the basis for PDE2A activation by cGMP and may be a general mechanism for regulation of all PDEs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh-kgJc6VX2bVg90H21EOLACvtfcHk0lhgW4_h0h3iBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVags7vO&md5=73ddfdb3ffb861674744a1fbeef7c881</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0907635106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0907635106%26sid%3Dliteratum%253Aachs%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DForman%26aufirst%3DM.%2BD.%26aulast%3DFennell%26aufirst%3DK.%2BF.%26aulast%3DDillman%26aufirst%3DK.%2BS.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26atitle%3DMechanism%2520for%2520the%2520allosteric%2520regulation%2520of%2520phosphodiesterase%25202A%2520deduced%2520from%2520the%2520X-ray%2520structure%2520of%2520a%2520near%2520full-length%2520construct%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D18225%26epage%3D18230%26doi%3D10.1073%2Fpnas.0907635106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianfrogna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harms, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx-LaFrance, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majchrzak, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siuciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span> </span><span class="NLM_article-title">Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: a New Therapeutic Approach to the Treatment of Schizophrenia</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span><span class="refDoi"> DOI: 10.1124/jpet.107.132910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1124%2Fjpet.107.132910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=18287214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsVOjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2008&pages=681-690&author=C.+J.+Schmidtauthor=D.+S.+Chapinauthor=J.+Cianfrognaauthor=M.+L.+Cormanauthor=M.+Hajosauthor=J.+F.+Harmsauthor=W.+E.+Hoffmanauthor=L.+A.+Lebelauthor=S.+A.+McCarthyauthor=F.+R.+Nelsonauthor=C.+Proulx-LaFranceauthor=M.+J.+Majchrzakauthor=A.+D.+Ramirezauthor=K.+Schmidtauthor=P.+A.+Seymourauthor=J.+A.+Siuciakauthor=F.+D.+Tingleyauthor=R.+D.+Williamsauthor=P.+R.+Verhoestauthor=F.+S.+Menniti&title=Preclinical+Characterization+of+Selective+Phosphodiesterase+10A+Inhibitors%3A+a+New+Therapeutic+Approach+to+the+Treatment+of+Schizophrenia&doi=10.1124%2Fjpet.107.132910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia</span></div><div class="casAuthors">Schmidt, C. J.; Chapin, D. S.; Cianfrogna, J.; Corman, M. L.; Hajos, M.; Harms, J. F.; Hoffman, W. E.; Lebel, L. A.; McCarthy, S. A.; Nelson, F. R.; Proulx-LaFrance, C.; Majchrzak, M. J.; Ramirez, A. D.; Schmidt, K.; Seymour, P. A.; Siuciak, J. A.; Tingley, F. D., III; Williams, R. D.; Verhoest, P. R.; Menniti, F. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">681-690</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We have recently proposed the hypothesis that inhibition of the cyclic nucleotide phosphodiesterase (PDE) 10A may represent a new pharmacol. approach to the treatment of schizophrenia.  PDE10A is highly expressed in the medium spiny neurons of the mammalian striatum, where the enzyme is hypothesized to regulate both cAMP and cGMP signaling cascades to impact early signal processing in the corticostriatothalamic circuit.  Our current understanding of the physiol. role of PDE10A and the therapeutic utility of PDE10A inhibitors derives in part from studies with papaverine, the only pharmacol. tool for this target extensively profiled to date.  However, this agent has significant limitations in this regard, namely, relatively poor potency and selectivity and a very short exposure half-life after systemic administration.  In the present report, we describe the discovery of a new class of PDE10A inhibitors exemplified by TP-10 (2-{4-[-pyridin-4-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazol-3-yl]-phenoxymethyl}-quinoline succinic acid), an agent with greatly improved potency, selectivity, and pharmaceutical properties.  These new pharmacol. tools enabled studies that provide further evidence that inhibition of PDE10A represents an important new target for the treatment of schizophrenia and related disorders of basal ganglia function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFUgwm6HoBH7Vg90H21EOLACvtfcHk0liQdzUJePCYtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsVOjtL8%253D&md5=8016c0ef88433e2c0bba1abc7473fa8b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.132910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.132910%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DCorman%26aufirst%3DM.%2BL.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DHarms%26aufirst%3DJ.%2BF.%26aulast%3DHoffman%26aufirst%3DW.%2BE.%26aulast%3DLebel%26aufirst%3DL.%2BA.%26aulast%3DMcCarthy%26aufirst%3DS.%2BA.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DProulx-LaFrance%26aufirst%3DC.%26aulast%3DMajchrzak%26aufirst%3DM.%2BJ.%26aulast%3DRamirez%26aufirst%3DA.%2BD.%26aulast%3DSchmidt%26aufirst%3DK.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DSiuciak%26aufirst%3DJ.%2BA.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DWilliams%26aufirst%3DR.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26atitle%3DPreclinical%2520Characterization%2520of%2520Selective%2520Phosphodiesterase%252010A%2520Inhibitors%253A%2520a%2520New%2520Therapeutic%2520Approach%2520to%2520the%2520Treatment%2520of%2520Schizophrenia%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D325%26spage%3D681%26epage%3D690%26doi%3D10.1124%2Fjpet.107.132910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Grimme, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antony, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrlich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieg, H.</span><span> </span><span class="NLM_article-title">A Consistent and Accurate Ab Initio Parametrization of Density Functional Dispersion Correction (DFT-D) for the 94 Elements H-Pu</span> <span class="citation_source-journal">J. Chem. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">154104</span><span class="refDoi"> DOI: 10.1063/1.3382344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1063%2F1.3382344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=20423165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVyks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=154104&author=S.+Grimmeauthor=J.+Antonyauthor=S.+Ehrlichauthor=H.+Krieg&title=A+Consistent+and+Accurate+Ab+Initio+Parametrization+of+Density+Functional+Dispersion+Correction+%28DFT-D%29+for+the+94+Elements+H-Pu&doi=10.1063%2F1.3382344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu</span></div><div class="casAuthors">Grimme, Stefan; Antony, Jens; Ehrlich, Stephan; Krieg, Helge</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">154104/1-154104/19</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">The method of dispersion correction as an add-on to std. Kohn-Sham d. functional theory (DFT-D) has been refined regarding higher accuracy, broader range of applicability, and less empiricism.  The main new ingredients are atom-pairwise specific dispersion coeffs. and cutoff radii that are both computed from first principles.  The coeffs. for new eighth-order dispersion terms are computed using established recursion relations.  System (geometry) dependent information is used for the first time in a DFT-D type approach by employing the new concept of fractional coordination nos. (CN).  They are used to interpolate between dispersion coeffs. of atoms in different chem. environments.  The method only requires adjustment of two global parameters for each d. functional, is asymptotically exact for a gas of weakly interacting neutral atoms, and easily allows the computation of at. forces.  Three-body nonadditivity terms are considered.  The method has been assessed on std. benchmark sets for inter- and intramol. noncovalent interactions with a particular emphasis on a consistent description of light and heavy element systems.  The mean abs. deviations for the S22 benchmark set of noncovalent interactions for 11 std. d. functionals decrease by 15%-40% compared to the previous (already accurate) DFT-D version.  Spectacular improvements are found for a tripeptide-folding model and all tested metallic systems.  The rectification of the long-range behavior and the use of more accurate C6 coeffs. also lead to a much better description of large (infinite) systems as shown for graphene sheets and the adsorption of benzene on an Ag(111) surface.  For graphene it is found that the inclusion of three-body terms substantially (by about 10%) weakens the interlayer binding.  We propose the revised DFT-D method as a general tool for the computation of the dispersion energy in mols. and solids of any kind with DFT and related (low-cost) electronic structure methods for large systems.  (c) 2010 American Institute of Physics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxTowaG814d7Vg90H21EOLACvtfcHk0lhFIQ_4ecwYaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVyks7o%253D&md5=2bca89d904579d5565537a0820dc2ae8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1063%2F1.3382344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.3382344%26sid%3Dliteratum%253Aachs%26aulast%3DGrimme%26aufirst%3DS.%26aulast%3DAntony%26aufirst%3DJ.%26aulast%3DEhrlich%26aufirst%3DS.%26aulast%3DKrieg%26aufirst%3DH.%26atitle%3DA%2520Consistent%2520and%2520Accurate%2520Ab%2520Initio%2520Parametrization%2520of%2520Density%2520Functional%2520Dispersion%2520Correction%2520%2528DFT-D%2529%2520for%2520the%252094%2520Elements%2520H-Pu%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D2010%26volume%3D132%26spage%3D154104%26doi%3D10.1063%2F1.3382344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truhlar, D. G.</span><span> </span><span class="NLM_article-title">The M06 Suite of Density Functionals for Main Group Thermochemistry, Thermochemical Kinetics, Noncovalent Interactions, Excited States, and Transition Elements: Two New Functionals and Systematic Testing of Four M06-Class Functionals and 12 Other Functionals</span> <span class="citation_source-journal">Theor. Chem. Acc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span><span class="refDoi"> DOI: 10.1007/s00214-007-0310-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1007%2Fs00214-007-0310-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFyltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2008&pages=215-241&author=Y.+Zhaoauthor=D.+G.+Truhlar&title=The+M06+Suite+of+Density+Functionals+for+Main+Group+Thermochemistry%2C+Thermochemical+Kinetics%2C+Noncovalent+Interactions%2C+Excited+States%2C+and+Transition+Elements%3A+Two+New+Functionals+and+Systematic+Testing+of+Four+M06-Class+Functionals+and+12+Other+Functionals&doi=10.1007%2Fs00214-007-0310-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other functionals</span></div><div class="casAuthors">Zhao, Yan; Truhlar, Donald G.</div><div class="citationInfo"><span class="NLM_cas:title">Theoretical Chemistry Accounts</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">215-241</span>CODEN:
                <span class="NLM_cas:coden">TCACFW</span>;
        ISSN:<span class="NLM_cas:issn">1432-881X</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">We present two new hybrid meta exchange-correlation functionals, called M06 and M06-2X.  The M06 functional is parametrized including both transition metals and nonmetals, whereas the M06-2X functional is a high-nonlocality functional with double the amt. of nonlocal exchange (2X), and it is parametrized only for nonmetals.  The functionals, along with the previously published M06-L local functional and the M06-HF full-Hartree-Fock functionals, constitute the M06 suite of complementary functionals.  We assess these four functionals by comparing their performance to that of 12 other functionals and Hartree-Fock theory for 403 energetic data in 29 diverse databases, including ten databases for thermochem., four databases for kinetics, eight databases for noncovalent interactions, three databases for transition metal bonding, one database for metal atom excitation energies, and three databases for mol. excitation energies.  We also illustrate the performance of these 17 methods for three databases contg. 40 bond lengths and for databases contg. 38 vibrational frequencies and 15 vibrational zero point energies.  We recommend the M06-2X functional for applications involving main-group thermochem., kinetics, noncovalent interactions, and electronic excitation energies to valence and Rydberg states.  We recommend the M06 functional for application in organometallic and inorganometallic chem. and for noncovalent interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPJNWFt06psLVg90H21EOLACvtfcHk0ljwoiasZyVdxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFyltbY%253D&md5=c31d6f319d7c7a45aa9b716220e4a422</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs00214-007-0310-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00214-007-0310-x%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DTruhlar%26aufirst%3DD.%2BG.%26atitle%3DThe%2520M06%2520Suite%2520of%2520Density%2520Functionals%2520for%2520Main%2520Group%2520Thermochemistry%252C%2520Thermochemical%2520Kinetics%252C%2520Noncovalent%2520Interactions%252C%2520Excited%2520States%252C%2520and%2520Transition%2520Elements%253A%2520Two%2520New%2520Functionals%2520and%2520Systematic%2520Testing%2520of%2520Four%2520M06-Class%2520Functionals%2520and%252012%2520Other%2520Functionals%26jtitle%3DTheor.%2520Chem.%2520Acc.%26date%3D2008%26volume%3D120%26spage%3D215%26epage%3D241%26doi%3D10.1007%2Fs00214-007-0310-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Hawkins, P. C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skillman, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, A.</span><span> </span><span class="NLM_article-title">Comparison of Shape-Matching and Docking as Virtual Screening Tools</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1021/jm0603365</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0603365" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlansb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=74-82&author=P.+C.+D.+Hawkinsauthor=A.+G.+Skillmanauthor=A.+Nicholls&title=Comparison+of+Shape-Matching+and+Docking+as+Virtual+Screening+Tools&doi=10.1021%2Fjm0603365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Shape-Matching and Docking as Virtual Screening Tools</span></div><div class="casAuthors">Hawkins, Paul C. D.; Skillman, A. Geoffrey; Nicholls, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-82</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ligand docking is a widely used approach in virtual screening.  In recent years a large no. of publications have appeared in which docking tools are compared and evaluated for their effectiveness in virtual screening against a wide variety of protein targets.  These studies have shown that the effectiveness of docking in virtual screening is highly variable due to a large no. of possible confounding factors.  Another class of method that has shown promise in virtual screening is the shape-based, ligand-centric approach.  Several direct comparisons of docking with the shape-based tool ROCS have been conducted using data sets from some of these recent docking publications.  The results show that a shape-based, ligand-centric approach is more consistent than, and often superior to, the protein-centric approach taken by docking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe0IKOly7zibVg90H21EOLACvtfcHk0ljwoiasZyVdxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlansb%252FF&md5=6f97f5c0cc092b4e225f7c2656c1bcf6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm0603365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603365%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DP.%2BC.%2BD.%26aulast%3DSkillman%26aufirst%3DA.%2BG.%26aulast%3DNicholls%26aufirst%3DA.%26atitle%3DComparison%2520of%2520Shape-Matching%2520and%2520Docking%2520as%2520Virtual%2520Screening%2520Tools%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D74%26epage%3D82%26doi%3D10.1021%2Fjm0603365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Otwinowski, Z.; Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray Diffraction Data Collected in Oscillation Mode</span>.  <span class="citation_source-book">Methods in Enzymology</span>; <span class="NLM_series">Macromolecular Crystallography, Part A</span>; <span class="NLM_contrib-group">Carter, C. W.,  Jr.; Sweet, R. M.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=307-326&author=Z.+Otwinowski&author=W.+Minorauthor=C.+W.+Carter&author=R.+M.+Sweet&title=Methods+in+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26atitle%3DProcessing%2520of%2520X-ray%2520Diffraction%2520Data%2520Collected%2520in%2520Oscillation%2520Mode%26btitle%3DMethods%2520in%2520Enzymology%26aulast%3DCarter%26aufirst%3DC.%2BW.%26pub%3DAcademic%2520Press%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Collaborative Computational Project, Number 4</span><span> </span><span class="NLM_article-title">The CCP4 Suite: Programs for Protein Crystallography</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">D50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span><span class="refDoi"> DOI: 10.1107/S0907444994003112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D50&publication_year=1994&pages=760-763&author=Collaborative+Computational+Project%2C+Number+4&title=The+CCP4+Suite%3A+Programs+for+Protein+Crystallography&doi=10.1107%2FS0907444994003112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DThe%2520CCP4%2520Suite%253A%2520Programs%2520for%2520Protein%2520Crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3DD50%26spage%3D760%26epage%3D763%26doi%3D10.1107%2FS0907444994003112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of Macromolecular Structures by the Maximum-Likelihood Method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">D53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+Macromolecular+Structures+by+the+Maximum-Likelihood+Method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0ljjlLJzviqOnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520Macromolecular%2520Structures%2520by%2520the%2520Maximum-Likelihood%2520Method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3DD53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit35"><span>Software: <span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span>BUSTER, <span class="NLM_edition">2.11.5</span>; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':[],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref128':['cit128'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 20 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Gary Tresadern, Ingrid Velter, Andrés A. Trabanco, Frans Van den Keybus, Gregor J. Macdonald, Marijke V. F. Somers, Greet Vanhoof, Philip M. Leonard, Marieke B. A. C. Lamers, Yves E. M. Van Roosbroeck, <span class="NLM_string-name hlFld-ContribAuthor">Peter J. J. A. Buijnsters</span>. </span><span class="cited-content_cbyCitation_article-title">[1,2,4]Triazolo[1,5-a]pyrimidine Phosphodiesterase 2A Inhibitors: Structure and Free-Energy Perturbation-Guided Exploration. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12887-12910. <a href="https://doi.org/10.1021/acs.jmedchem.0c01272" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01272</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01272%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%25255B1%25252C2%25252C4%25255DTriazolo%25255B1%25252C5-a%25255Dpyrimidine%252BPhosphodiesterase%252B2A%252BInhibitors%25253A%252BStructure%252Band%252BFree-Energy%252BPerturbation-Guided%252BExploration%26aulast%3DTresadern%26aufirst%3DGary%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21072020%26date%3D27102020%26volume%3D63%26issue%3D21%26spage%3D12887%26epage%3D12910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marat Korsik, Edwin G. Tse, David G. Smith, William Lewis, Peter J. Rutledge, <span class="NLM_string-name hlFld-ContribAuthor">Matthew H. Todd</span>. </span><span class="cited-content_cbyCitation_article-title">tele-Substitution Reactions in the Synthesis of a Promising Class of 1,2,4-Triazolo[4,3-a]pyrazine-Based Antimalarials. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (21)
                                     , 13438-13452. <a href="https://doi.org/10.1021/acs.joc.0c01045" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01045%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3Dtele-Substitution%252BReactions%252Bin%252Bthe%252BSynthesis%252Bof%252Ba%252BPromising%252BClass%252Bof%252B1%25252C2%25252C4-Triazolo%25255B4%25252C3-a%25255Dpyrazine-Based%252BAntimalarials%26aulast%3DKorsik%26aufirst%3DMarat%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28042020%26date%3D13102020%26date%3D13082020%26volume%3D85%26issue%3D21%26spage%3D13438%26epage%3D13452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher J. Helal, Mark Bundesmann, Susan Hammond, Melissa Holmstrom, Jacquelyn Klug-McLeod, Bruce A. Lefker, Dale McLeod, Chakrapani Subramanyam, Oleg Zakaryants, <span class="NLM_string-name hlFld-ContribAuthor">Sylvie Sakata</span>. </span><span class="cited-content_cbyCitation_article-title">Quick Building Blocks (QBB): An Innovative and Efficient Business Model To Speed Medicinal Chemistry Analog Synthesis. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (8)
                                     , 1104-1109. <a href="https://doi.org/10.1021/acsmedchemlett.9b00205" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00205%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DQuick%252BBuilding%252BBlocks%252B%252528QBB%252529%25253A%252BAn%252BInnovative%252Band%252BEfficient%252BBusiness%252BModel%252BTo%252BSpeed%252BMedicinal%252BChemistry%252BAnalog%252BSynthesis%26aulast%3DHelal%26aufirst%3DChristopher%2BJ.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06052019%26date%3D05072019%26date%3D18072019%26date%3D05072019%26volume%3D10%26issue%3D8%26spage%3D1104%26epage%3D1109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yinuo Wu, Zhe Li, Yi-You Huang, Deyan Wu, <span class="NLM_string-name hlFld-ContribAuthor">Hai-Bin Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (13)
                                     , 5467-5483. <a href="https://doi.org/10.1021/acs.jmedchem.7b01370" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01370</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01370%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BPhosphodiesterase%252BInhibitors%252Bfor%252BCognitive%252BImprovement%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DWu%26aufirst%3DYinuo%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D15092017%26date%3D05022018%26date%3D24012018%26volume%3D61%26issue%3D13%26spage%3D5467%26epage%3D5483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>, <span class="hlFld-ContribAuthor ">Eric  Arnold</span>, <span class="hlFld-ContribAuthor ">Tracey  Boyden</span>, <span class="hlFld-ContribAuthor ">Cheng  Chang</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Chappie</span>, <span class="hlFld-ContribAuthor ">Ethan  Fisher</span>, <span class="hlFld-ContribAuthor ">Mihaly  Hajos</span>, <span class="hlFld-ContribAuthor ">John F.  Harms</span>, <span class="hlFld-ContribAuthor ">William E.  Hoffman</span>, <span class="hlFld-ContribAuthor ">John M.  Humphrey</span>, <span class="hlFld-ContribAuthor ">Jayvardhan  Pandit</span>, <span class="hlFld-ContribAuthor ">Zhijun  Kang</span>, <span class="hlFld-ContribAuthor ">Robin J.  Kleiman</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>, <span class="hlFld-ContribAuthor ">Che-Wah  Lee</span>, <span class="hlFld-ContribAuthor ">Jiemin  Lu</span>, <span class="hlFld-ContribAuthor ">Noha  Maklad</span>, <span class="hlFld-ContribAuthor ">Laura  McDowell</span>, <span class="hlFld-ContribAuthor ">Dina  McGinnis</span>, <span class="hlFld-ContribAuthor ">Rebecca E.  O’Connor</span>, <span class="hlFld-ContribAuthor ">Christopher J.  O’Donnell</span>, <span class="hlFld-ContribAuthor ">Adam  Ogden</span>, <span class="hlFld-ContribAuthor ">Mary  Piotrowski</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Patricia A.  Seymour</span>, <span class="hlFld-ContribAuthor ">Hirokazu  Ueno</span>, <span class="hlFld-ContribAuthor ">Nichole  Vansell</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>, and <span class="hlFld-ContribAuthor ">Edward X.  Yang</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical Candidate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 1001-1018. <a href="https://doi.org/10.1021/acs.jmedchem.7b01466" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01466</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01466%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Ba%252BPotent%25252C%252BHighly%252BSelective%25252C%252Band%252BBrain%252BPenetrant%252BPhosphodiesterase%252B2A%252BInhibitor%252BClinical%252BCandidate%26aulast%3DHelal%26aufirst%3DChristopher%2BJ.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D02102017%26date%3D16012018%26date%3D08022018%26date%3D02012018%26volume%3D61%26issue%3D3%26spage%3D1001%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonia F.  Stepan</span>, <span class="hlFld-ContribAuthor ">Tuan P.  Tran</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>, <span class="hlFld-ContribAuthor ">Maria S.  Brown</span>, <span class="hlFld-ContribAuthor ">Cheng  Chang</span>, <span class="hlFld-ContribAuthor ">Rebecca E.  O’Connor</span>, <span class="hlFld-ContribAuthor ">Michael  De Vivo</span>, <span class="hlFld-ContribAuthor ">Shawn D.  Doran</span>, <span class="hlFld-ContribAuthor ">Ethan L.  Fisher</span>, <span class="hlFld-ContribAuthor ">Stephen  Jenkinson</span>, <span class="hlFld-ContribAuthor ">David  Karanian</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>, <span class="hlFld-ContribAuthor ">Raman  Sharma</span>, <span class="hlFld-ContribAuthor ">Gregory S.  Walker</span>, <span class="hlFld-ContribAuthor ">Ann S.  Wright</span>, <span class="hlFld-ContribAuthor ">Edward X.  Yang</span>, <span class="hlFld-ContribAuthor ">Michael A.  Brodney</span>, <span class="hlFld-ContribAuthor ">Travis T.  Wager</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>, and <span class="hlFld-ContribAuthor ">R. Scott  Obach</span>  . </span><span class="cited-content_cbyCitation_article-title">Late-Stage Microsomal Oxidation Reduces Drug–Drug Interaction and Identifies Phosphodiesterase 2A Inhibitor PF-06815189. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (2)
                                     , 68-72. <a href="https://doi.org/10.1021/acsmedchemlett.7b00343" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00343</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00343%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DLate-Stage%252BMicrosomal%252BOxidation%252BReduces%252BDrug%2525E2%252580%252593Drug%252BInteraction%252Band%252BIdentifies%252BPhosphodiesterase%252B2A%252BInhibitor%252BPF-06815189%26aulast%3DStepan%26aufirst%3DAntonia%2BF.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D19082017%26date%3D03012018%26date%3D30012018%26date%3D08022018%26date%3D04012018%26volume%3D9%26issue%3D2%26spage%3D68%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satoshi  Mikami</span>, <span class="hlFld-ContribAuthor ">Shinji  Nakamura</span>, <span class="hlFld-ContribAuthor ">Tomoko  Ashizawa</span>, <span class="hlFld-ContribAuthor ">Izumi  Nomura</span>, <span class="hlFld-ContribAuthor ">Masanori  Kawasaki</span>, <span class="hlFld-ContribAuthor ">Shigekazu  Sasaki</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Oki</span>, <span class="hlFld-ContribAuthor ">Hironori  Kokubo</span>, <span class="hlFld-ContribAuthor ">Isaac D.  Hoffman</span>, <span class="hlFld-ContribAuthor ">Hua  Zou</span>, <span class="hlFld-ContribAuthor ">Noriko  Uchiyama</span>, <span class="hlFld-ContribAuthor ">Kosuke  Nakashima</span>, <span class="hlFld-ContribAuthor ">Naomi  Kamiguchi</span>, <span class="hlFld-ContribAuthor ">Haruka  Imada</span>, <span class="hlFld-ContribAuthor ">Noriko  Suzuki</span>, <span class="hlFld-ContribAuthor ">Hiroki  Iwashita</span>, and <span class="hlFld-ContribAuthor ">Takahiko  Taniguchi</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Clinical Candidate N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915): A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (18)
                                     , 7677-7702. <a href="https://doi.org/10.1021/acs.jmedchem.7b00807" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00807%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BClinical%252BCandidate%252BN-%252528%2525281S%252529-1-%2525283-Fluoro-4-%252528trifluoromethoxy%252529phenyl%252529-2-methoxyethyl%252529-7-methoxy-2-oxo-2%25252C3-dihydropyrido%25255B2%25252C3-b%25255Dpyrazine-4%2525281H%252529-carboxamide%252B%252528TAK-915%252529%25253A%252BA%252BHighly%252BPotent%25252C%252BSelective%25252C%252Band%252BBrain-Penetrating%252BPhosphodiesterase%252B2A%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BCognitive%252BDisorders%26aulast%3DMikami%26aufirst%3DSatoshi%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D02062017%26date%3D05092017%26date%3D28092017%26date%3D10082017%26volume%3D60%26issue%3D18%26spage%3D7677%26epage%3D7702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satoshi  Mikami</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Clinical Candidate TAK-915, a Highly Potent, Selective, and Brain Penetrating Novel Phosphodiesterase 2A Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Synthetic Organic Chemistry, Japan</span><span> <strong>2021,</strong> <em>79 </em>
                                    (6)
                                     , 581-591. <a href="https://doi.org/10.5059/yukigoseikyokaishi.79.581" title="DOI URL">https://doi.org/10.5059/yukigoseikyokaishi.79.581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5059/yukigoseikyokaishi.79.581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5059%2Fyukigoseikyokaishi.79.581%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Synthetic%2520Organic%2520Chemistry%252C%2520Japan%26atitle%3DDiscovery%252Bof%252BClinical%252BCandidate%252BTAK-915%25252C%252Ba%252BHighly%252BPotent%25252C%252BSelective%25252C%252Band%252BBrain%252BPenetrating%252BNovel%252BPhosphodiesterase%252B2A%252BInhibitor%26aulast%3DMikami%26aufirst%3DSatoshi%26date%3D2021%26volume%3D79%26issue%3D6%26spage%3D581%26epage%3D591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathalia Fonseca  Nadur</span>, <span class="hlFld-ContribAuthor ">Luciana Luiz  de Azevedo</span>, <span class="hlFld-ContribAuthor ">Lucas  Caruso</span>, <span class="hlFld-ContribAuthor ">Cedric Stephan  Graebin</span>, <span class="hlFld-ContribAuthor ">Renata Barbosa  Lacerda</span>, <span class="hlFld-ContribAuthor ">Arthur Eugen  Kümmerle</span>. </span><span class="cited-content_cbyCitation_article-title">The long and winding road of designing phosphodiesterase inhibitors for the treatment of heart failure. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 113123. <a href="https://doi.org/10.1016/j.ejmech.2020.113123" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113123%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Blong%252Band%252Bwinding%252Broad%252Bof%252Bdesigning%252Bphosphodiesterase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bheart%252Bfailure%26aulast%3DNadur%26aufirst%3DNathalia%2BFonseca%26date%3D2021%26volume%3D212%26spage%3D113123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dean  Paes</span>, <span class="hlFld-ContribAuthor ">Keqiang  Xie</span>, <span class="hlFld-ContribAuthor ">Damian G.  Wheeler</span>, <span class="hlFld-ContribAuthor ">Douglas  Zook</span>, <span class="hlFld-ContribAuthor ">Jos  Prickaerts</span>, <span class="hlFld-ContribAuthor ">Marco  Peters</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of PDE2 and PDE4 synergistically improves memory consolidation processes. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2021,</strong> <em>184 </em>, 108414. <a href="https://doi.org/10.1016/j.neuropharm.2020.108414" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2020.108414</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2020.108414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2020.108414%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DInhibition%252Bof%252BPDE2%252Band%252BPDE4%252Bsynergistically%252Bimproves%252Bmemory%252Bconsolidation%252Bprocesses%26aulast%3DPaes%26aufirst%3DDean%26date%3D2021%26volume%3D184%26spage%3D108414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eddie L  Myers</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5–6 Systems: Other Four Heteroatoms 2:2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00056-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00056-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00056-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00056-1%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5%2525E2%252580%2525936%252BSystems%25253A%252BOther%252BFour%252BHeteroatoms%252B2%25253A2%26aulast%3DMyers%26aufirst%3DEddie%2BL%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mayasah Y.  Al-Nema</span>, <span class="hlFld-ContribAuthor ">Anand  Gaurav</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphodiesterase as a Target for Cognition Enhancement in Schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (26)
                                     , 2404-2421. <a href="https://doi.org/10.2174/1568026620666200613202641" title="DOI URL">https://doi.org/10.2174/1568026620666200613202641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620666200613202641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620666200613202641%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DPhosphodiesterase%252Bas%252Ba%252BTarget%252Bfor%252BCognition%252BEnhancement%252Bin%252BSchizophrenia%26aulast%3DAl-Nema%26aufirst%3DMayasah%2BY.%26date%3D2020%26volume%3D20%26issue%3D26%26spage%3D2404%26epage%3D2421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura Elena  Hofmann</span>, <span class="hlFld-ContribAuthor ">Dagmar  Hofmann</span>, <span class="hlFld-ContribAuthor ">Lea  Prusko</span>, <span class="hlFld-ContribAuthor ">Lisa‐Marie  Altmann</span>, <span class="hlFld-ContribAuthor ">Markus R.  Heinrich</span>. </span><span class="cited-content_cbyCitation_article-title">Sequential Cleavage of Lignin Systems by Nitrogen Monoxide and Hydrazine. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (7)
                                     , 1485-1489. <a href="https://doi.org/10.1002/adsc.201901641" title="DOI URL">https://doi.org/10.1002/adsc.201901641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201901641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201901641%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DSequential%252BCleavage%252Bof%252BLignin%252BSystems%252Bby%252BNitrogen%252BMonoxide%252Band%252BHydrazine%26aulast%3DHofmann%26aufirst%3DLaura%2BElena%26date%3D2020%26volume%3D362%26issue%3D7%26spage%3D1485%26epage%3D1489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ritawidya</span>, <span class="hlFld-ContribAuthor ">Wenzel</span>, <span class="hlFld-ContribAuthor ">Teodoro</span>, <span class="hlFld-ContribAuthor ">Toussaint</span>, <span class="hlFld-ContribAuthor ">Kranz</span>, <span class="hlFld-ContribAuthor ">Deuther-Conrad</span>, <span class="hlFld-ContribAuthor ">Dukic-Stefanovic</span>, <span class="hlFld-ContribAuthor ">Ludwig</span>, <span class="hlFld-ContribAuthor ">Scheunemann</span>, <span class="hlFld-ContribAuthor ">Brust</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine- Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (22)
                                     , 4149. <a href="https://doi.org/10.3390/molecules24224149" title="DOI URL">https://doi.org/10.3390/molecules24224149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24224149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24224149%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRadiosynthesis%252Band%252BBiological%252BInvestigation%252Bof%252Ba%252BNovel%252BFluorine-18%252BLabeled%252BBenzoimidazotriazine-%252BBased%252BRadioligand%252Bfor%252Bthe%252BImaging%252Bof%252BPhosphodiesterase%252B2A%252Bwith%252BPositron%252BEmission%252BTomography%26aulast%3DRitawidya%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D22%26spage%3D4149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jole  Fiorito</span>, <span class="hlFld-ContribAuthor ">Shi-Xian  Deng</span>, <span class="hlFld-ContribAuthor ">Donald  W. Landry</span>, <span class="hlFld-ContribAuthor ">Ottavio  Arancio</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the NO/cGMP/CREB Phosphorylation Signaling Pathway in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,<a href="https://doi.org/10.5772/intechopen.81029" title="DOI URL">https://doi.org/10.5772/intechopen.81029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.81029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.81029%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252Bthe%252BNO%25252FcGMP%25252FCREB%252BPhosphorylation%252BSignaling%252BPathway%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DFiorito%26aufirst%3DJole%26date%3D2019%26date%3D2019%26pub%3DIntechOpen%26atitle%3DNeurochemical%252BBasis%252Bof%252BBrain%252BFunction%252Band%252BDysfunction%26aulast%3DHeinbockel%26aufirst%3DThomas%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Douglas  Zook</span>, <span class="hlFld-ContribAuthor ">Lindsay  Crickard</span>, <span class="hlFld-ContribAuthor ">Ali  Tabatabaei</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of phosphodiesterase (1B, 2A, 9A and 10A) inhibitors on central nervous system cyclic nucleotide levels in rats and mice. </span><span class="cited-content_cbyCitation_journal-name">Neurochemistry International</span><span> <strong>2019,</strong> <em>129 </em>, 104471. <a href="https://doi.org/10.1016/j.neuint.2019.104471" title="DOI URL">https://doi.org/10.1016/j.neuint.2019.104471</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuint.2019.104471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuint.2019.104471%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurochemistry%2520International%26atitle%3DEffect%252Bof%252Bphosphodiesterase%252B%2525281B%25252C%252B2A%25252C%252B9A%252Band%252B10A%252529%252Binhibitors%252Bon%252Bcentral%252Bnervous%252Bsystem%252Bcyclic%252Bnucleotide%252Blevels%252Bin%252Brats%252Band%252Bmice%26aulast%3DChen%26aufirst%3DJie%26date%3D2019%26volume%3D129%26spage%3D104471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ritawidya</span>, <span class="hlFld-ContribAuthor ">Ludwig</span>, <span class="hlFld-ContribAuthor ">Briel</span>, <span class="hlFld-ContribAuthor ">Brust</span>, <span class="hlFld-ContribAuthor ">Scheunemann</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and In Vitro Evaluation of 8-Pyridinyl-Substituted Benzo[e]imidazo[2,1-c][1,2,4]triazines as Phosphodiesterase 2A Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (15)
                                     , 2791. <a href="https://doi.org/10.3390/molecules24152791" title="DOI URL">https://doi.org/10.3390/molecules24152791</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24152791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24152791%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BIn%252BVitro%252BEvaluation%252Bof%252B8-Pyridinyl-Substituted%252BBenzo%25255Be%25255Dimidazo%25255B2%25252C1-c%25255D%25255B1%25252C2%25252C4%25255Dtriazines%252Bas%252BPhosphodiesterase%252B2A%252BInhibitors%26aulast%3DRitawidya%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D15%26spage%3D2791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P.  Muthuraja</span>, <span class="hlFld-ContribAuthor ">V.  Veeramani</span>, <span class="hlFld-ContribAuthor ">S.  Prakash</span>, <span class="hlFld-ContribAuthor ">M.  Himesh</span>, <span class="hlFld-ContribAuthor ">U.  Venkatasubramanian</span>, <span class="hlFld-ContribAuthor ">P.  Manisankar</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationship of pyrazolo pyrimidine derivatives as inhibitors of mitotic kinesin Eg5 and anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>, 493-504. <a href="https://doi.org/10.1016/j.bioorg.2018.12.014" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.12.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.12.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DStructure-activity%252Brelationship%252Bof%252Bpyrazolo%252Bpyrimidine%252Bderivatives%252Bas%252Binhibitors%252Bof%252Bmitotic%252Bkinesin%252BEg5%252Band%252Banticancer%252Bagents%26aulast%3DMuthuraja%26aufirst%3DP.%26date%3D2019%26volume%3D84%26spage%3D493%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piyoosh  Sharma</span>, <span class="hlFld-ContribAuthor ">Pavan  Srivastava</span>, <span class="hlFld-ContribAuthor ">Ankit  Seth</span>, <span class="hlFld-ContribAuthor ">Prabhash Nath  Tripathi</span>, <span class="hlFld-ContribAuthor ">Anupam G.  Banerjee</span>, <span class="hlFld-ContribAuthor ">Sushant K.  Shrivastava</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies. </span><span class="cited-content_cbyCitation_journal-name">Progress in Neurobiology</span><span> <strong>2019,</strong> <em>174 </em>, 53-89. <a href="https://doi.org/10.1016/j.pneurobio.2018.12.006" title="DOI URL">https://doi.org/10.1016/j.pneurobio.2018.12.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pneurobio.2018.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pneurobio.2018.12.006%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Neurobiology%26atitle%3DComprehensive%252Breview%252Bof%252Bmechanisms%252Bof%252Bpathogenesis%252Binvolved%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Band%252Bpotential%252Btherapeutic%252Bstrategies%26aulast%3DSharma%26aufirst%3DPiyoosh%26date%3D2019%26volume%3D174%26spage%3D53%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher E.  Keefer</span>, <span class="hlFld-ContribAuthor ">George  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">The use of matched molecular series networks for cross target structure activity relationship translation and potency prediction. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (11)
                                     , 2067-2078. <a href="https://doi.org/10.1039/C7MD00465F" title="DOI URL">https://doi.org/10.1039/C7MD00465F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00465F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00465F%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DThe%252Buse%252Bof%252Bmatched%252Bmolecular%252Bseries%252Bnetworks%252Bfor%252Bcross%252Btarget%252Bstructure%252Bactivity%252Brelationship%252Btranslation%252Band%252Bpotency%252Bprediction%26aulast%3DKeefer%26aufirst%3DChristopher%2BE.%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D11%26spage%3D2067%26epage%3D2078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0049.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0049.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0001.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray structure of <b>1</b> bound to PDE2A cyclic nucleotide binding site (hydrogen bond distances in Å). Polar hydrogen atoms used in in silico docking calculations have been indicated in their modeled positions in this and all other figures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0002.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) X-ray crystal structure of <b>3</b> bound to PDE2A cyclic nucleotide binding site (hydrogen bond distances in Å). (b) X-ray crystal structure of <b>4</b> bound to PDE2A cyclic nucleotide binding site (hydrogen bond distances in Å). (c) Overlap of PDE2A X-ray crystal structures of <b>3</b> (cyan) and <b>1</b> (blue). (d) Overlap of PDE2A X-ray crystal structures of <b>4</b> (yellow) and <b>1</b> (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0015.jpeg" id="rightTab-GRAPHIC-d50e988-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to Pyrazolo[3,4-<i>d</i>]pyrimidine Targets of General Structure <b>13</b> with Key Diversity Points Highlighted in Green<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) NaH, THF, acid chloride, 76%; (b) Me<sub>2</sub>SO<sub>4</sub>, NaHCO<sub>3</sub>, dioxane, water, 56%; (c) MeNHNH<sub>2</sub>, EtOH, 35%; (d) H<sub>2</sub>SO<sub>4</sub>, 68%; (e) HCO<sub>2</sub>H, 71%; (f) POCl<sub>3</sub>, crude; (g) R′R″NH, K<sub>2</sub>CO<sub>3</sub>, THF, H<sub>2</sub>O (75% for <b>2</b>).</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0016.jpeg" id="rightTab-GRAPHIC-d50e1094-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route to [1,2,4]Triazolo[4,3-<i>a</i>]pyrazine Targets of General Structure <b>3</b> with Key Diversity Points Highlighted in Green<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) KOtBu, CH<sub>2</sub>Cl<sub>2</sub>; (b) NH<sub>2</sub>NH<sub>2</sub>, EtOH; (c) (i) <b>17</b> + <b>18</b>, ClCH<sub>2</sub>CH<sub>2</sub>Cl, (ii) (diacetoxy)iodobenzene.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0017.jpeg" id="rightTab-GRAPHIC-d50e1160-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. One-Step Synthetic Scheme to Vary Vector Headed towards Induced Pocket<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (i) <b>20</b> + <b>18</b>, ClCH<sub>2</sub>CH<sub>2</sub>Cl; (ii) (diacetoxy)iodobenzene.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0003.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Modeled pose of <b>22</b> (cyan) overlaid with <b>1</b> (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0018.jpeg" id="rightTab-GRAPHIC-d50e1291-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Parallel Synthesis Route to Introduce Different Ether Substituents and Substituted Pyrazoles Using Methods of <a class="ref internalNav" href="#sch3" aria-label="Scheme 2">Scheme 2</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) KOtBu, CH<sub>2</sub>Cl<sub>2</sub>; (b) NH<sub>2</sub>NH<sub>2</sub>, EtOH; (c) (i) <b>17</b> + <b>18</b>, ClCH<sub>2</sub>CH<sub>2</sub>Cl; (ii) (diacetoxy)iodobenzene.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0019.jpeg" id="rightTab-GRAPHIC-d50e1364-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) ArB(OH)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DMF; (b) NIS, MeCN; (c) Pd(OAc)<sub>2</sub>, dppf, CO, TEA, SiHEt<sub>3</sub>; (d) 2-hydrazinyl-6-propoxypyrazine <b>17a</b>, EtOH, (diacetoxyiodo)benzene, EtOH.</p></p></figure><figure data-id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0020.jpeg" id="rightTab-GRAPHIC-d50e1400-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Resynthesis Route for Key Library Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (i) <b>28</b> + <b>18</b>, ClCH<sub>2</sub>CH<sub>2</sub>Cl; (ii) (diacetoxy)iodobenzene; (b) ROH, NaH, THF.</p></p></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0004.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) X-ray crystal structure of <b>39</b> bound to PDE2A. (b) Overlap of <b>1</b> and <b>39</b> in PDE2A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0005.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Truncated systems used to calculate dihedral angles in ground state.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0006.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Overlap of <b>4</b> (yellow) and <b>39</b> (gray) in PDE2A. (b) Merging <b>4</b> and <b>39</b> to yield a proposed hybrid series <b>43</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0021.jpeg" id="rightTab-GRAPHIC-d50e1852-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, NaHCO<sub>3</sub>, DME, H<sub>2</sub>O; (b) DMF, POCl<sub>3</sub>; (c) (i) <b>48</b>, LDA, THF, (ii) <b>47</b>; (d) Dess–Martin periodinane; (e) HNRR′, MeCN; (f) MeNHNH<sub>2</sub>, pyridine.</p></p></figure><figure data-id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0007.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. X-ray crystal structure of <b>56</b> bound to PDE2A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0022.jpeg" id="rightTab-GRAPHIC-d50e2101-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthetic Route to Heteroaryl Substituted Pyrazole Analogues <b>67</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Azetidine, DIPEA, CHCl<sub>3</sub>, 64%; (b) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,2-DME, H<sub>2</sub>O; (c) NIS, AcOH; (d) <i>n</i>-butyl lithium or <i>I</i>-PrMgCl, THF; (e) Dess–Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>; (f) NH<sub>2</sub>NHMe, pyridine.</p></p></figure><figure data-id="fig8" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0008.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Activity of <b>71</b> in a kinase selectivity panel at a concentration of 10 μM (Invitrogen).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0009.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Activity of <b>71</b> in a selectivity panel at a concentration of 10 μM (CEREP).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch10" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0023.jpeg" id="rightTab-GRAPHIC-d50e2616-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of <i>N</i>-1 CT<sub>3</sub> Radioligand <b>78</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) NH<sub>2</sub>NH<sub>2</sub>, THF, 56%; (b) NaH, THF, CT<sub>3</sub>I, HPLC purification.</p></p></figure><figure data-id="fig10" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0010.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Saturation binding assay data in rat, dog, and monkey striatal tissue using <b>78</b> as radioligand.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0011.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Mouse <i>C</i><sub>bu</sub> of <b>71</b> plotted against brain cGMP levels in different brain regions. cGMP = cyclic guanosine monophosphate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0012.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Effects of <b>71</b> on ketamine-disrupted working memory in LE rats in radial arm maze. doses of <b>71</b> are in mg/kg. Ket = ketamine; SEM = standard error of the mean; Veh = vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0013.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Timecourse of <b>71</b> (0.3 mg/kg, IV) effects on MK-801-induced changes in low frequency cortical oscillation activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/medium/jm-2017-00397j_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0014.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Rat exposure (0.3 mg/kg, IV) of <b>71</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00397/20170707/images/large/jm-2017-00397j_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00397&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i165">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 36 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><div class="note"><p class="first last">For a recent review of PDE10A inhibitors, see:</p></div><span class="NLM_contrib-group">Chappie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span> </span><span class="NLM_article-title">Current Landscape of Phosphodiesterase 10A (PDE10A) Inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7299</span><span class="NLM_x">–</span> <span class="NLM_lpage">7331</span><span class="refDoi"> DOI: 10.1021/jm3004976</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3004976" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2gsbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7299-7331&author=T.+A.+Chappieauthor=C.+J.+Helalauthor=X.+Hou&title=Current+Landscape+of+Phosphodiesterase+10A+%28PDE10A%29+Inhibition&doi=10.1021%2Fjm3004976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Current Landscape of Phosphodiesterase 10A (PDE10A) Inhibition</span></div><div class="casAuthors">Chappie, Thomas A.; Helal, Christopher J.; Hou, Xinjun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7299-7331</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  No abstr. required for Perspectives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolfNGPFFnnOrVg90H21EOLACvtfcHk0lhU23ZA-GrTTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2gsbrF&md5=b50361a522ec669cad0a65b2d33d5dfb</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm3004976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3004976%26sid%3Dliteratum%253Aachs%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26atitle%3DCurrent%2520Landscape%2520of%2520Phosphodiesterase%252010A%2520%2528PDE10A%2529%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7299%26epage%3D7331%26doi%3D10.1021%2Fjm3004976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harms, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx-LaFrance, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suiciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span> </span><span class="NLM_article-title">Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920)(I) for the Treatment of Schizophrenia</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5188</span><span class="NLM_x">–</span> <span class="NLM_lpage">5196</span><span class="refDoi"> DOI: 10.1021/jm900521k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900521k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5188-5196&author=P.+R.+Verhoestauthor=D.+S.+Chapinauthor=M.+Cormanauthor=K.+Fonsecaauthor=J.+F.+Harmsauthor=X.+Houauthor=E.+S.+Marrauthor=F.+S.+Mennitiauthor=F.+Nelsonauthor=R.+O%E2%80%99Connorauthor=J.+Panditauthor=C.+Proulx-LaFranceauthor=A.+W.+Schmidtauthor=C.+J.+Schmidtauthor=J.+A.+Suiciakauthor=S.+Liras&title=Discovery+of+a+Novel+Class+of+Phosphodiesterase+10A+Inhibitors+and+Identification+of+Clinical+Candidate+2-%5B4-%281-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl%29-phenoxymethyl%5D-quinoline+%28PF-2545920%29%28I%29+for+the+Treatment+of+Schizophrenia&doi=10.1021%2Fjm900521k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm900521k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900521k%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DCorman%26aufirst%3DM.%26aulast%3DFonseca%26aufirst%3DK.%26aulast%3DHarms%26aufirst%3DJ.%2BF.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DMarr%26aufirst%3DE.%2BS.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DProulx-LaFrance%26aufirst%3DC.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DSuiciak%26aufirst%3DJ.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520Phosphodiesterase%252010A%2520Inhibitors%2520and%2520Identification%2520of%2520Clinical%2520Candidate%25202-%255B4-%25281-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl%2529-phenoxymethyl%255D-quinoline%2520%2528PF-2545920%2529%2528I%2529%2520for%2520the%2520Treatment%2520of%2520Schizophrenia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5188%26epage%3D5196%26doi%3D10.1021%2Fjm900521k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx-Lafrance, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claffey, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuttle, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanase-Frawley, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span> </span><span class="NLM_article-title">Design and Discovery of 6-[(3<i>S</i>,4<i>S</i>)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-d]pyrimidin-4-one (PF-04447943) a Selective Brain Penetrant PDE9A Inhibitor for the Treatment of Cognitive Disorders</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9045</span><span class="NLM_x">–</span> <span class="NLM_lpage">9054</span><span class="refDoi"> DOI: 10.1021/jm3007799</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3007799" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9045-9054&author=P.+R.+Verhoestauthor=K.+R.+Fonsecaauthor=X.+Houauthor=C.+Proulx-Lafranceauthor=M.+Cormanauthor=C.+J.+Helalauthor=M.+M.+Claffeyauthor=J.+B.+Tuttleauthor=K.+J.+Coffmanauthor=S.+Liuauthor=F.+R.+Nelsonauthor=R.+J.+Kleimanauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=M.+A.+Vanase-Frawleyauthor=S.+Liras&title=Design+and+Discovery+of+6-%5B%283S%2C4S%29-4-methyl-1-%28pyrimidin-2-ylmethyl%29pyrrolidin-3-yl%5D-1-%28tetrahydro-2H-pyran-4-yl%29-1%2C5-dihydro-4H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-one+%28PF-04447943%29+a+Selective+Brain+Penetrant+PDE9A+Inhibitor+for+the+Treatment+of+Cognitive+Disorders&doi=10.1021%2Fjm3007799"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm3007799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007799%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DProulx-Lafrance%26aufirst%3DC.%26aulast%3DCorman%26aufirst%3DM.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26aulast%3DTuttle%26aufirst%3DJ.%2BB.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DVanase-Frawley%26aufirst%3DM.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DDesign%2520and%2520Discovery%2520of%25206-%255B%25283S%252C4S%2529-4-methyl-1-%2528pyrimidin-2-ylmethyl%2529pyrrolidin-3-yl%255D-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C5-dihydro-4H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2520%2528PF-04447943%2529%2520a%2520Selective%2520Brain%2520Penetrant%2520PDE9A%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Cognitive%2520Disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9045%26epage%3D9054%26doi%3D10.1021%2Fjm3007799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Claffey, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fors, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundesmann, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanase-Frawley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDougall-Murphy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span> </span><span class="NLM_article-title">Application of Structure-Based Drug Design and Parallel Chemistry to Identify Selective, Brain Penetrant, In Vivo Active Phosphodiesterase 9A Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9055</span><span class="NLM_x">–</span> <span class="NLM_lpage">9068</span><span class="refDoi"> DOI: 10.1021/jm3009635</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3009635" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVejsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9055-9068&author=M.+M.+Claffeyauthor=C.+J.+Helalauthor=P.+R.+Verhoestauthor=Z.+Kangauthor=K.+S.+Forsauthor=S.+Jungauthor=J.+Zhongauthor=M.+W.+Bundesmannauthor=X.+Houauthor=S.+Luiauthor=R.+J.+Kleimanauthor=M.+Vanase-Frawleyauthor=A.+W.+Schmidtauthor=F.+Mennitiauthor=C.+J.+Schmidtauthor=W.+E.+Hoffmanauthor=M.+Hajosauthor=L.+McDowellauthor=R.+E.+O%E2%80%99Connorauthor=M.+MacDougall-Murphyauthor=K.+R.+Fonsecaauthor=S.+L.+Beckerauthor=F.+R.+Nelsonauthor=S.+Liras&title=Application+of+Structure-Based+Drug+Design+and+Parallel+Chemistry+to+Identify+Selective%2C+Brain+Penetrant%2C+In+Vivo+Active+Phosphodiesterase+9A+Inhibitors&doi=10.1021%2Fjm3009635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Structure-Based Drug Design and Parallel Chemistry to Identify Selective, Brain Penetrant, In Vivo Active Phosphodiesterase 9A Inhibitors</span></div><div class="casAuthors">Claffey, Michelle M.; Helal, Christopher J.; Verhoest, Patrick R.; Kang, Zhijun; Bundesmann, Mark W.; Hou, Xinjun; Lui, Shenping; Kleiman, Robin J.; Vanase-Frawley, Michelle; Schmidt, Anne W.; Menniti, Frank; Schmidt, Christopher J.; Hoffman, William E.; Hajos, Mihaly; McDowell, Laura; O'Connor, Rebecca E.; MacDougall-Murphy, Mary; Fonseca, Kari R.; Becker, Stacey L.; Nelson, Frederick R.; Liras, Spiros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9055-9068</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase 9A inhibitors have shown activity in preclin. models of cognition with potential application as novel therapies for treating Alzheimer's disease.  Our clin. candidate, PF-04447943 (2), demonstrated acceptable CNS permeability in rats with modest asymmetry between central and peripheral compartments (free brain/free plasma = 0.32; CSF/free plasma = 0.19) yet had physicochem. properties outside the range assocd. with traditional CNS drugs.  To address the potential risk of restricted CNS penetration with 2 in human clin. trials, we sought to identify a preclin. candidate with no asymmetry in rat brain penetration and that could advance into development.  Merging the medicinal chem. strategies of structure-based design with parallel chem., a novel series of PDE9A inhibitors was identified that showed improved selectivity over PDE1C.  Optimization afforded preclin. candidate 19 that demonstrated free brain/free plasma ≥1 in rat and reduced microsomal clearance along with the ability to increase cyclic guanosine monophosphosphate levels in rat CSF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphK4OmJAu-pbVg90H21EOLACvtfcHk0lhRMhdZ8qXdRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVejsrvJ&md5=5e3aea9b0bfd660973c1e5fd56b6d933</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm3009635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009635%26sid%3Dliteratum%253Aachs%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DKang%26aufirst%3DZ.%26aulast%3DFors%26aufirst%3DK.%2BS.%26aulast%3DJung%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DJ.%26aulast%3DBundesmann%26aufirst%3DM.%2BW.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DLui%26aufirst%3DS.%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DMenniti%26aufirst%3DF.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DHoffman%26aufirst%3DW.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DMcDowell%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%2BE.%26aulast%3DMacDougall-Murphy%26aufirst%3DM.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DApplication%2520of%2520Structure-Based%2520Drug%2520Design%2520and%2520Parallel%2520Chemistry%2520to%2520Identify%2520Selective%252C%2520Brain%2520Penetrant%252C%2520In%2520Vivo%2520Active%2520Phosphodiesterase%25209A%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9055%26epage%3D9068%26doi%3D10.1021%2Fjm3009635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Boess, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Staay, F.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Staveren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vente, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prickaerts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blokland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, G.</span><span> </span><span class="NLM_article-title">Inhibition of Phosphodiesterase 2 Increases Neuronal cGMP, Synaptic Plasticity and Memory Performance</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1081</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2004.07.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2Fj.neuropharm.2004.07.040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1081-1092&author=F.+G.+Boessauthor=M.+Hendrixauthor=F.-J.+van+der+Staayauthor=C.+Erbauthor=R.+Schreiberauthor=W.+van+Staverenauthor=J.+de+Venteauthor=J.+Prickaertsauthor=A.+Bloklandauthor=G.+Koenig&title=Inhibition+of+Phosphodiesterase+2+Increases+Neuronal+cGMP%2C+Synaptic+Plasticity+and+Memory+Performance&doi=10.1016%2Fj.neuropharm.2004.07.040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2004.07.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2004.07.040%26sid%3Dliteratum%253Aachs%26aulast%3DBoess%26aufirst%3DF.%2BG.%26aulast%3DHendrix%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BStaay%26aufirst%3DF.-J.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DSchreiber%26aufirst%3DR.%26aulast%3Dvan%2BStaveren%26aufirst%3DW.%26aulast%3Dde%2BVente%26aufirst%3DJ.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DKoenig%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520Phosphodiesterase%25202%2520Increases%2520Neuronal%2520cGMP%252C%2520Synaptic%2520Plasticity%2520and%2520Memory%2520Performance%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D47%26spage%3D1081%26epage%3D1092%26doi%3D10.1016%2Fj.neuropharm.2004.07.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Masood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajjhussein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, C.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. M.</span><span> </span><span class="NLM_article-title">Anxiolytic Effects of Phosphodiesterase-2 Inhibitors Associated with Increased cGMP Signaling</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x">, </span> <span class="NLM_fpage">690</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span><span class="refDoi"> DOI: 10.1124/jpet.109.156729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1124%2Fjpet.109.156729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=19684253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlKnu7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=2009&pages=690-699&author=A.+Masoodauthor=Y.+Huangauthor=H.+Hajjhusseinauthor=L.+Xiaoauthor=H.+Liauthor=W.+Wangauthor=A.+Hamzaauthor=C.-G.+Zhanauthor=J.+M.+O%E2%80%99Donnell&title=Anxiolytic+Effects+of+Phosphodiesterase-2+Inhibitors+Associated+with+Increased+cGMP+Signaling&doi=10.1124%2Fjpet.109.156729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Anxiolytic effects of phosphodiesterase-2 inhibitors associated with increased cGMP signaling</span></div><div class="casAuthors">Masood, Anbrin; Huang, Ying; Hajjhussein, Hassan; Xiao, Lan; Li, Hao; Wang, Wei; Hamza, Adel; Zhan, Chang-Guo; O'Donnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">690-699</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE)-2 is a component of the nitric-oxide synthase (NOS)/guanylyl cyclase signaling pathway in the brain.  Given recent evidence that pharmacol. induced changes in NO-cGMP signaling can affect anxiety-related behaviors, the effects of the PDE2 inhibitors (2-(3,4-dimethoxybenzyl)-7-det-5-methylimidazo-[5,1-f][1,2,4]triazin-4(3H)-one) (Bay 60-7550) and 3-(8-methoxy-1-methyl-2-oxo-7-phenyl-2,3-dihydro-1H-benzo[e]-[1,4]diazepin-5-yl)benzamide (ND7001), as well as modulators of NO, were assessed on cGMP signaling in neurons and on the behavior of mice in the elevated plus-maze, hole-board, and open-field tests, well established procedures for the evaluation of anxiolytics.  Bay 60-7550 (1 μM) and ND7001 (10 μM) increased basal and N-methyl-D-aspartate- or detanonoate-stimulated cGMP in primary cultures of rat cerebral cortical neurons; Bay 60-7550, but not ND7001, also increased cAMP.  Increased cGMP signaling, either by administration of the PDE2 inhibitors Bay 60-7550 (0.5, 1, and 3 mg/kg) or ND7001 (1 mg/kg), or the NO donor detanonoate (0.5 mg/kg), antagonized the anxiogenic effects of restraint stress on behavior in the three tests.  These drugs also produced anxiolytic effects on behavior in nonstressed mice in the elevated plus-maze and hole-board tests; these effects were antagonized by the guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (20 mg/kg).  By contrast, the NOS inhibitor Nω-nitro-L-arginine Me ester (50 mg/kg), which reduces cGMP signaling, produced anxiogenic effects similar to restraint stress.  Overall, the present behavioral and neurochem. data suggest that PDE2 may be a novel pharmacol. target for the development of drugs for the treatment of anxiety disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjfkIU0E1A7LVg90H21EOLACvtfcHk0lhStpTyViq35g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlKnu7rP&md5=168305397ab25ef6b2c20ede9b287ff0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.156729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.156729%26sid%3Dliteratum%253Aachs%26aulast%3DMasood%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DHajjhussein%26aufirst%3DH.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DHamza%26aufirst%3DA.%26aulast%3DZhan%26aufirst%3DC.-G.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26atitle%3DAnxiolytic%2520Effects%2520of%2520Phosphodiesterase-2%2520Inhibitors%2520Associated%2520with%2520Increased%2520cGMP%2520Signaling%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D331%26spage%3D690%26epage%3D699%26doi%3D10.1124%2Fjpet.109.156729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="note"><p class="first last">All reported PDE2A IC<sub>50</sub> values are the geometric mean of at least three independent IC<sub>50</sub> determinations unless otherwise noted. The PDE2A3 human splice variant was used for enzyme inhibition studies. PDE1, 3–11 IC<sub>50</sub> values/% inhibition are the geometric mean of four independent assays. See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00397/suppl_file/jm7b00397_si_001.pdf" class="ext-link">Supporting Information</a> for full data tables.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand Efficiency: a Useful Metric for Lead Selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+Efficiency%3A+a+Useful+Metric+for+Lead+Selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eZi9MPmVvyOvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520Efficiency%253A%2520a%2520Useful%2520Metric%2520for%2520Lead%2520Selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span> </span><span class="NLM_article-title">Role of Physicochemical Properties and Ligand Lipophilicity Efficiency in Addressing Drug Safety Risks</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span><span class="refDoi"> DOI: 10.1016/S0065-7743(10)45023-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2FS0065-7743%2810%2945023-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=380-391&author=M.+P.+Edwardsauthor=D.+A.+Price&title=Role+of+Physicochemical+Properties+and+Ligand+Lipophilicity+Efficiency+in+Addressing+Drug+Safety+Risks&doi=10.1016%2FS0065-7743%2810%2945023-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0065-7743%2810%2945023-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-7743%252810%252945023-X%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26atitle%3DRole%2520of%2520Physicochemical%2520Properties%2520and%2520Ligand%2520Lipophilicity%2520Efficiency%2520in%2520Addressing%2520Drug%2520Safety%2520Risks%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D380%26epage%3D391%26doi%3D10.1016%2FS0065-7743%2810%2945023-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremaine, L.</span><span> </span><span class="NLM_article-title"><i>In vitro</i> and in vivo Approaches to Characterize Transporter-Mediated Disposition in Drug Discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">873</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span><span class="refDoi"> DOI: 10.1517/17460441.2014.922540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1517%2F17460441.2014.922540" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=873-890&author=B.+Fengauthor=M.+V.+Varmaauthor=C.+Costalesauthor=H.+Zhangauthor=L.+Tremaine&title=In+vitro+and+in+vivo+Approaches+to+Characterize+Transporter-Mediated+Disposition+in+Drug+Discovery&doi=10.1517%2F17460441.2014.922540"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1517%2F17460441.2014.922540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2014.922540%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DCostales%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DTremaine%26aufirst%3DL.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520Approaches%2520to%2520Characterize%2520Transporter-Mediated%2520Disposition%2520in%2520Drug%2520Discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2014%26volume%3D9%26spage%3D873%26epage%3D890%26doi%3D10.1517%2F17460441.2014.922540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Reneerkens, O. A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hage, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blokland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbusch, H. W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prickaerts, J.</span><span> </span><span class="NLM_article-title">Inhibition of Phoshodiesterase Type 2 or Type 10 Reverses Object Memory Deficits Induced by Scopolamine or MK-801</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">236</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/j.bbr.2012.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2Fj.bbr.2012.08.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=2013&pages=16-22&author=O.+A.+H.+Reneerkensauthor=K.+Ruttenauthor=E.+Bollenauthor=T.+Hageauthor=A.+Bloklandauthor=H.+W.+M.+Steinbuschauthor=J.+Prickaerts&title=Inhibition+of+Phoshodiesterase+Type+2+or+Type+10+Reverses+Object+Memory+Deficits+Induced+by+Scopolamine+or+MK-801&doi=10.1016%2Fj.bbr.2012.08.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2012.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2012.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DReneerkens%26aufirst%3DO.%2BA.%2BH.%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DBollen%26aufirst%3DE.%26aulast%3DHage%26aufirst%3DT.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DSteinbusch%26aufirst%3DH.%2BW.%2BM.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520Phoshodiesterase%2520Type%25202%2520or%2520Type%252010%2520Reverses%2520Object%2520Memory%2520Deficits%2520Induced%2520by%2520Scopolamine%2520or%2520MK-801%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2013%26volume%3D236%26spage%3D16%26epage%3D22%26doi%3D10.1016%2Fj.bbr.2012.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span> </span><span class="NLM_article-title">X-ray Crystal Structure of Phosphodiesterase 2 in Complex with a Highly Selective, Nanomolar Inhibitor Reveals a Binding-Induced Pocket Important for Selectivity</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">11708</span><span class="NLM_x">–</span> <span class="NLM_lpage">11711</span><span class="refDoi"> DOI: 10.1021/ja404449g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja404449g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=11708-11711&author=J.+Zhuauthor=Q.+Yangauthor=D.+Daiauthor=Q.+Huang&title=X-ray+Crystal+Structure+of+Phosphodiesterase+2+in+Complex+with+a+Highly+Selective%2C+Nanomolar+Inhibitor+Reveals+a+Binding-Induced+Pocket+Important+for+Selectivity&doi=10.1021%2Fja404449g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fja404449g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja404449g%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DDai%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DQ.%26atitle%3DX-ray%2520Crystal%2520Structure%2520of%2520Phosphodiesterase%25202%2520in%2520Complex%2520with%2520a%2520Highly%2520Selective%252C%2520Nanomolar%2520Inhibitor%2520Reveals%2520a%2520Binding-Induced%2520Pocket%2520Important%2520for%2520Selectivity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D11708%26epage%3D11711%26doi%3D10.1021%2Fja404449g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleo, M. D.</span><span> </span><span class="NLM_article-title">Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1345</span><span class="NLM_x">–</span> <span class="NLM_lpage">1410</span><span class="refDoi"> DOI: 10.1021/tx200168d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200168d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1345-1410&author=A.+F.+Stepanauthor=D.+P.+Walkerauthor=J.+Baumanauthor=D.+A.+Priceauthor=T.+A.+Baillieauthor=A.+S.+Kalgutkarauthor=M.+D.+Aleo&title=Structural+Alert%2FReactive+Metabolite+Concept+as+Applied+in+Medicinal+Chemistry+to+Mitigate+the+Risk+of+Idiosyncratic+Drug+Toxicity%3A+A+Perspective+Based+on+the+Critical+Examination+of+Trends+in+the+Top+200+Drugs+Marketed+in+the+United+States&doi=10.1021%2Ftx200168d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States</span></div><div class="casAuthors">Stepan, Antonia F.; Walker, Daniel P.; Bauman, Jonathan; Price, David A.; Baillie, Thomas A.; Kalgutkar, Amit S.; Aleo, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1345-1410</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Because of a preconceived notion that eliminating reactive metabolite (RM) formation with new drug candidates could mitigate the risk of idiosyncratic drug toxicity, the potential for RM formation is routinely examd. as part of lead optimization efforts in drug discovery.  Likewise, avoidance of "structural alerts" is almost a norm in drug design.  However, there is a growing concern that the perceived safety hazards assocd. with structural alerts and/or RM screening tools as standalone predictors of toxicity risks may be over exaggerated.  In addn., the multifactorial nature of idiosyncratic toxicity is now well recognized based upon observations that mechanisms other than RM formation (e.g., mitochondrial toxicity and inhibition of bile salt export pump (BSEP)) also can account for certain target organ toxicities.  Hence, fundamental questions arise such as: When is a mol. that contains a structural alert (RM pos. or neg.) a cause for concern.  Could the mol. in its parent form exert toxicity.  Can a low dose drug candidate truly mitigate metab.-dependent and -independent idiosyncratic toxicity risks.  In an effort to address these questions, we have retrospectively examd. 68 drugs (recalled or assocd. with a black box warning due to idiosyncratic toxicity) and the top 200 drugs (prescription and sales) in the United States in 2009 for trends in physiochem. characteristics, daily doses, presence of structural alerts, evidence for RM formation as well as toxicity mechanism(s) potentially mediated by parent drugs.  Collectively, our anal. revealed that a significant proportion (∼78-86%) of drugs assocd. with toxicity contained structural alerts and evidence indicating that RM formation as a causative factor for toxicity has been presented in 62-69% of these mols.  In several cases, mitochondrial toxicity and BSEP inhibition mediated by parent drugs were also noted as potential causative factors.  Most drugs were administered at daily doses exceeding several hundred milligrams.  There was no obvious link between idiosyncratic toxicity and physicochem. properties such as mol. wt., lipophilicity, etc.  Approx. half of the top 200 drugs for 2009 (prescription and sales) also contained one or more alerts in their chem. architecture, and many were found to be RM-pos.  Several instances of BSEP and mitochondrial liabilities were also noted with agents in the top 200 category.  However, with relatively few exceptions, the vast majority of these drugs are rarely assocd. with idiosyncratic toxicity, despite years of patient use.  The major differentiating factor appeared to be the daily dose; most of the drugs in the top 200 list are administered at low daily doses.  In addn., competing detoxication pathways and/or alternate nonmetabolic clearance routes provided suitable justifications for the safety records of RM-pos. drugs in the top 200 category.  Thus, while RM elimination may be a useful and pragmatic starting point in mitigating idiosyncratic toxicity risks, our anal. suggests a need for a more integrated screening paradigm for chem. hazard identification in drug discovery.  Thus, in addn. to a detailed assessment of RM formation potential (in relationship to the overall elimination mechanisms of the compd.(s)) for lead compds., effects on cellular health (e.g., cytotoxicity assays), BSEP inhibition, and mitochondrial toxicity are the recommended suite of assays to characterize compd. liabilities.  However, the prospective use of such data in compd. selection will require further validation of the cellular assays using marketed agents.  Until we gain a better understanding of the pathophysiol. mechanisms assocd. with idiosyncratic toxicities, improving pharmacokinetics and intrinsic potency as means of decreasing the dose size and the assocd. "body burden" of the parent drug and its metabolites will remain an overarching goal in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3IhczIcvVDLVg90H21EOLACvtfcHk0ljwg3kKFhgS5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D&md5=632b73f755738e49eb233bc8dca1fbcc</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Ftx200168d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200168d%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DStructural%2520Alert%252FReactive%2520Metabolite%2520Concept%2520as%2520Applied%2520in%2520Medicinal%2520Chemistry%2520to%2520Mitigate%2520the%2520Risk%2520of%2520Idiosyncratic%2520Drug%2520Toxicity%253A%2520A%2520Perspective%2520Based%2520on%2520the%2520Critical%2520Examination%2520of%2520Trends%2520in%2520the%2520Top%2520200%2520Drugs%2520Marketed%2520in%2520the%2520United%2520States%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1345%26epage%3D1410%26doi%3D10.1021%2Ftx200168d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Zhang, K. Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neiman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milburn, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollag, G.</span><span> </span><span class="NLM_article-title">A Glutamine Switch Mechanism for Nucleotide Selectivity by Phosphodiesterases</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span><span class="refDoi"> DOI: 10.1016/j.molcel.2004.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2Fj.molcel.2004.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=15260978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD2cXms1ektLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=279-286&author=K.+Y.+J.+Zhangauthor=G.+L.+Cardauthor=Y.+Suzukiauthor=D.+R.+Artisauthor=D.+Fongauthor=S.+Gilletteauthor=D.+Hsiehauthor=J.+Neimanauthor=B.+L.+Westauthor=C.+Zhangauthor=M.+V.+Milburnauthor=S.-H.+Kimauthor=J.+Schlessingerauthor=G.+Bollag&title=A+Glutamine+Switch+Mechanism+for+Nucleotide+Selectivity+by+Phosphodiesterases&doi=10.1016%2Fj.molcel.2004.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases</span></div><div class="casAuthors">Zhang, Kam Y. J.; Card, Graeme L.; Suzuki, Yoshihisa; Artis, D. Richard; Fong, Daniel; Gillette, Sam; Hsieh, Davin; Neiman, Joshua; West, Brian L.; Zhang, Chao; Milburn, Michael V.; Kim, Sung-Hou; Schlessinger, Joseph; Bollag, Gideon</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">279-286</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) comprise a family of enzymes that modulate the immune response, inflammation, and memory, among many other functions.  There are three types of PDEs: cAMP-specific, cGMP-specific, and dual-specific.  Here we describe the mechanism of nucleotide selectivity on the basis of high-resoln. co-crystal structures of the cAMP-specific PDE4B and PDE4D with AMP, the cGMP-specific PDE5A with GMP, and the apo-structure of the dual-specific PDE1B.  These structures show that an invariant glutamine functions as the key specificity determinant by a "glutamine switch" mechanism for recognizing the purine moiety in cAMP or cGMP.  The surrounding residues anchor the glutamine residue in different orientations for cAMP and for cGMP.  The PDE1B structure shows that in dual-specific PDEs a key histidine residue may enable the invariant glutamine to toggle between cAMP and cGMP.  The structural understanding of nucleotide binding enables the design of new PDE inhibitors that may treat diseases in which cyclic nucleotides play a crit. role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorRXGTDdAa1bVg90H21EOLACvtfcHk0lhWiF8eTlbkUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXms1ektLs%253D&md5=32fab6a75031a67290ec5eda2c3e080b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2004.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2004.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%2BY.%2BJ.%26aulast%3DCard%26aufirst%3DG.%2BL.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DFong%26aufirst%3DD.%26aulast%3DGillette%26aufirst%3DS.%26aulast%3DHsieh%26aufirst%3DD.%26aulast%3DNeiman%26aufirst%3DJ.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DMilburn%26aufirst%3DM.%2BV.%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DBollag%26aufirst%3DG.%26atitle%3DA%2520Glutamine%2520Switch%2520Mechanism%2520for%2520Nucleotide%2520Selectivity%2520by%2520Phosphodiesterases%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D15%26spage%3D279%26epage%3D286%26doi%3D10.1016%2Fj.molcel.2004.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Shah, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louise-May, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span> </span><span class="NLM_article-title">Chemotypes Sensitivity and Predictivity of in vivo Outcomes for Cytotoxic Assays in THLE and HepG2 Cell Lines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2753</span><span class="NLM_x">–</span> <span class="NLM_lpage">2757</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.04.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2Fj.bmcl.2014.04.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=24794102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntlOhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2753-2757&author=F.+Shahauthor=S.+Louise-Mayauthor=N.+Greene&title=Chemotypes+Sensitivity+and+Predictivity+of+in+vivo+Outcomes+for+Cytotoxic+Assays+in+THLE+and+HepG2+Cell+Lines&doi=10.1016%2Fj.bmcl.2014.04.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Chemotypes sensitivity and predictivity of in vivo outcomes for cytotoxic assays in THLE and HepG2 cell lines</span></div><div class="casAuthors">Shah, Falgun; Louise-May, Shirley; Greene, Nigel</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2753-2757</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In the present study, we demonstrate the utility of in vitro ATP depletion assays in both THLE and HepG2 cells for predicting the toxicol. outcome in Exploratory Toxicol. Studies across 446 Pfizer proprietary compds.  Our results suggest a higher likelihood of selecting suitable compds. for in vivo safety studies by using cytotoxicity assays in multiple cell-lines over a single cell line.  In addn., we demonstrate that different cell-lines have different sensitivities to compds. depending on their ionization state, i.e., acid, base or neutral.  HepG2 cells are more sensitive for basic compds., whereas THLE cells have a relatively higher sensitivity for the acidic and neutral compds.  These in vitro cytotoxicity assays when combined with physicochem. properties (c Log P >3 and topol. polar surface area (TPSA) <75 Å2), are the most effective means to prioritize compds. having a lower probability of causing adverse events in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro0b4p6N8hM7Vg90H21EOLACvtfcHk0lhWiF8eTlbkUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntlOhtbo%253D&md5=883eeb3b4ef422581ca7bd653105b7f1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.04.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.04.039%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DF.%26aulast%3DLouise-May%26aufirst%3DS.%26aulast%3DGreene%26aufirst%3DN.%26atitle%3DChemotypes%2520Sensitivity%2520and%2520Predictivity%2520of%2520in%2520vivo%2520Outcomes%2520for%2520Cytotoxic%2520Assays%2520in%2520THLE%2520and%2520HepG2%2520Cell%2520Lines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2753%26epage%3D2757%26doi%3D10.1016%2Fj.bmcl.2014.04.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, R.</span><span> </span><span class="NLM_article-title">In Vivo Site-Directed Radiotracers: Mini-Review</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">–</span> <span class="NLM_lpage">815</span><span class="refDoi"> DOI: 10.1016/j.nucmedbio.2008.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2Fj.nucmedbio.2008.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=19026942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=805-815&author=S.+Patelauthor=R.+Gibson&title=In+Vivo+Site-Directed+Radiotracers%3A+Mini-Review&doi=10.1016%2Fj.nucmedbio.2008.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo site-directed radiotracers: a mini-review</span></div><div class="casAuthors">Patel, Shil; Gibson, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">805-815</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review on the process for developing reversible, monovalent site-specific radiotracers in drug design.  It is concerned with the characteristics of radiotracers such as binding, lipophilicity, and binding specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYUEhMFA7d7bVg90H21EOLACvtfcHk0lhWiF8eTlbkUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL&md5=869985e0741d52a76cb546972097e2a8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DGibson%26aufirst%3DR.%26atitle%3DIn%2520Vivo%2520Site-Directed%2520Radiotracers%253A%2520Mini-Review%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D805%26epage%3D815%26doi%3D10.1016%2Fj.nucmedbio.2008.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chappie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaddan, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zasadny, K.</span><span> </span><span class="NLM_article-title">Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4568</span><span class="NLM_x">–</span> <span class="NLM_lpage">4579</span><span class="refDoi"> DOI: 10.1021/jm400312y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400312y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4568-4579&author=L.+Zhangauthor=A.+Villalobosauthor=E.+M.+Beckauthor=T.+Bocanauthor=T.+A.+Chappieauthor=L.+Chenauthor=S.+Grimwoodauthor=S.+D.+Heckauthor=C.+J.+Helalauthor=X.+Houauthor=J.+M.+Humphreyauthor=J.+Luauthor=M.+B.+Skaddanauthor=T.+J.+McCarthyauthor=P.+R.+Verhoestauthor=T.+T.+Wagerauthor=K.+Zasadny&title=Design+and+Selection+Parameters+to+Accelerate+the+Discovery+of+Novel+Central+Nervous+System+Positron+Emission+Tomography+%28PET%29+Ligands+and+Their+Application+in+the+Development+of+a+Novel+Phosphodiesterase+2A+PET+Ligand&doi=10.1021%2Fjm400312y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand</span></div><div class="casAuthors">Zhang, Lei; Villalobos, Anabella; Beck, Elizabeth M.; Bocan, Thomas; Chappie, Thomas A.; Chen, Laigao; Grimwood, Sarah; Heck, Steven D.; Helal, Christopher J.; Hou, Xinjun; Humphrey, John M.; Lu, Jiemin; Skaddan, Marc B.; McCarthy, Timothy J.; Verhoest, Patrick R.; Wager, Travis T.; Zasadny, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4568-4579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To accelerate the discovery of novel small mol. central nervous system (CNS) positron emission tomog. (PET) ligands, we aimed to define a property space that would facilitate ligand design and prioritization, thereby providing a higher probability of success for novel PET ligand development.  Toward this end, we built a database consisting of 62 PET ligands that have successfully reached the clinic and 15 radioligands that failed in late-stage development as neg. controls.  A systematic anal. of these ligands identified a set of preferred parameters for physicochem. properties, brain permeability, and nonspecific binding (NSB).  These preferred parameters have subsequently been applied to several programs and have led to the successful development of novel PET ligands with reduced resources and timelines.  This strategy is illustrated here by the discovery of the novel phosphodiesterase 2A (PDE2A) PET ligand 4-(3-[18F]fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine, [18F]PF-05270430 (5).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTCG9TZE0X-bVg90H21EOLACvtfcHk0lgHjRySNMIPVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D&md5=ee7ce04829d7456a632c02c331c4edfa</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm400312y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400312y%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBocan%26aufirst%3DT.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHeck%26aufirst%3DS.%2BD.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DMcCarthy%26aufirst%3DT.%2BJ.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DZasadny%26aufirst%3DK.%26atitle%3DDesign%2520and%2520Selection%2520Parameters%2520to%2520Accelerate%2520the%2520Discovery%2520of%2520Novel%2520Central%2520Nervous%2520System%2520Positron%2520Emission%2520Tomography%2520%2528PET%2529%2520Ligands%2520and%2520Their%2520Application%2520in%2520the%2520Development%2520of%2520a%2520Novel%2520Phosphodiesterase%25202A%2520PET%2520Ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4568%26epage%3D4579%26doi%3D10.1021%2Fjm400312y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Stephenson, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coskran, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelms, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamowicz, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muravnick, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, D.</span><span> </span><span class="NLM_article-title">Immunohistochemical Localization of Phosphodiesterase 2A in Multiple Mammalian Species</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">949</span><span class="refDoi"> DOI: 10.1369/jhc.2009.953471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1369%2Fjhc.2009.953471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=19506089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOgtrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2009&pages=933-949&author=D.+T.+Stephensonauthor=T.+M.+Coskranauthor=M.+B.+Wilhelmsauthor=W.+O.+Adamowiczauthor=M.+M.+O%E2%80%99Donnellauthor=K.+B.+Muravnickauthor=F.+S.+Mennitiauthor=R.+J.+Kleimanauthor=D.+Morton&title=Immunohistochemical+Localization+of+Phosphodiesterase+2A+in+Multiple+Mammalian+Species&doi=10.1369%2Fjhc.2009.953471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Immunohistochemical localization of phosphodiesterase 2A in multiple mammalian species</span></div><div class="casAuthors">Stephenson, Diane T.; Coskran, Tim M.; Wilhelms, Margaret B.; Adamowicz, Wendy O.; O'Donnell, Michele M.; Muravnick, Kathleen B.; Menniti, Frank S.; Kleiman, Robin J.; Morton, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">933-949</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) comprise a family of enzymes that regulate the levels of cyclic nucleotides, key second messengers that mediate a diverse array of functions.  PDE2A is an evolutionarily conserved cGMP-stimulated cAMP and cGMP PDE.  In the present study, the regional and cellular distribution of PDE2A in tissues of rats, mice, cynomolgus monkeys, dogs, and humans was evaluated by immunohistochem.  A polyclonal antibody directed to the C-terminal portion of PDE2A specifically detected PDE2A by Western blotting and by immunohistochem.  The pattern of PDE2A immunoreactivity (ir) was consistent across all species.  Western blot anal. demonstrated that PDE2A was most abundant in the brain relative to peripheral tissues.  PDE2A ir was heterogeneously distributed within brain and was selectively expressed in particular peripheral tissues.  In the brain, prominent immunoreactivity was apparent in components of the limbic system, including the isocortex, hippocampus, amygdala, habenula, basal ganglia, and interpeduncular nucleus.  Cytoplasmic PDE2A staining was prominent in several peripheral tissues, including the adrenal zona glomerulosa, neurons of enteric ganglia, endothelial cells in all organs, lymphocytes of spleen and lymph nodes, and pituitary.  These studies suggest that PDE2A is evolutionarily conserved across mammalian species and support the hypothesis that the enzyme plays a fundamental role in signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVQCCm4loO7Vg90H21EOLACvtfcHk0lgHjRySNMIPVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOgtrrJ&md5=ce1dfa99cc99c02f31ab8071a9e438fd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1369%2Fjhc.2009.953471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1369%252Fjhc.2009.953471%26sid%3Dliteratum%253Aachs%26aulast%3DStephenson%26aufirst%3DD.%2BT.%26aulast%3DCoskran%26aufirst%3DT.%2BM.%26aulast%3DWilhelms%26aufirst%3DM.%2BB.%26aulast%3DAdamowicz%26aufirst%3DW.%2BO.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DM.%2BM.%26aulast%3DMuravnick%26aufirst%3DK.%2BB.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DMorton%26aufirst%3DD.%26atitle%3DImmunohistochemical%2520Localization%2520of%2520Phosphodiesterase%25202A%2520in%2520Multiple%2520Mammalian%2520Species%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2009%26volume%3D57%26spage%3D933%26epage%3D949%26doi%3D10.1369%2Fjhc.2009.953471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Padovan-Neto, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammut, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakroborty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dec, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threlfell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudrakola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harms, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. R.</span><span> </span><span class="NLM_article-title">Facilitation of Corticostriatal Transmission Following Pharmacological Inhibition of Striatal Phosphodiesterase 10A: Role of Nitric Oxide-Soluble Guanylyl Cyclase-cGMP Signaling Pathways</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">5781</span><span class="NLM_x">–</span> <span class="NLM_lpage">5791</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1238-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1523%2FJNEUROSCI.1238-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=25855188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvFKqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=5781-5791&author=F.+E.+Padovan-Netoauthor=S.+Sammutauthor=S.+Chakrobortyauthor=A.+M.+Decauthor=S.+Threlfellauthor=P.+W.+Campbellauthor=V.+Mudrakolaauthor=J.+F.+Harmsauthor=C.+J.+Schmidtauthor=A.+R.+West&title=Facilitation+of+Corticostriatal+Transmission+Following+Pharmacological+Inhibition+of+Striatal+Phosphodiesterase+10A%3A+Role+of+Nitric+Oxide-Soluble+Guanylyl+Cyclase-cGMP+Signaling+Pathways&doi=10.1523%2FJNEUROSCI.1238-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways</span></div><div class="casAuthors">Padovan-Neto, Fernando E.; Sammut, Stephen; Chakroborty, Shreaya; Dec, Alexander M.; Threlfell, Sarah; Campbell, Peter W.; Mudrakola, Vishnu; Harms, John F.; Schmidt, Christopher J.; West, Anthony R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5781-5791</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The striatum contains a rich variety of cyclic nucleotide phosphodiesterases (PDEs), which play a crit. role in the regulation of cAMP and cGMP signaling.  The dual-substrate enzyme PDE10A is the most highly expressed PDE in striatal medium-sized spiny neurons (MSNs) with low micromolar affinity for both cyclic nucleotides.  Previously, we have shown that systemic and local administration of the selective PDE10A inhibitor TP-10 potently increased the responsiveness of MSNs to cortical stimulation.  However, the signaling mechanisms underlying PDE10A inhibitor-induced changes in corticostriatal transmission are only partially understood.  The current studies assessed the resp. roles of cAMP and cGMP in the above effects using sol. guanylyl cyclase (sGC) or adenylate cyclase (AC) specific inhibitors.  Cortically evoked spike activity was monitored in urethane-anesthetized rats using in vivo extracellular recordings performed proximal to a microdialysis probe during local infusion of vehicle, the selective sGC inhibitor ODQ, or the selective AC inhibitor SQ 22536.  Systemic administration of TP-10 (3.2 mg/kg) robustly increased cortically evoked spike activity in a manner that was blocked following intrastriatal infusion of ODQ (50 μm).  The effects of TP-10 on evoked activity were due to accumulation of cGMP, rather than cAMP, as the AC inhibitor SQ was without effect.  Consistent with these observations, studies in neuronal NO synthase (nNOS) knock-out (KO) mice confirmed that PDE10A operates downstream of nNOS to limit cGMP prodn. and excitatory corticostriatal transmission.  Thus, stimulation of PDE10A acts to attenuate corticostriatal transmission in a manner largely dependent on effects directed at the NO-sGC-cGMP signaling cascade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBBIU11UPbv7Vg90H21EOLACvtfcHk0li10Tae5EEOIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvFKqt7k%253D&md5=5dc33171f0b3548b195e3cb3e9591a61</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1238-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1238-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DPadovan-Neto%26aufirst%3DF.%2BE.%26aulast%3DSammut%26aufirst%3DS.%26aulast%3DChakroborty%26aufirst%3DS.%26aulast%3DDec%26aufirst%3DA.%2BM.%26aulast%3DThrelfell%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DP.%2BW.%26aulast%3DMudrakola%26aufirst%3DV.%26aulast%3DHarms%26aufirst%3DJ.%2BF.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DWest%26aufirst%3DA.%2BR.%26atitle%3DFacilitation%2520of%2520Corticostriatal%2520Transmission%2520Following%2520Pharmacological%2520Inhibition%2520of%2520Striatal%2520Phosphodiesterase%252010A%253A%2520Role%2520of%2520Nitric%2520Oxide-Soluble%2520Guanylyl%2520Cyclase-cGMP%2520Signaling%2520Pathways%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D5781%26epage%3D5791%26doi%3D10.1523%2FJNEUROSCI.1238-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Frank, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberg, M. E.</span><span> </span><span class="NLM_article-title">CREB: A Mediator of Long-Term Memory from Mollusks to Mammals</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1016/0092-8674(94)90394-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2F0092-8674%2894%2990394-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1994&pages=5-8&author=D.+A.+Frankauthor=M.+E.+Greenberg&title=CREB%3A+A+Mediator+of+Long-Term+Memory+from+Mollusks+to+Mammals&doi=10.1016%2F0092-8674%2894%2990394-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2894%2990394-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252894%252990394-8%26sid%3Dliteratum%253Aachs%26aulast%3DFrank%26aufirst%3DD.%2BA.%26aulast%3DGreenberg%26aufirst%3DM.%2BE.%26atitle%3DCREB%253A%2520A%2520Mediator%2520of%2520Long-Term%2520Memory%2520from%2520Mollusks%2520to%2520Mammals%26jtitle%3DCell%26date%3D1994%26volume%3D79%26spage%3D5%26epage%3D8%26doi%3D10.1016%2F0092-8674%2894%2990394-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Stephenson, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coskran, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span> </span><span class="NLM_article-title">The Distribution of Phosphodiesterase 2A in the Rat Brain</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2012.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2Fj.neuroscience.2012.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=23000621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1ahur7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2012&pages=145-155&author=D.+T.+Stephensonauthor=T.+M.+Coskranauthor=M.+P.+Kellyauthor=R.+J.+Kleimanauthor=D.+Mortonauthor=S.+M.+O%E2%80%99Neillauthor=C.+J.+Schmidtauthor=R.+J.+Weinbergauthor=F.+S.+Menniti&title=The+Distribution+of+Phosphodiesterase+2A+in+the+Rat+Brain&doi=10.1016%2Fj.neuroscience.2012.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The distribution of phosphodiesterase 2A in the rat brain</span></div><div class="casAuthors">Stephenson, D. T.; Coskran, T. M.; Kelly, M. P.; Kleiman, R. J.; Morton, D.; O'Neill, S. M.; Schmidt, C. J.; Weinberg, R. J.; Menniti, F. S.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">145-155</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The phosphodiesterases (PDEs) are a superfamily of enzymes that regulate spatio-temporal signaling by the intracellular second messengers cAMP and cGMP.  PDE2A is expressed at high levels in the mammalian brain.  To advance our understanding of the role of this enzyme in regulation of neuronal signaling, we here describe the distribution of PDE2A in the rat brain.  PDE2A mRNA was prominently expressed in glutamatergic pyramidal cells in cortex, and in pyramidal and dentate granule cells in the hippocampus.  Protein concd. in the axons and nerve terminals of these neurons; staining was markedly weaker in the cell bodies and proximal dendrites.  In addn., in both hippocampus and cortex, small populations of non-pyramidal cells, presumed to be interneurons, were strongly immunoreactive.  PDE2A mRNA was expressed in medium spiny neurons in neostriatum.  Little immunoreactivity was obsd. in cell bodies, whereas dense immunoreactivity was found in the axon tracts of these neurons and their terminal regions in globus pallidus and substantia nigra pars reticulata.  Immunostaining was dense in the medial habenula, but weak in other diencephalic regions.  In midbrain and hindbrain, immunostaining was restricted to discrete regions of the neuropil or clusters of cell bodies.  These results suggest that PDE2A may modulate cortical, hippocampal and striatal networks at several levels.  Preferential distribution of PDE2A into axons and terminals of the principal neurons suggests roles in regulation of axonal excitability or transmitter release.  The enzyme is also in forebrain interneurons, and in mid- and hindbrain neurons that may modulate forebrain networks and circuits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxNSYsU1HXSrVg90H21EOLACvtfcHk0li10Tae5EEOIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ahur7F&md5=3bb5ae07b9fcae2a917cc4aed4fef4a1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2012.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2012.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DStephenson%26aufirst%3DD.%2BT.%26aulast%3DCoskran%26aufirst%3DT.%2BM.%26aulast%3DKelly%26aufirst%3DM.%2BP.%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DMorton%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DS.%2BM.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DWeinberg%26aufirst%3DR.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26atitle%3DThe%2520Distribution%2520of%2520Phosphodiesterase%25202A%2520in%2520the%2520Rat%2520Brain%26jtitle%3DNeuroscience%26date%3D2012%26volume%3D226%26spage%3D145%26epage%3D155%26doi%3D10.1016%2Fj.neuroscience.2012.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Fernandez-Fernandez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbrock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroker, K. S.</span><span> </span><span class="NLM_article-title">Inhibition of PDE2A, but Not PDE9A, Modulates Presynaptic Short-Term Plasticity Measured by Paired-Pulse Facilitation in the CA1 Region of the Hippocampus</span> <span class="citation_source-journal">Synapse (Hoboken, NJ, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1002/syn.21840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1002%2Fsyn.21840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=26178667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1elu7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2015&pages=484-496&author=D.+Fernandez-Fernandezauthor=H.+Rosenbrockauthor=K.+S.+Kroker&title=Inhibition+of+PDE2A%2C+but+Not+PDE9A%2C+Modulates+Presynaptic+Short-Term+Plasticity+Measured+by+Paired-Pulse+Facilitation+in+the+CA1+Region+of+the+Hippocampus&doi=10.1002%2Fsyn.21840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus</span></div><div class="casAuthors">Fernandez-Fernandez, Diego; Rosenbrock, Holger; Kroker, Katja S.</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">484-496</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) inhibitors are currently considered promising therapeutic targets for treatment of cognitive impairment in diseases such as Schizophrenia and Alzheimer's disease.  Inhibitors of PDE2A and PDE9A have emerged as potential candidates shown to improve synaptic plasticity and memory function in animals.  However, the functional relevance of their putative different localization in the neuron is not understood.  Thus, this study aims at elucidating potential presynaptic effects of PDE2A inhibition in comparison to the inhibition of PDE9A.  For this purpose, we used paired-pulse facilitation (PPF), a model of short-term synaptic plasticity related to presynaptic function.  First, we performed a series of expts. to validate the model in acute rat hippocampal slices using several ref. substances including calcium channel blockers, glutamatergic receptor antagonists, and GPCR agonists.  Second, we analyzed the effect of PDE2A and PDE9A inhibition and their role regulating the influence that the second messengers cAMP and cGMP exert on basal transmission.  Our results show that the interplay between the adenylyl cyclase activator forskolin, the sol. guanylyl cyclase activator BAY 41-8543 and the PDE2A inhibitor PF-999 reveals a primarily presynaptic mechanism of action of PDE2A inhibition.  On the contrary, inhibition of PDE9A did not alter PPF under similar conditions.  In conclusion, these data provide new evidence supporting a role of PDE2A modulating short-term synaptic plasticity.  Moreover, this function of PDE2A is suggested to rely on an active modulation of the cAMP hydrolysis as a response to changes in cGMP levels at the presynaptic level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMx3KC2TNDKrVg90H21EOLACvtfcHk0lgVFXDTUfTjOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1elu7vI&md5=990c6e54c53f4d8a08ae91d2fbdcef83</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fsyn.21840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.21840%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez-Fernandez%26aufirst%3DD.%26aulast%3DRosenbrock%26aufirst%3DH.%26aulast%3DKroker%26aufirst%3DK.%2BS.%26atitle%3DInhibition%2520of%2520PDE2A%252C%2520but%2520Not%2520PDE9A%252C%2520Modulates%2520Presynaptic%2520Short-Term%2520Plasticity%2520Measured%2520by%2520Paired-Pulse%2520Facilitation%2520in%2520the%2520CA1%2520Region%2520of%2520the%2520Hippocampus%26jtitle%3DSynapse%2520%2528Hoboken%252C%2520NJ%252C%2520U.%2520S.%2529%26date%3D2015%26volume%3D69%26spage%3D484%26epage%3D496%26doi%3D10.1002%2Fsyn.21840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Suvarna, N. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. M.</span><span> </span><span class="NLM_article-title">Hydrolysis of <i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-Aspartate Receptor-Stimulated cAMP and cGMP by PDE4 and PDE2 Phosphodiesterases in Primary Neuronal Cultures of Rat Cerebral Cortex and Hippocampus</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span><span class="refDoi"> DOI: 10.1124/jpet.302.1.249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1124%2Fjpet.302.1.249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=12065724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD38Xlt1Sns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2002&pages=249-256&author=N.+U.+Suvarnaauthor=J.+M.+O%E2%80%99Donnell&title=Hydrolysis+of+N-Methyl-d-Aspartate+Receptor-Stimulated+cAMP+and+cGMP+by+PDE4+and+PDE2+Phosphodiesterases+in+Primary+Neuronal+Cultures+of+Rat+Cerebral+Cortex+and+Hippocampus&doi=10.1124%2Fjpet.302.1.249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus</span></div><div class="casAuthors">Suvarna, Neesha U.; O'Donnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">249-256</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Stimulation of N-methyl-D-aspartate (NMDA) receptors on neurons activates both cAMP and cGMP signaling pathways.  Expts. were carried out to det. which phosphodiesterase (PDE) families are involved in the hydrolysis of the cyclic nucleotides formed via this mechanism, using primary neuronal cultures prepd. from rat cerebral cortex and hippocampus.  The nonselective PDE inhibitor 3-isobutyl-1-methylxanthine (IBMX) potentiated the ability of NMDA to increase cAMP and cGMP.  However, among the family-selective inhibitors, only the PDE4 inhibitor rolipram enhanced the ability of NMDA to increase cAMP in the neurons.  In contrast, only the PDE2 inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) enhanced the ability of NMDA to increase cGMP.  Neither adenosine nor an adenosine deaminase inhibitor mimicked the effect of EHNA; this suggests that EHNA's inhibition of PDE2, not its effects on adenosine metab., mediates its effects on NMDA-stimulated cGMP concns.  The PDE inhibitor-augmented effects of NMDA on cAMP and cGMP formation were antagonized by 5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine maleate (MK-801), verifying NMDA receptor mediation.  In contrast, only NMDA-mediated cGMP formation was affected by altering either nitric oxide signaling or guanylyl cyclase; this suggests that NMDA-induced changes in cAMP are not secondary to altered cGMP concns.  Overall, the present findings indicate that cAMP and cGMP formed in neurons as a result of NMDA receptor stimulation are hydrolyzed by PDE4 and PDE2, resp.  Selective inhibitors of the two PDE families will differentially affect the functional consequences of activation of these two signaling pathways by NMDA receptor stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8KrZylzTUKLVg90H21EOLACvtfcHk0lgVFXDTUfTjOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xlt1Sns78%253D&md5=5b7864065cd635b4b32718baa6a726fa</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fjpet.302.1.249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.302.1.249%26sid%3Dliteratum%253Aachs%26aulast%3DSuvarna%26aufirst%3DN.%2BU.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26atitle%3DHydrolysis%2520of%2520N-Methyl-d-Aspartate%2520Receptor-Stimulated%2520cAMP%2520and%2520cGMP%2520by%2520PDE4%2520and%2520PDE2%2520Phosphodiesterases%2520in%2520Primary%2520Neuronal%2520Cultures%2520of%2520Rat%2520Cerebral%2520Cortex%2520and%2520Hippocampus%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D302%26spage%3D249%26epage%3D256%26doi%3D10.1124%2Fjpet.302.1.249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Hajjhussein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suvarna, N. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gremillion, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandler, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. M.</span><span> </span><span class="NLM_article-title">Changes in NMDA Receptor-Induced Cyclic Nucleotide Synthesis Regulate the Age-Dependent Increase in PDE4A Expression in Primary Cortical Cultures</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1149</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><span class="refDoi"> DOI: 10.1016/j.brainres.2007.02.090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2Fj.brainres.2007.02.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=17407767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvFGmu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1149&publication_year=2007&pages=58-68&author=H.+Hajjhusseinauthor=N.+U.+Suvarnaauthor=C.+Gremillionauthor=L.+J.+Chandlerauthor=J.+M.+O%E2%80%99Donnell&title=Changes+in+NMDA+Receptor-Induced+Cyclic+Nucleotide+Synthesis+Regulate+the+Age-Dependent+Increase+in+PDE4A+Expression+in+Primary+Cortical+Cultures&doi=10.1016%2Fj.brainres.2007.02.090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Changes in NMDA receptor-induced cyclic nucleotide synthesis regulate the age-dependent increase in PDE4A expression in primary cortical cultures</span></div><div class="casAuthors">Hajjhussein, Hassan; Suvarna, Neesha U.; Gremillion, Carmen; Chandler, L. Judson; O'Donnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1149</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">58-68</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">NMDA receptor-induced cAMP and cGMP are selectively hydrolyzed by PDE4 and PDE2, resp., in rat primary cerebral cortical and hippocampal cultures.  Because cAMP levels regulate the expression of PDE4 in rat primary cortical cultures, we examd. the manner in which NMDA receptor activity regulates the age-dependent increase in the expression of PDE4A obsd. in vivo and in vitro.  Inhibiting the activity of NR2B subunit with ifenprodil blocked NMDA receptor-induced cGMP synthesis and increased NMDA receptor-induced cAMP levels in a manner that reduced PDE4 activity.  Therefore, NR1/NR2B receptor-induced cGMP signaling is involved in an acute cross-talk regulation of NR1/NR2A receptor-induced cAMP levels, mediated by PDE4.  Chronic inhibition of NMDA receptor activity with MK-801 reduced PDE4A1 and PDE4A5 expression and activity in a time-dependent manner; this effect was reversed by adding the PKA activator dbr-cAMP.  Inhibiting GABA receptors with bicuculline increased NMDA receptor-induced cAMP synthesis and PDE4A expression in cultures treated between DIV 16 and DIV 21 but not in cultures treated between DIV 8 and DIV 13.  This effect was due to a high tone of NMDA receptor-induced cGMP in younger cultures, which neg. regulated the expression of PDE4A by a PKG-mediated process.  The present results are consistent with behavioral data showing that both PDE4 and PDE2 are involved in NMDA receptor-mediated memory processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrihRRUfgxxGbVg90H21EOLACvtfcHk0lgVFXDTUfTjOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvFGmu7c%253D&md5=f7da05d9846bad0e9295c7062bc2fe2c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2007.02.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2007.02.090%26sid%3Dliteratum%253Aachs%26aulast%3DHajjhussein%26aufirst%3DH.%26aulast%3DSuvarna%26aufirst%3DN.%2BU.%26aulast%3DGremillion%26aufirst%3DC.%26aulast%3DChandler%26aufirst%3DL.%2BJ.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26atitle%3DChanges%2520in%2520NMDA%2520Receptor-Induced%2520Cyclic%2520Nucleotide%2520Synthesis%2520Regulate%2520the%2520Age-Dependent%2520Increase%2520in%2520PDE4A%2520Expression%2520in%2520Primary%2520Cortical%2520Cultures%26jtitle%3DBrain%2520Res.%26date%3D2007%26volume%3D1149%26spage%3D58%26epage%3D68%26doi%3D10.1016%2Fj.brainres.2007.02.090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Roberts, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castner, S. A.</span><span> </span><span class="NLM_article-title">Prevention of Ketamine-Induced Working Memory Impairments by AMPA Potentiators in a Nonhuman Primate Model of Cognitive Dysfunction</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span><span class="refDoi"> DOI: 10.1016/j.bbr.2010.03.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2Fj.bbr.2010.03.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=20347881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFWrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2010&pages=41-48&author=B.+M.+Robertsauthor=D.+E.+Holdenauthor=C.+L.+Shafferauthor=P.+A.+Seymourauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=G.+V.+Williamsauthor=S.+A.+Castner&title=Prevention+of+Ketamine-Induced+Working+Memory+Impairments+by+AMPA+Potentiators+in+a+Nonhuman+Primate+Model+of+Cognitive+Dysfunction&doi=10.1016%2Fj.bbr.2010.03.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction</span></div><div class="casAuthors">Roberts, Brooke M.; Holden, Daniel E.; Shaffer, Christopher L.; Seymour, Patricia A.; Menniti, Frank S.; Schmidt, Christopher J.; Williams, Graham V.; Castner, Stacy A.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">212</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-48</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Working memory impairments are a core aspect of schizophrenia, yet current medicines do not address such cognitive dysfunction.  We have developed a model of these working memory deficits by acutely disrupting glutamatergic synaptic transmission by administration of the N-methyl-3-aspartate (NMDA) antagonist ketamine in the nonhuman primate.  The current studies evaluated the effect of pos. allosteric modulators ("potentiators") of the α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors on the working memory and behavioral effects of ketamine.  AMPA receptors mediate fast excitatory synaptic transmission throughout the brain and play a crit. role in the activity-dependent regulation of NMDA receptors.  We find that pos. modulation of AMPA receptors with LY451646 (0.1-1.0 mg/kg, SC) and structurally distinct PF-4778574 (0.01 mg/kg, SC) robustly ameliorates ketamine-induced working memory impairments without altering behavioral effects of acute ketamine we consider related to pos.- and neg.-like symptoms.  These results support AMPA receptor potentiators as a potential adjunctive treatment for cognitive impairment assocd. with schizophrenia (CIAS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ3Id6D1EeSrVg90H21EOLACvtfcHk0liHNlg7xBHebw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFWrsb8%253D&md5=a7e67cfd3027b0013e4ab448503219dc</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2010.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2010.03.039%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DB.%2BM.%26aulast%3DHolden%26aufirst%3DD.%2BE.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DWilliams%26aufirst%3DG.%2BV.%26aulast%3DCastner%26aufirst%3DS.%2BA.%26atitle%3DPrevention%2520of%2520Ketamine-Induced%2520Working%2520Memory%2520Impairments%2520by%2520AMPA%2520Potentiators%2520in%2520a%2520Nonhuman%2520Primate%2520Model%2520of%2520Cognitive%2520Dysfunction%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2010%26volume%3D212%26spage%3D41%26epage%3D48%26doi%3D10.1016%2Fj.bbr.2010.03.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Kawashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takita, M.</span><span> </span><span class="NLM_article-title">Cooperativity Between Hippocampal-Prefrontal Short-Term Plasticity Through Associative Long-Term Potentiation</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1109</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span><span class="refDoi"> DOI: 10.1016/j.brainres.2006.06.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2Fj.brainres.2006.06.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=16859647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVShtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1109&publication_year=2006&pages=37-44&author=H.+Kawashimaauthor=Y.+Izakiauthor=A.+A.+Graceauthor=M.+Takita&title=Cooperativity+Between+Hippocampal-Prefrontal+Short-Term+Plasticity+Through+Associative+Long-Term+Potentiation&doi=10.1016%2Fj.brainres.2006.06.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Cooperativity between hippocampal-prefrontal short-term plasticity through associative long-term potentiation</span></div><div class="casAuthors">Kawashima, Hitoshi; Izaki, Yoshinori; Grace, Anthony A.; Takita, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1109</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-44</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The hippocampal-medial prefrontal cortex (mPFC) pathway provides highly convergent input to the mPFC in rats and shows two types of short-term plasticity in terms of paired-pulse facilitation (PPF) of the field potential under urethane anesthesia.  We now report that stimulating either the dorsal or ventral subregions of the posterior hippocampus elicited PPF (by about 335 and 120%, resp.) of field potentials recorded in the mPFC at 100 ms interpulse interval.  This PPF-like interaction occurred when projections were stimulated in the ventral-dorsal order (by about 200% of the single-pulsed response), but not vice versa.  When weak long-term potentiation (LTP) of the dorsal projection was evoked simultaneously with strong LTP of the ventral projection, an associative effect was revealed (about + 55%), although the magnitudes of LTP in each projection were not correlated.  Even when the impermutable PPF-like facilitation was further enhanced (by about + 120%), the enhancement was not correlated with either form of LTP, but exhibited the interaction of changes in the dorsal PPF, rather than in the heterotopic priming effect through the ventral projection.  Moreover, this change was correlated with the assocd. LTP ratio of dorsal to ventral projection LTP (i.e., LTP associativity).  Larger increases in LTP associativity correlated with greater impermutable PPF-like facilitation; in addn., there was hardly attenuation of the response to the dorsal projection by subsequent electrolytic lesions of the ventral subregion.  These results indicate that the mPFC functionally integrates discrete sources of hippocampal information via cooperativity between short- and long-term plasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMS4E25Z8AAbVg90H21EOLACvtfcHk0liHNlg7xBHebw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVShtLg%253D&md5=812e28913413526255e35b7cbb6c8f79</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2006.06.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2006.06.034%26sid%3Dliteratum%253Aachs%26aulast%3DKawashima%26aufirst%3DH.%26aulast%3DIzaki%26aufirst%3DY.%26aulast%3DGrace%26aufirst%3DA.%2BA.%26aulast%3DTakita%26aufirst%3DM.%26atitle%3DCooperativity%2520Between%2520Hippocampal-Prefrontal%2520Short-Term%2520Plasticity%2520Through%2520Associative%2520Long-Term%2520Potentiation%26jtitle%3DBrain%2520Res.%26date%3D2006%26volume%3D1109%26spage%3D37%26epage%3D44%26doi%3D10.1016%2Fj.brainres.2006.06.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Kiss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span> </span><span class="NLM_article-title">Delta Oscillation and Short-Term Plasticity in the Rat Medial Prefrontal Cortex: Modelling NMDA Hypofunction of Schizophrenia</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1017/S1461145710000271</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1017%2FS1461145710000271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=20334724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=29-42&author=T.+Kissauthor=W.+E.+Hoffmannauthor=M.+Hajos&title=Delta+Oscillation+and+Short-Term+Plasticity+in+the+Rat+Medial+Prefrontal+Cortex%3A+Modelling+NMDA+Hypofunction+of+Schizophrenia&doi=10.1017%2FS1461145710000271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Delta oscillation and short-term plasticity in the rat medial prefrontal cortex: modelling NMDA hypofunction of schizophrenia</span></div><div class="casAuthors">Kiss, Tamas; Hoffmann, William E.; Hajos, Mihaly</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-42</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Dysfunction of the prefrontal cortex (PFC) is considered to be an important factor contributing to a decrease in cognitive performance of schizophrenia patients.  The medial PFC (mPFC) is innervated by the hippocampus/subiculum, and the subiculum-mPFC pathway is known to be involved in various cognitive processes.  Glutamate-contg. subicular axons innervate cortical pyramidal neurons and interneurons where AMPA and NMDA receptors are implicated in synaptic transmission.  In our expts., properties of subiculum-mPFC interactions were studied using pathway stimulation and local field potential (LFP) recordings of the mPFC in urethane-anesthetized rats.  Changes in paired-pulse facilitation (PPF) and LFP oscillations, effects of the NMDA receptor antagonist MK-801, and the AMPAkine LY451395 were evaluated.  Effects of disruption of the thalamo-cortical loop with local microinjection of lidocaine into the mediodorsal thalamic nucleus (MD) were also studied.  Our findings demonstrate that both systemic administration of MK-801 and local MD lidocaine microinjection produce similar changes in LFP oscillations and redn. in PPF.  Specifically, it was obsd. that MK-801 (0.05 mg/kg i.v.) and intra-thalamic lidocaine changed regular, 2 Hz delta oscillation to a less regular 0.5-1.5 Hz delta rhythm.  Concurrently, PPF in response to elec. stimulation of the subiculum was significantly attenuated.  Administration of the AMPAkine LY451395 (0.01 mg/kg i.v.) reversed the MK-801- and lidocaine-induced changes, and was itself blocked by the AMPA receptor antagonist CP-465022.  Anal. of our findings suggests a crit. role of cortical interneurons in NMDA/AMPA receptor-mediated changes in thalamo-cortical oscillations and PPF, and contributes to our understanding of the NMDA hypofunction model of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5APr_ncoDP7Vg90H21EOLACvtfcHk0ljQY7U9w2KqeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLnO&md5=5cf78907f9690c37011f8d3e39f7b110</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1017%2FS1461145710000271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145710000271%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26atitle%3DDelta%2520Oscillation%2520and%2520Short-Term%2520Plasticity%2520in%2520the%2520Rat%2520Medial%2520Prefrontal%2520Cortex%253A%2520Modelling%2520NMDA%2520Hypofunction%2520of%2520Schizophrenia%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2011%26volume%3D14%26spage%3D29%26epage%3D42%26doi%3D10.1017%2FS1461145710000271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fennell, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillman, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span> </span><span class="NLM_article-title">Mechanism for the allosteric regulation of phosphodiesterase 2A deduced from the X-ray structure of a near full-length construct</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">18225</span><span class="NLM_x">–</span> <span class="NLM_lpage">18230</span><span class="refDoi"> DOI: 10.1073/pnas.0907635106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1073%2Fpnas.0907635106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=19828435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVags7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=18225-18230&author=J.+Panditauthor=M.+D.+Formanauthor=K.+F.+Fennellauthor=K.+S.+Dillmanauthor=F.+S.+Menniti&title=Mechanism+for+the+allosteric+regulation+of+phosphodiesterase+2A+deduced+from+the+X-ray+structure+of+a+near+full-length+construct&doi=10.1073%2Fpnas.0907635106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism for the allosteric regulation of phosphodiesterase 2A deduced from the X-ray structure of a near full-length construct</span></div><div class="casAuthors">Pandit, Jayvardhan; Forman, Michael D.; Fennell, Kimberly F.; Dillman, Keith S.; Menniti, Frank S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">18225-18230, S18225/1-S18225/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We report the x-ray crystal structure of a phosphodiesterase (PDE) that includes both catalytic and regulatory domains.  PDE2A (215-900) crystd. as a dimer in which each subunit had an extended organization of regulatory GAF-A and GAF-B and catalytic domains connected by long α-helixes.  The subunits cross at the GAF-B/catalytic domain linker, and each side of the dimer contains in series the GAF-A and GAF-B of one subunit and the catalytic domain of the other subunit.  A dimer interface extends over the entire length of the mol.  The substrate binding pocket of each catalytic domain is occluded by the H-loop.  We deduced from comparisons with structures of isolated, ligand-bound catalytic subunits that the H-loop swings out to allow substrate access.  However, in dimeric PDE2A (215-900), the H-loops of the two catalytic subunits pack against each other at the dimer interface, necessitating movement of the catalytic subunits to allow for H-loop movement.  Comparison of the unliganded GAF-B of PDE2A (215-900) with previous structures of isolated, cGMP-bound GAF domains indicates that cGMP binding induces a significant shift in the GAF-B/catalytic domain linker.  We propose that cGMP binding to GAF-B causes movement, through this linker region, of the catalytic domains, such that the H-loops no longer pack at the dimer interface and are, instead, free to swing out to allow substrate access.  This increase in substrate access is proposed as the basis for PDE2A activation by cGMP and may be a general mechanism for regulation of all PDEs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh-kgJc6VX2bVg90H21EOLACvtfcHk0ljQY7U9w2KqeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVags7vO&md5=73ddfdb3ffb861674744a1fbeef7c881</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0907635106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0907635106%26sid%3Dliteratum%253Aachs%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DForman%26aufirst%3DM.%2BD.%26aulast%3DFennell%26aufirst%3DK.%2BF.%26aulast%3DDillman%26aufirst%3DK.%2BS.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26atitle%3DMechanism%2520for%2520the%2520allosteric%2520regulation%2520of%2520phosphodiesterase%25202A%2520deduced%2520from%2520the%2520X-ray%2520structure%2520of%2520a%2520near%2520full-length%2520construct%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D18225%26epage%3D18230%26doi%3D10.1073%2Fpnas.0907635106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianfrogna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harms, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx-LaFrance, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majchrzak, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siuciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span> </span><span class="NLM_article-title">Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: a New Therapeutic Approach to the Treatment of Schizophrenia</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span><span class="refDoi"> DOI: 10.1124/jpet.107.132910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1124%2Fjpet.107.132910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=18287214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsVOjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2008&pages=681-690&author=C.+J.+Schmidtauthor=D.+S.+Chapinauthor=J.+Cianfrognaauthor=M.+L.+Cormanauthor=M.+Hajosauthor=J.+F.+Harmsauthor=W.+E.+Hoffmanauthor=L.+A.+Lebelauthor=S.+A.+McCarthyauthor=F.+R.+Nelsonauthor=C.+Proulx-LaFranceauthor=M.+J.+Majchrzakauthor=A.+D.+Ramirezauthor=K.+Schmidtauthor=P.+A.+Seymourauthor=J.+A.+Siuciakauthor=F.+D.+Tingleyauthor=R.+D.+Williamsauthor=P.+R.+Verhoestauthor=F.+S.+Menniti&title=Preclinical+Characterization+of+Selective+Phosphodiesterase+10A+Inhibitors%3A+a+New+Therapeutic+Approach+to+the+Treatment+of+Schizophrenia&doi=10.1124%2Fjpet.107.132910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia</span></div><div class="casAuthors">Schmidt, C. J.; Chapin, D. S.; Cianfrogna, J.; Corman, M. L.; Hajos, M.; Harms, J. F.; Hoffman, W. E.; Lebel, L. A.; McCarthy, S. A.; Nelson, F. R.; Proulx-LaFrance, C.; Majchrzak, M. J.; Ramirez, A. D.; Schmidt, K.; Seymour, P. A.; Siuciak, J. A.; Tingley, F. D., III; Williams, R. D.; Verhoest, P. R.; Menniti, F. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">681-690</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We have recently proposed the hypothesis that inhibition of the cyclic nucleotide phosphodiesterase (PDE) 10A may represent a new pharmacol. approach to the treatment of schizophrenia.  PDE10A is highly expressed in the medium spiny neurons of the mammalian striatum, where the enzyme is hypothesized to regulate both cAMP and cGMP signaling cascades to impact early signal processing in the corticostriatothalamic circuit.  Our current understanding of the physiol. role of PDE10A and the therapeutic utility of PDE10A inhibitors derives in part from studies with papaverine, the only pharmacol. tool for this target extensively profiled to date.  However, this agent has significant limitations in this regard, namely, relatively poor potency and selectivity and a very short exposure half-life after systemic administration.  In the present report, we describe the discovery of a new class of PDE10A inhibitors exemplified by TP-10 (2-{4-[-pyridin-4-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazol-3-yl]-phenoxymethyl}-quinoline succinic acid), an agent with greatly improved potency, selectivity, and pharmaceutical properties.  These new pharmacol. tools enabled studies that provide further evidence that inhibition of PDE10A represents an important new target for the treatment of schizophrenia and related disorders of basal ganglia function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFUgwm6HoBH7Vg90H21EOLACvtfcHk0ljQY7U9w2KqeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsVOjtL8%253D&md5=8016c0ef88433e2c0bba1abc7473fa8b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.132910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.132910%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DCorman%26aufirst%3DM.%2BL.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DHarms%26aufirst%3DJ.%2BF.%26aulast%3DHoffman%26aufirst%3DW.%2BE.%26aulast%3DLebel%26aufirst%3DL.%2BA.%26aulast%3DMcCarthy%26aufirst%3DS.%2BA.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DProulx-LaFrance%26aufirst%3DC.%26aulast%3DMajchrzak%26aufirst%3DM.%2BJ.%26aulast%3DRamirez%26aufirst%3DA.%2BD.%26aulast%3DSchmidt%26aufirst%3DK.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DSiuciak%26aufirst%3DJ.%2BA.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DWilliams%26aufirst%3DR.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26atitle%3DPreclinical%2520Characterization%2520of%2520Selective%2520Phosphodiesterase%252010A%2520Inhibitors%253A%2520a%2520New%2520Therapeutic%2520Approach%2520to%2520the%2520Treatment%2520of%2520Schizophrenia%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D325%26spage%3D681%26epage%3D690%26doi%3D10.1124%2Fjpet.107.132910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Grimme, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antony, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrlich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieg, H.</span><span> </span><span class="NLM_article-title">A Consistent and Accurate Ab Initio Parametrization of Density Functional Dispersion Correction (DFT-D) for the 94 Elements H-Pu</span> <span class="citation_source-journal">J. Chem. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">154104</span><span class="refDoi"> DOI: 10.1063/1.3382344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1063%2F1.3382344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=20423165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVyks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=154104&author=S.+Grimmeauthor=J.+Antonyauthor=S.+Ehrlichauthor=H.+Krieg&title=A+Consistent+and+Accurate+Ab+Initio+Parametrization+of+Density+Functional+Dispersion+Correction+%28DFT-D%29+for+the+94+Elements+H-Pu&doi=10.1063%2F1.3382344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu</span></div><div class="casAuthors">Grimme, Stefan; Antony, Jens; Ehrlich, Stephan; Krieg, Helge</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">154104/1-154104/19</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">The method of dispersion correction as an add-on to std. Kohn-Sham d. functional theory (DFT-D) has been refined regarding higher accuracy, broader range of applicability, and less empiricism.  The main new ingredients are atom-pairwise specific dispersion coeffs. and cutoff radii that are both computed from first principles.  The coeffs. for new eighth-order dispersion terms are computed using established recursion relations.  System (geometry) dependent information is used for the first time in a DFT-D type approach by employing the new concept of fractional coordination nos. (CN).  They are used to interpolate between dispersion coeffs. of atoms in different chem. environments.  The method only requires adjustment of two global parameters for each d. functional, is asymptotically exact for a gas of weakly interacting neutral atoms, and easily allows the computation of at. forces.  Three-body nonadditivity terms are considered.  The method has been assessed on std. benchmark sets for inter- and intramol. noncovalent interactions with a particular emphasis on a consistent description of light and heavy element systems.  The mean abs. deviations for the S22 benchmark set of noncovalent interactions for 11 std. d. functionals decrease by 15%-40% compared to the previous (already accurate) DFT-D version.  Spectacular improvements are found for a tripeptide-folding model and all tested metallic systems.  The rectification of the long-range behavior and the use of more accurate C6 coeffs. also lead to a much better description of large (infinite) systems as shown for graphene sheets and the adsorption of benzene on an Ag(111) surface.  For graphene it is found that the inclusion of three-body terms substantially (by about 10%) weakens the interlayer binding.  We propose the revised DFT-D method as a general tool for the computation of the dispersion energy in mols. and solids of any kind with DFT and related (low-cost) electronic structure methods for large systems.  (c) 2010 American Institute of Physics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxTowaG814d7Vg90H21EOLACvtfcHk0ljaZr1FjB8ABw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVyks7o%253D&md5=2bca89d904579d5565537a0820dc2ae8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1063%2F1.3382344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.3382344%26sid%3Dliteratum%253Aachs%26aulast%3DGrimme%26aufirst%3DS.%26aulast%3DAntony%26aufirst%3DJ.%26aulast%3DEhrlich%26aufirst%3DS.%26aulast%3DKrieg%26aufirst%3DH.%26atitle%3DA%2520Consistent%2520and%2520Accurate%2520Ab%2520Initio%2520Parametrization%2520of%2520Density%2520Functional%2520Dispersion%2520Correction%2520%2528DFT-D%2529%2520for%2520the%252094%2520Elements%2520H-Pu%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D2010%26volume%3D132%26spage%3D154104%26doi%3D10.1063%2F1.3382344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truhlar, D. G.</span><span> </span><span class="NLM_article-title">The M06 Suite of Density Functionals for Main Group Thermochemistry, Thermochemical Kinetics, Noncovalent Interactions, Excited States, and Transition Elements: Two New Functionals and Systematic Testing of Four M06-Class Functionals and 12 Other Functionals</span> <span class="citation_source-journal">Theor. Chem. Acc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span><span class="refDoi"> DOI: 10.1007/s00214-007-0310-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1007%2Fs00214-007-0310-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFyltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2008&pages=215-241&author=Y.+Zhaoauthor=D.+G.+Truhlar&title=The+M06+Suite+of+Density+Functionals+for+Main+Group+Thermochemistry%2C+Thermochemical+Kinetics%2C+Noncovalent+Interactions%2C+Excited+States%2C+and+Transition+Elements%3A+Two+New+Functionals+and+Systematic+Testing+of+Four+M06-Class+Functionals+and+12+Other+Functionals&doi=10.1007%2Fs00214-007-0310-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other functionals</span></div><div class="casAuthors">Zhao, Yan; Truhlar, Donald G.</div><div class="citationInfo"><span class="NLM_cas:title">Theoretical Chemistry Accounts</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">215-241</span>CODEN:
                <span class="NLM_cas:coden">TCACFW</span>;
        ISSN:<span class="NLM_cas:issn">1432-881X</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">We present two new hybrid meta exchange-correlation functionals, called M06 and M06-2X.  The M06 functional is parametrized including both transition metals and nonmetals, whereas the M06-2X functional is a high-nonlocality functional with double the amt. of nonlocal exchange (2X), and it is parametrized only for nonmetals.  The functionals, along with the previously published M06-L local functional and the M06-HF full-Hartree-Fock functionals, constitute the M06 suite of complementary functionals.  We assess these four functionals by comparing their performance to that of 12 other functionals and Hartree-Fock theory for 403 energetic data in 29 diverse databases, including ten databases for thermochem., four databases for kinetics, eight databases for noncovalent interactions, three databases for transition metal bonding, one database for metal atom excitation energies, and three databases for mol. excitation energies.  We also illustrate the performance of these 17 methods for three databases contg. 40 bond lengths and for databases contg. 38 vibrational frequencies and 15 vibrational zero point energies.  We recommend the M06-2X functional for applications involving main-group thermochem., kinetics, noncovalent interactions, and electronic excitation energies to valence and Rydberg states.  We recommend the M06 functional for application in organometallic and inorganometallic chem. and for noncovalent interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPJNWFt06psLVg90H21EOLACvtfcHk0ljaZr1FjB8ABw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFyltbY%253D&md5=c31d6f319d7c7a45aa9b716220e4a422</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs00214-007-0310-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00214-007-0310-x%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DTruhlar%26aufirst%3DD.%2BG.%26atitle%3DThe%2520M06%2520Suite%2520of%2520Density%2520Functionals%2520for%2520Main%2520Group%2520Thermochemistry%252C%2520Thermochemical%2520Kinetics%252C%2520Noncovalent%2520Interactions%252C%2520Excited%2520States%252C%2520and%2520Transition%2520Elements%253A%2520Two%2520New%2520Functionals%2520and%2520Systematic%2520Testing%2520of%2520Four%2520M06-Class%2520Functionals%2520and%252012%2520Other%2520Functionals%26jtitle%3DTheor.%2520Chem.%2520Acc.%26date%3D2008%26volume%3D120%26spage%3D215%26epage%3D241%26doi%3D10.1007%2Fs00214-007-0310-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Hawkins, P. C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skillman, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, A.</span><span> </span><span class="NLM_article-title">Comparison of Shape-Matching and Docking as Virtual Screening Tools</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1021/jm0603365</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0603365" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlansb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=74-82&author=P.+C.+D.+Hawkinsauthor=A.+G.+Skillmanauthor=A.+Nicholls&title=Comparison+of+Shape-Matching+and+Docking+as+Virtual+Screening+Tools&doi=10.1021%2Fjm0603365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Shape-Matching and Docking as Virtual Screening Tools</span></div><div class="casAuthors">Hawkins, Paul C. D.; Skillman, A. Geoffrey; Nicholls, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-82</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ligand docking is a widely used approach in virtual screening.  In recent years a large no. of publications have appeared in which docking tools are compared and evaluated for their effectiveness in virtual screening against a wide variety of protein targets.  These studies have shown that the effectiveness of docking in virtual screening is highly variable due to a large no. of possible confounding factors.  Another class of method that has shown promise in virtual screening is the shape-based, ligand-centric approach.  Several direct comparisons of docking with the shape-based tool ROCS have been conducted using data sets from some of these recent docking publications.  The results show that a shape-based, ligand-centric approach is more consistent than, and often superior to, the protein-centric approach taken by docking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe0IKOly7zibVg90H21EOLACvtfcHk0ljaZr1FjB8ABw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlansb%252FF&md5=6f97f5c0cc092b4e225f7c2656c1bcf6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm0603365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603365%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DP.%2BC.%2BD.%26aulast%3DSkillman%26aufirst%3DA.%2BG.%26aulast%3DNicholls%26aufirst%3DA.%26atitle%3DComparison%2520of%2520Shape-Matching%2520and%2520Docking%2520as%2520Virtual%2520Screening%2520Tools%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D74%26epage%3D82%26doi%3D10.1021%2Fjm0603365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Otwinowski, Z.; Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray Diffraction Data Collected in Oscillation Mode</span>.  <span class="citation_source-book">Methods in Enzymology</span>; <span class="NLM_series">Macromolecular Crystallography, Part A</span>; <span class="NLM_contrib-group">Carter, C. W.,  Jr.; Sweet, R. M.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=307-326&author=Z.+Otwinowski&author=W.+Minorauthor=C.+W.+Carter&author=R.+M.+Sweet&title=Methods+in+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26atitle%3DProcessing%2520of%2520X-ray%2520Diffraction%2520Data%2520Collected%2520in%2520Oscillation%2520Mode%26btitle%3DMethods%2520in%2520Enzymology%26aulast%3DCarter%26aufirst%3DC.%2BW.%26pub%3DAcademic%2520Press%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Collaborative Computational Project, Number 4</span><span> </span><span class="NLM_article-title">The CCP4 Suite: Programs for Protein Crystallography</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">D50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span><span class="refDoi"> DOI: 10.1107/S0907444994003112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D50&publication_year=1994&pages=760-763&author=Collaborative+Computational+Project%2C+Number+4&title=The+CCP4+Suite%3A+Programs+for+Protein+Crystallography&doi=10.1107%2FS0907444994003112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DThe%2520CCP4%2520Suite%253A%2520Programs%2520for%2520Protein%2520Crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3DD50%26spage%3D760%26epage%3D763%26doi%3D10.1107%2FS0907444994003112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of Macromolecular Structures by the Maximum-Likelihood Method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">D53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+Macromolecular+Structures+by+the+Maximum-Likelihood+Method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0liltdPnfRb4-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520Macromolecular%2520Structures%2520by%2520the%2520Maximum-Likelihood%2520Method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3DD53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit35"><span>Software: <span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span>BUSTER, <span class="NLM_edition">2.11.5</span>; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ITU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ITU','PDB','3ITU'); return false;">PDB: 3ITU</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i152"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00397">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_62262"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00397">10.1021/acs.jmedchem.7b00397</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">PDE2A protein X-ray crystal structure data collection and refinement statistics; BAY-60-7550 (<b>1</b>) brain exposure in mice; derivation of estimated human dose equation; number of replicates and standard error of the mean (SEM) for PDE2A IC<sub>50</sub> data and compound purity by HPLC; impact of pyrazole methylation on dihedral angles; kinase inhibition data for <b>71</b>; CEREP selectivity data for <b>71</b> dosed at 10 μM; PDE selectivity data for <b>1</b>, <b>2</b>, <b>3</b>, <b>4</b>, <b>39</b>, <b>52</b>, and <b>71</b>; rat IV pharmacokinetic data for <b>71</b> from <a class="ref internalNav" href="#fig14">Figure 14</a>; PK/PD modeling of <b>71</b> in MK-801 disruption of cortical delta oscillation in rat (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00397/suppl_file/jm7b00397_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00397/suppl_file/jm7b00397_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00397/suppl_file/jm7b00397_si_001.pdf">jm7b00397_si_001.pdf (0.99 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00397/suppl_file/jm7b00397_si_002.csv">jm7b00397_si_002.csv (2.49 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00397%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-13%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00397" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679948bd7df22458","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
